recursive_content,recrusive_source,content,source
,,"2023  
Annual  
Report","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 0}"
,,"FINANCIAL HIGHLIGHTS (UNAUDITED) 
Amounts in billions, except per share amounts
2023 2022 2021 2020 2019
Net Sales $82.0 $80.2 $76.1 $71.0 $67.7
Operating Income $18.1 $17.8 $18.0 $15.7 $5.5
Net Earnings  
Attributable to P&G$14.7 $14.7 $14.3 $13.0 $3.9
Net Earnings Margin 18.0% 18.4% 18.9% 18.5% 5.9%
Diluted Net Earnings  per Common Share 
1$5.90 $5.81 $5.50 $4.96 $1.43
Core Earnings  per Share 
2$5.90 $5.81 $5.66 $5.12 $4.52
Operating Cash Flow $16.8 $16.7 $18.4 $17.4 $15.2","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 1}"
,,"Operating Cash Flow $16.8 $16.7 $18.4 $17.4 $15.2
Dividends per  Common Share$3.68 $3.52 $3.24 $3.03 $2.902023 NET SALES BY BUSINESS SEGMENT 3
  
  
  
 
 
2
023 NET SALES BY GEOGRAPHIC REGION
 
 
 
 
 
(1) Diluted net earnings per common share are calculated based on net earnings attributable to Procter & Gamble.
(2)  Core EPS is a measure of the Company’s diluted net earnings per common share adjusted for certain items not viewed as part of our sustainable results.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 1}"
,,"Please see page 70 of the Annual Report for detail on the reconciling items.
(3) These results exclude net sales in Corporate.
(4) North America includes the United States, Canada and Puerto Rico.
VARIOUS STATEMENTS IN THIS ANNUAL REPORT , including estimates, projections, objectives and expected results, are “forward-looking statements”  
within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 1}"
,,"of 1934 and are generally identified by the words “believe,” “expect,” “anticipate,” “intend,” “opportunity,” “plan,” “project,” “will,” “should,” “could,” “would,” “likely” 
and similar expressions. Forward-looking statements are based on current assumptions that are subject to risks and uncertainties that may cause actual results  
to differ materially from the forward-looking statements, including the risks and uncertainties discussed in Item 1A – Risk Factors of the Form 10-K included","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 1}"
,,"in this Annual Report. Such forward-looking statements speak only as of the date they are made, and we undertake no obligation to update or revise publicly  
any forward-looking statements, except as required by law.
Brand names referenced in this Annual Report are trademarks of The Procter & Gamble Company or one of its subsidiaries. All other brand names are trademarks  
of their respective owners.
FISCAL YEAR 2023 BY THE NUMBERS
$82.0B
N et Sales 
(up 2%)O
rganic Sales  
GrowthCore EPS 
Growth","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 1}"
,,"N et Sales 
(up 2%)O
rganic Sales  
GrowthCore EPS 
Growth
$16.8B 95%
O perating  
Cash FlowAdjusted Free Cash 
Flow Productivity7%2%","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 1}"
,,"Dear  
Shareowners,
Your Company delivered another strong year  
in fiscal 2023 with robust top-line growth across 
categories and regions, strong earnings per share growth in the face of significant cost headwinds and continued strong cash return — in a very difficult operating environment — an outcome of continued excellent execution of our integrated strategies  by P&G people. 
Organic sales for the fiscal year grew 7%. Core","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 2}"
,,"Organic sales for the fiscal year grew 7%. Core 
earnings per share grew 2%. Currency-neutral core earnings per share were up 11%. Adjusted free cash flow productivity was 95%. 
This was our second consecutive year of 7% organic 
sales growth and fifth consecutive year of 5% or  better organic growth — starting in fiscal 2019:  
5%, 6%, 6%, 7%, 7%. 
Growth was broad-based across business units, with","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 2}"
,,"Growth was broad-based across business units, with 
all 10 of our product categories growing organic sales. Personal Health Care grew mid-teens. Feminine Care grew double digits. Fabric Care, Home Care and Hair Care were each up high single digits. Skin & Personal Care, Baby Care, Family Care and Grooming each grew mid-single digits. Oral Care grew low single digits.
Focus markets grew 5% for the year. We delivered strong results in our largest and most","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 2}"
,,"profitable market, the United States, with organic sales growing 6%. This is on top of a strong 8% growth comparison in the base period. Sales in the U.S. are  up 32% on a four-year stack basis (across fiscal years 2020, 2021, 2022 and 2023).
Enterprise markets were up 15%, led by Latin America 
with 24% organic sales growth. 
E-commerce sales increased 7%, now representing 
17% of total Company sales.
Seven of 10 product categories grew share globally","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 2}"
,,"Seven of 10 product categories grew share globally 
over the past year. Twenty-nine of our top 50 category/country combinations held or grew share for the year. 
On the bottom line, our core earnings per share growth 
of 2% overcame a 24 percentage-point headwind from higher materials costs and foreign exchange. We increased our dividend by 3% and returned over $
16 billion of value to shareowners with $9 billion in 
dividends and over $7 billion in share repurchase.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 2}"
,,"dividends and over $7 billion in share repurchase.  
Over the past 10 years, we have returned $145 billion to shareowners through dividends and share repurchase.
P&G has paid a dividend for 133 consecutive years, 
raising our dividend for 67 consecutive years.  
Only seven U.S. publicly traded companies have  
paid a dividend more consecutive years than P&G,  
and only three U.S. companies have raised their dividend more consecutive years. 
In summary — another year of strong performance","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 2}"
,,"In summary — another year of strong performance 
in difficult operating conditions, in which we met or exceeded each of our going-in target ranges for the year — organic sales growth, core EPS growth, free cash flow productivity and cash returned to shareowners. 
P&G’s Strategy","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 2}"
,,"P&G’s Strategy
The team has been growing and creating value prior to, during, and following the pandemic through a strategy that drives growth and value creation through five integrated choices: a portfolio of daily-use products where performance drives brand choice; superiority across product, package, brand communication, retail execution, and value; productivity; constructive disruption of the entire value chain; and a highly efficient and effective organization structure. 
JON R. MOELLER","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 2}"
,,"JON R. MOELLER
Chairman of the Board,  
President and Chief Executive Officer","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 2}"
,,"ii • The Procter & Gamble Company
The model is dynamic and sustainable. It adapts to the 
changing needs of consumers, customers and society 
and is focused on growing markets — creating versus taking business — the most sustainable and typically most profitable way to grow. We believe the best path forward is to double down on this integrated set of strategies that are driving our results.
A Portfolio of Daily-Use 
Products 
We go to market with a portfolio of daily-use products","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 3}"
,,"We go to market with a portfolio of daily-use products 
in 10 categories: Fabric Care, Home Care, Baby Care, Feminine Care, Family Care, Hair Care, Skin & Personal Care, Oral Care, Personal Health Care and Grooming. 
With a portfolio of brands in categories where 
performance drives brand choice, the superiority  of our offerings versus competition matters.Superiority that Wins with 
Consumers and Grows Markets 
We continue to raise the bar on all aspects of","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 3}"
,,"We continue to raise the bar on all aspects of 
superiority — to win with the consumers we serve —  in all price tiers where we compete.
With innovation-driven superior products, packages, 
brand communication, retail execution and value,  
we aim to be a disproportionate contributor to market growth — creating business by growing markets and P&G’s share in them through new solutions, better and more delightful experiences, adding usage occasions and building regimens.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 3}"
,,"We are committed to continue to invest to strengthen 
the superiority of our brands to deliver superior value for consumers, which requires ongoing productivity.
I
NTEGRATED GROWTH STRATEGY
Our strategic choices are the foundation  
for balanced top- and bottom-line growthC
ONSTRUCTIVE  
DISRUPTION
across our 
businessORGANIZATION
empowered, agile, 
accountablePORTFOLIO
performance drives  
brand choice
SUPERIORITY
t
o win with  
consumers
PRODUCTIVITY
to fuel  
investments","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 3}"
,,"The Procter & Gamble Company • iii 
Productivity in All We Do 
The strategic need for investment to strengthen the 
long-term health and competitiveness of our brands, the short-term need to manage through significant cost increases, and the ongoing need to drive balanced top- and bottom-line growth, including margin expansion, underscore the importance  of productivity.
We have developed a strong productivity muscle  
over the last decade, completing two $10 billion","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 4}"
,,"over the last decade, completing two $10 billion 
savings programs. Productivity is now fully embedded in our operating model and is embraced in every  part of our operation.
We are getting more productive, for example,  
with our marketing spending. More efficient and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 4}"
,,"effective communication enables us to reach target consumers when and where they are most receptive to our advertising. This leads to higher quality engagement, and when orchestrated across media platforms, avoids excessive advertising frequency  that is, at best, wasteful spending and, at worst,  an annoyance. As we continue to integrate data  and analytics and artificial intelligence, brand teams will be working to make our marketing investments even more efficient and effective to reach more consumers","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 4}"
,,even more efficient and effective to reach more consumers with improved demand creation at  equal or lower cost.,"{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 4}"
,,"There are also significant opportunities in cost  
of goods sold. Real-time formula flexibility is  helping improve superiority and reduce cost.  We are also able to reduce transportation costs through real-time optimization of truck loads, dynamic routing and sourcing optimization.  We are embracing SKU rationalization to drive  both top- and bottom-line growth.We remain fully committed to productivity as a  
core driver of balanced top- and bottom-line growth","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 4}"
,,"core driver of balanced top- and bottom-line growth  
and strong cash generation. We cannot let up here. Productivity will remain a significant part of our  work, especially now. 
An Approach of  
Constructive Disruption 
Success in our highly competitive industry and 
increasingly dynamic world requires agility that  comes with a mindset of constructive disruption —  a willingness to change, adapt and create new  trends and technologies that will shape our  industry for the future.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 4}"
,,"We are creating proprietary algorithms to digitally 
design molecules. We are using this capability  
in our Fabric Care business, together with virtual  
reality tools, to reformulate perfume molecules  
and formulations based on real-time raw material availability and cost data. This has enabled us to reduce product development time from years to months,  while creating irresistible consumer experiences. 
We are using proprietary algorithms for fast-cycle","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 4}"
,,"We are using proprietary algorithms for fast-cycle 
testing to optimize brand communications — iterating on changes to visuals, music and copy in a few hours to achieve the best communications performance across the full range of media vehicles.
Our digitized manufacturing processes are enabling 
on-line quality control testing — identifying problems at the point they occur versus at the end of the line  or in our warehouses — saving money, reducing  scrap and increasing quality.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 4}"
,,"The best way to manage disruption is to lead it —  
in a way that creates value.
PRODUCTIVITY INTEGRATED INTO OUR STRATEGY
Delivering the same or better output measures with lower spending or resource investment
Materials Manufacturing Overhead Ad Spend &  
PromotionWorking  
Capital","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 4}"
,,"iv • The Procter & Gamble Company
Superiority 
that Wins with 
Consumers and Grows Markets
Read more about 
superiority at pg.com/annualreport2023
PRODUCT
Products so good, consumers 
recognize the difference. Superior products raise expectations for performance in the category.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 5}"
,,"Superiority is helping us delight consumers and drive category growth with Pampers Swaddlers  in North America. We have invested to drive superiority across all five vectors, including the product itself, with superior comfort, ultra-soft absorbent layers and up to 100% leakproof skin protection. In fiscal 2023, Pampers delivered mid-single digit organic sales growth and contributed to market growth  
of the category in North America. PACKAGING
P ackaging that attracts","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 5}"
,,"P ackaging that attracts  
consumers, conveys brand equity, helps consumers select the best product for their needs and delights consumers during use.
I
n Europe, Fabric Care is driving","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 5}"
,,"I
n Europe, Fabric Care is driving 
strong demand and consumer value with a superior product in superior packaging. Ariel PODS ECOCLIC packaging is made from 70% recycled fibers and is recyclable. We introduced a similar recyclable cardboard package for Lenor Unstoppables scent boosters. The new packaging is consumer preferred, helps reduce use of plastic in line with P&G’s packaging goals and contributed to high single digit organic sales growth in Europe Fabric Care  in fiscal 2023.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 5}"
,,"The Procter & Gamble Company • v 
Superiority that Wins with Consumers and Grows Markets
BRAND  
COMMUNICATION
Advertising that reaches consumers 
and communicates the superiority of the brand’s product and packaging benefits — attracting consumers to the brand and driving brand and category growth.
V
icks, the #1 OTC cough, cold","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 6}"
,,"V
icks, the #1 OTC cough, cold 
and flu brand in the world, is an example of enduring irresistible superiority that we have continued to build upon with innovations like NyQuil and DayQuil Honey. Superior communication like the print advertising seen here, which highlights the products’ great tasting formula and powerful  
relief, has helped Vicks become  the preferred choice by millions.  
Vicks grew organic sales more than 25% in fiscal 2023 and contributed","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 6}"
,,"to double-digit growth of the category globally. R ETAIL  
EXECUTION
I n-store: with the right store 
coverage, product forms, sizes, price points, shelving and merchandising. Online: with the right content, assortment, ratings, reviews,  search and subscription offerings.
A
lways Discreet has disrupted","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 6}"
,,"A
lways Discreet has disrupted 
traditional ideas of the adult incontinence category, focusing on superior protection with thinner, more discreet products and beautiful, feminine retail displays — making a meaningful change in consumers’ quality of  life and driving strong business results. With superior retail execution, Always Discreet delivered low teens organic sales growth  in fiscal 2023 and drove 1.5 times  our fair share of the adult incontinence category growth.CONSUMER  
& CUSTOMER  
VALUE","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 6}"
,,"& CUSTOMER  
VALUE
F or consumers: all these elements 
presented in a clear and shoppable way at a compelling price. For customers: margin, penny profit,  trip generation, basket size and category growth.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 6}"
,,"Sold in China for more than 30  years, Safeguard is the country’s  #1 personal cleansing brand. Consumers appreciate the value  of innovations such as Safeguard Detox Body Wash, which provides deep cleansing with a superior usage experience of a luxurious, creamy foam. Safeguard Detox  Body Wash sales nearly doubled  in fiscal 2023, leading the China  body wash category up more than 10% — great value for consumers  
and category value growth for  P&G and our retail partners.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 6}"
,,"v
i • The Procter & Gamble Company
A Structure that Yields 
an Empowered, Agile and Accountable Organization 
P&G’s organization structure is designed to focus  
our human, technical and financial resources on  our biggest opportunities for growth.
We are organized around five industry-based","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 7}"
,,"We are organized around five industry-based 
sector business units, which manage our 10 product categories, with full sales, profit, cash and value creation responsibility for our largest and most profitable markets. Enterprise Markets, which represent the rest of the world, are a separate unit  
with sales, profit and value creation responsibility. 
This structure yields a more empowered, agile","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 7}"
,,"This structure yields a more empowered, agile  
and accountable organization and culture with  little overlap or redundancy — flowing to new demands, seamlessly supporting each other to  
deliver against our priorities around the world.
Four Focus Areas to Improve 
Execution of Our Strategy 
We are working in four areas to further improve the 
execution of our integrated strategy.
The first is supply. We are further upgrading our world","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 7}"
,,"The first is supply. We are further upgrading our world 
class supply chain to one that enables even greater agility, flexibility, scalability, transparency, and resilience for a new reality and a new age. We call this Supply 
3.0  — an end-to-end synchronized, sustainable, and 
resilient supply chain, amplified by data and analytics and enabled by an organization that is at the leading edge of transformation, mastery and leadership.
Second, environmental sustainability has been","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 7}"
,,"Second, environmental sustainability has been 
integrated into each of our businesses and processes with a mindset of ‘no trade offs’— continuing to  deliver and improve the irresistible performance  of our products and packages, while improving their sustainability. An example is Ariel PODS ECOCLIC.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 7}"
,,"Ariel PODS, our leading European laundry brand, provides consumers superior cold-water cleaning performance that enables energy cost savings and improves sustainability by allowing consumers to reduce the energy required to heat water in the laundry process. Additionally, the Ariel ECOCLIC packaging is made from 70% recycled fibers and  is recyclable, saving up to 6,500 tons of plastic annually in Europe if all Ariel PODS users switch  to ECOCLIC packaging. 
Third, digital acumen — to drive consumer and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 7}"
,,"Third, digital acumen — to drive consumer and 
customer preference, reduce cost and enable rapid and efficient decision making across the entire value chain — how we engage with consumers, how we innovate, how we go to market, and how we operate our business. Through this, we are able to put  
more focus on the highest order work — work that serves consumers, customers, employees, society and shareowners. 
OUR FOUR  
FOCUS AREAS
These are further","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 7}"
,,"OUR FOUR  
FOCUS AREAS
These are further 
strengthening the execution of our integrated growth strategy.
Supply  
ChainEnvironmental  
SustainabilityDigital  
AcumenEmployee Value 
Equation","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 7}"
,,"The Procter & Gamble Company • vii 
Fourth, a superior employee value equation for all","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 8}"
,,"employees, inclusive of all genders, races, ethnicities, sexual orientations, ages and abilities — for all roles — to ensure we continue to attract, retain and develop the best talent. We are focusing on four vectors, ensuring employees have the opportunity to make an impact daily; have the ability to grow their skills and capabilities; feel valued and rewarded; and are inspired to serve consumers better than competition — to grow markets, build the business, and be part of a Company that is a force for","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 8}"
,,"the business, and be part of a Company that is a force for growth and a force for good.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 8}"
,,"These four areas — supply, environmental 
sustainability, digital acumen and a superior employee value equation — are not new or separate strategies. They are necessary elements in continuing to build superiority, in reducing cost to enable investment and value creation, and in strengthening our organization. They are part of the constructive disruption we must continue to lead.
Meeting and Balancing the 
Needs of All Stakeholders 
Our objective is balanced top- and bottom-line","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 8}"
,,"Our objective is balanced top- and bottom-line 
growth, but in the ever more complex world we  live in, balance also requires serving the needs of all stakeholders — consumers, customers, employees, society and shareowners. This is particularly  
important when it comes to environmental,  
social and governance areas.
Our efforts in Environmental Sustainability are","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 8}"
,,"Our efforts in Environmental Sustainability are 
important to create value while improving P&G’s environmental impact, enabling consumers to reduce their footprint, and helping society solve some of the most pressing challenges. We start where we have  
the most control — our operations. Then, we look at how we can innovate to extend our level of superiority in a way that allows consumers to reduce their","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 8}"
,,"own footprint without making tradeoffs between performance and sustainability. Finally, we help industry reduce its footprint by making innovative technologies available broadly for application. 
In our Community Impact work, we support people  
in need around the world through our brands and 
products that help restore normalcy in uncertain times. With our partners, we also provide clean drinking water with our Children’s Safe Drinking  
Water Program to support people who lack access","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 8}"
,,"Water Program to support people who lack access  
to clean water daily. 
We serve billions of consumers all over the world.  
Our ability to do this most effectively is enabled by  a workforce and culture that understands, respects and reflects the uniqueness of all the consumers","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 8}"
,,"we serve — inclusive of all genders, races, ethnicities, sexual orientations, ages and abilities. As of the end  of the fiscal year, 41% of our global employees and 50% of our global management employees are women. Thirty percent of our U.S. employees are multicultural. Our current Board is 46% women and 38% multicultural leaders. More balanced and representative leadership, and diversity throughout our organization, is helping","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 8}"
,,"to drive balanced and sustainable growth as we serve an increasingly diverse set of consumers.
P&G was founded on uncompromising beliefs that  
our products should be of the highest quality and value and that the only way to run a business is with honest and fair dealings. These beliefs come to life today in P&G’s Purpose, Values and Principles, which set high standards that we hold ourselves and each other accountable for, and create a strong culture focused on winning the right way. 
A FORCE FOR GROWTH","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 8}"
,,"A FORCE FOR GROWTH  
AND A FORCE FOR GOOD
To learn more about our work, visit our ESG  
for Investors website at pginvestor.com/esg   
and read our latest Citizenship Report at pg.com/citizenship . Citizenship
Community
ImpactEquality
& InclusionEnvironmental
Sustainability
Ethics & Corporate
Responsibility","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 8}"
,,"viii • The Procter & Gamble Company
Confidence in P&G’s Strategy 
and People 
I want to close this letter with a few thoughts about 
this Company, its strategy and organization — as  a reflection back on what has been accomplished  and as a glimpse forward into what is possible.
First, pre-COVID, during COVID and since COVID —","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 9}"
,,"First, pre-COVID, during COVID and since COVID —  
pre-inflation and since inflation — we have delivered consistent, strong top-line growth across categories and geographies, core EPS growth each of the  last five fiscal years, and consistent cash return  to shareowners. Our strategy has sustained us through all of it.
Second, in the past two years, nearly half our  
earnings have been wiped out by commodities,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 9}"
,,"earnings have been wiped out by commodities, 
transportation and foreign exchange headwinds.  Yet, we still grew earnings per share in each of those years, while delivering 7% organic sales growth each year, increasing investment in innovation, brand building and market growth, and growing market share, in aggregate, in the process.
Third, if you had asked me four years ago if we could","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 9}"
,,"Third, if you had asked me four years ago if we could 
grow top line, bottom line and deliver strong cash return to shareowners through a global pandemic, with employees challenged to get to the workplace,  in the context of a war in Europe, major disruption  in global supply chains, rapidly escalating costs,  
the highest consumer inflation in 40 years, and fundamental shifts in consumer behavior and channel relevance — it would have been hard to say “yes.”
But that is exactly what your team has done.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 9}"
,,"But that is exactly what your team has done.  
Over the last five years, they have added over $15 
billion in incremental sales, grown our share of the global market, grown core earnings per share by  40% and returned over $80 billion of value through dividends and share repurchase to shareowners.
As you well know, past performance is no guarantee","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 9}"
,,"As you well know, past performance is no guarantee  
of future results and no excuse to stand still — quite the opposite. There will be bumps in the road ahead. We are still navigating through plenty of bumps right now. Each of these three look-backs, though, gives  us confidence in the effectiveness of our strategy —  grounded in and focused on consumers — and an appreciation for the capability of a talented, creative, agile and committed organization.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 9}"
,,"At the end of the day, we serve people — with a strong 
desire to improve their lives and the lives of their families. We stand by consumers and support them in small but meaningful ways every day — with superior performing products of high quality at a superior  value. We strive to do this in the most responsible  way, consistent with P&G’s Values and Principles.
This approach, with consumers at the center, and an","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 9}"
,,"This approach, with consumers at the center, and an 
organization built to serve them, has served us and our many stakeholders well. It will guide our actions as we move forward. If we do this effectively, consumers will benefit, customers will grow their businesses, employees will develop and thrive, we will have a positive impact on society, and shareholders will continue to be rewarded for their investment.
I believe in this Company, in our organization — its","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 9}"
,,"I believe in this Company, in our organization — its 
capabilities and in the commitment of P&G people  to serve consumers. I am excited about what lies ahead. Of course, we will continue to weather some dark days and nights. But the future, in general,  
holds great promise. At all times, we will continue to  
be guided by P&G’s Purpose, Values and Principles  and the relentless execution of our strategy to  move toward an even brighter dawn. 
As P&G celebrates our 186th anniversary this year,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 9}"
,,"As P&G celebrates our 186th anniversary this year,  
I believe we have a stronger hand to play today  than we have ever had.
JON R. MOELLER
Chairman of the Board, President  and Chief Executive Officer","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 9}"
,,"UNITED STATES SECURITIES AND EXCHANGE COMMISSION  
Washington, D.C. 20549  
 Form 10-K 
(Mark one)  
[x] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 TRUE  
For the Fiscal Year Ended June 30, 2023  
OR 
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 False 
For the transition perio d from                     to                      
Commission File No. 1-434 
Cincinnati  THE PROCTER & GAMBLE CO MPANY  OH","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 10}"
,,"Cincinnati  THE PROCTER & GAMBLE CO MPANY  OH 
One Procter & Gamble Plaza  One Procter & Gamble Plaza, Cincinnati, Ohio 45202  45202  
513 Telephone (513) 983 -1100 983-1100 
 IRS Employer Identification No. 31 -0411980  31-0411980  
 State of Incorporation:  Ohio  OH 
Securities registered pursuant to Section 12(b) of the Act:  
Title of each class  Trading Symbol  Name of each exchange on which registered  
Common Stock, without Par Value PG New York Stock Exchange","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 10}"
,,"Common Stock, without Par Value PG New York Stock Exchange  
1.125% Notes due 2023  PG23A  New York Stock Exchange  
0.500% Notes due 2024  PG24A  New York Stock Exchange  
0.625% Notes due 2024  PG24B  New York Stock Exchange  
1.375% Notes due 2025  PG25 New York Stock Exchange  
0.110% Notes due 2026  PG26D  New York Stock Exchange  
3.250% EUR Notes due 2026  PG26E  New York Stock Exchange  
4.875% EUR Notes due May 2027  PG27A  New York Stock Exchange","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 10}"
,,"4.875% EUR Notes due May 2027  PG27A  New York Stock Exchange  
1.200% Notes due 2028  PG28 New York Stock Exchange  
1.250% Notes due 2029  PG29B  New York Stock Exchange  
1.800% Notes due 2029  PG29A  New York Stock Exchange  
6.250% GBP Notes due January 2030  PG30 New York Stock Exchange  
0.350% Notes due 2030  PG30C  New York Stock Exchange  
0.230% Notes due 2031  PG31A  New York Stock Exchange  
3.250% EUR Notes due 2031  PG31B  New York Stock Exchange","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 10}"
,,"3.250% EUR Notes due 2031  PG31B  New York Stock Exchange  
5.250% GBP Notes due January 2033  PG33 New York Stock Exchange  
1.875% Notes due 2038  PG38 New York Stock Exchange  
0.900% Notes due 2041  PG41 New York Stock Exchange  
Indicate by check mark if the registrant is a well -known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes    No   
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.    Yes    No  ","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 10}"
,,"Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Se curities Exchange Act of 1934 during the  
preceding 12 months (or for such shorter period that the registrant was required  to file such reports), and (2) has been subject to such filing requirements for the past 90 
days.    Yes    No  ","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 10}"
,,"days.    Yes    No   
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitt ed pursuant to Rule 405 of Regulation S -T 
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period tha t the registrant was required to submit and post such files).    Yes    No  ","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 10}"
,,"Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non -accelerated filer, smaller reporting company, or an emerging growth 
compa ny.  See the definitions of ""large accelerated filed,"" ""accelerated filer,"" ""smaller reporting company,"" and ""emerging growth  company"" in Rule 12b -2 of the  
Exchange Act.  
 Large accelerated filer   Accelerated filer   Emerging growth company   
 Non-accelerated filer   Smaller reporting company   FALSE  FALS","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 10}"
,,"E If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period  for complying with any new or revised  
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the eff ectiveness of its internal control over financial","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 10}"
,,"reporting under Section 404(b) of the Sarbanes -Oxley Act (15 U.S.C.  7262(b)) by  the registered public accounting firm that prepared or issued its audit report.  
Yes   No   TRUE  
If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of  the registrant included in the filing reflect the 
correction of an error to previously issued financial statements. ","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 10}"
,,"Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive -based compensation  received by any of the 
registrant’s executive officers during the relevant recovery period pursuant to §240.10D -1(b).  
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b -2 of the Exchange Act).    Yes   No   False","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 10}"
,,"The aggregate market value of the voting stock held by non -affiliates amounted to $357 billion  on December  31, 2022 . 
There were 2,357,306,187  shares of Common Stock outstanding as of July 31, 2023 .  
Documents Incorporated by Reference  
Portions of the Proxy Statement for the 2023  Annual Meeting of Shareholders, which will be filed within one hundred and twenty days of the fiscal year ended June 30,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 10}"
,,"2023  (2023  Proxy Statement), are incorporated by reference into Part III of this report to  the extent described herein.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 10}"
,,"FORM 10 -K TABLE OF CONTENTS  Page  
PART I  Item 1.  Business  2 
Item 1A.  Risk Factors  4 
Item 1B.  Unresolved Staff Comments  10 
Item 2.  Properties  10 
Item 3.  Legal Proceedings  10 
Item 4.  Mine Safety Disclosure  10 
Information about our Executive Officers  11 
PART II  Item 5.  Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of 
Equity Securities  12 
Item 6.  Intentionally Omitted  13","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 11}"
,,"Equity Securities  12 
Item 6.  Intentionally Omitted  13 
Item 7.  Management's Discussion and Analysis of Financial Condition and Results of Operations  13 
Item 7A.  Quantitative and Qualitative Disclosures about Market Risk  31 
Item 8.  Financial Statements and Supplementary Data  32 
Management's Report and Reports of Independent Registered Public Accounting Firm  32 
Consolidated Statements of Earnings  36 
Consolidated Statements of Comprehensive Income  36 
Consolidated Balance Sheets  37","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 11}"
,,"Consolidated Balance Sheets  37 
Consolidated Statements of Shareholders' Equity  38 
Consolidated Statements of Cash Flows  39 
Notes to Consolidated Financial Statements  40 
Note 1:  Summary of Significant Accounting Policies  40 
Note 2:  Segment Information  42 
Note 3:  Supplemental Financial Information  45 
Note 4:  Goodwill and Intangible Assets  46 
Note 5:  Income Taxes  47 
Note 6:  Earnings Per Share  49 
Note 7:  S hare-based Compensation  50","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 11}"
,,"Note 7:  S hare-based Compensation  50 
Note 8:  Postretirement Benefits and Employee Stock Ownership Plan  52 
Note 9:  Risk Management Activities and Fair Value Measurements  57 
Note 10:  Short -term and Long -term Debt  59 
Note 11:  Accumulated Other Comprehensive Income/(Loss)  61 
Note 12:  Leases  61 
Note 13:  Commitments and Contingencies  62 
Item 9.  Changes in and Disagreements with Accountants on Accounting and Financial Disclosure  63 
Item 9A.  Controls and Procedures  63","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 11}"
,,"Item 9A.  Controls and Procedures  63 
Item 9B.  Other Information  63 
Item 9C.  Disclosure Regarding Foreign Jurisdictions that Prevent Inspections  63 
PART III  Item 10.  Directors, Executive Officers and Corporate Governance  64 
Item 11.  Executive Compensation  64 
Item 12.  Security Ownership of Certain Beneficial Owners and Management and Related Stockholder 
Matters  64 
Item 13.  Certain Relationships and Related Transactions and Director Independence  64","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 11}"
,,"Item 14.  Principal Accountant Fees and Services  64 
PART IV  Item 15.  Exhibits and Financial Statement Schedules  65 
Item 16.  Form 10 -K Summary  67 
Signatures  68","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 11}"
,,"PART I  
Item 1. Business.  
The Procter  & Gamble Company (the Company) is focused on providing branded products of superior quality and value to 
improve the lives of the world's consumers, now and for generations to come. The Company was incorporated in Ohio in 1905, 
having first been e stablished as a New Jersey corporation in 1890, and was built from a business founded in Cincinnati in 1837 
by William Procter and James Gamble.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 12}"
,,"by William Procter and James Gamble.  
Additional information required by this item is incorporated herein by reference to Management's Discussion an d Analysis 
(MD&A); and Notes 1 and 2 to our Consolidated Financial Statements. Unless the context indicates otherwise, the terms 
""Company,""  ""P&G,"" ""we,"" ""our"" or ""us"" as used herein refer to The Procter  & Gamble Company (the registrant) and its","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 12}"
,,"subsidiarie s. Throughout this Form 10 -K, we incorporate by reference information from other documents filed with the Securities 
and Exchange Commission (SEC).  
The Company's Annual Report on Form 10 -K, quarterly reports on Form 10 -Q and current reports on Form 8 -K, an d 
amendments thereto, are filed electronically with the SEC. The SEC maintains an internet site that contains these reports at:","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 12}"
,,"www.sec.gov. Reports can also be accessed through links from our website at: www.pginvestor.com. P&G includes the website 
link solely as a textual reference and the information on our website is not incorporated by reference into this report.  
Copies of these reports are also available, without charge, by contacting EQ Shareowner Services, 1100 Centre Pointe Curve, 
Suite 101, Mendo ta, MN 55120 -4100.  
Financial Information about Segments","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 12}"
,,"Financial Information about Segments  
Information about our reportable segments can be found in the MD&A and Note 2 to our Consolidated Financial Statements.  
Narrative Description of Business  
Business Model . Our business model is built to deliver balanced top - and bottom -line growth and value creation. We rely on 
the continued growth and success of existing brands and products, as well as the creation of new innovative products and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 12}"
,,"brands. We offer product s in markets and industry  segments that are highly competitive. Our products are sold in approximately 
180 countries and territories through numerous  channels as well as direct -to-consumer. Our growth strategy is to deliver 
meaningful and noticeable superi ority across five key vectors of our consumer proposition - product performance, packaging, 
brand communication, retail execution and consumer and customer value. We use our research and development (R&D) and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 12}"
,,"consumer insights to provide superior products and packaging. We utilize our marketing and online presence to deliver superior 
brand messaging to our consumers. We partner with our customers to deliver superior retail execution, both in -store and online. 
In conjunction with the above vectors, we provid e superior value to consumers and our retail customers in each price tier in 
which we compete. Productivity improvement is also critical to delivering our objectives of balanced top - and bottom -line","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 12}"
,,"growth and value creation.  
Key Product Categories . Information on key product categories can be found in the MD&A and Note 2 to our Consolidated 
Financial Statements.  
Key Customers . Our customers include mass merchandisers, e -commerce (including social commerce) channels, grocery 
stores, membership club stor es, drug stores, department stores, distributors, wholesalers, specialty beauty stores (including","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 12}"
,,"airport duty -free stores), high -frequency stores, pharmacies, electronics stores and professional channels. We also sell direct to 
consumers. Sales to Walmar t Inc. and its affiliates represent approximately 15% of our total sales in 2023 , 2022  and 2021 . No 
other customer represents more than 10% of our total sales. Our top ten customers accounted for 40% of our total net sales in 
2023 and 39% in 2022 and 2021.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 12}"
,,"2023 and 39% in 2022 and 2021.   
Sources and Availability of Materials . Almost all of the raw and packaging  materials used by the Company are purchased 
from third parties, some of whom are single -source suppliers. We produce certain raw materials, primarily chemicals, for 
further use in the manufacturing process. In addition, fuel, natural gas and derivative products are important commodities","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 12}"
,,"consumed in our manufacturing processes and in the transportation of input materials and finished products. The prices we pay  
for materials and o ther commodities are subject to fluctuation. When prices for these items change, we may or may not pass the 
change to our customers. The Company purchases a substantial variety of other raw and packaging materials, none of which are 
material to our busines s taken as a whole.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 12}"
,,"material to our busines s taken as a whole.  
Trademarks and Patents . We own or have licenses under patents and registered trademarks, which are used in connection 
with our activity in all businesses. Some of these patents or licenses cover significant product formulation and proc esses used to 
manufacture our products. The trademarks are important to the overall marketing and branding of our products. All major","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 12}"
,,"trademarks in each business are registered. In part, our success can be attributed to the existence and continued protecti on of 
these trademarks, patents and licenses.  
Competitive Condition . The markets in which our products are sold are highly competitive. Our products compete against 
similar products from many large and small companies, including well -known global competi tors. In many of the markets and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 12}"
,,"industry segments in which we sell our products, we compete against other branded products as well as retailers' private -label 
brands. We are well positioned in the industry segments and markets in which we operate, often h olding a leadership or 
significant market share position. We support our products with advertising, promotions and other marketing vehicles to build  
awareness and trial of our brands and products in conjunction with our sales force. We believe this combin ation provides the","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 12}"
,,The Procter & Gamble Company        1,"{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 12}"
,,"most efficient method of marketing for these types of products. Product quality, performance, value and packaging are also 
important differentiating factors.  
Government Regulation . Our Company is subject to a wide variety of laws and re gulations across the countries in which we 
do business. In the United States, many of our products and manufacturing operations are subject to one or more federal or st ate","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 13}"
,,"regulatory agencies, including the U.S. Food and Drug Administration (FDA), the Env ironmental Protection Agency (EPA), the 
Occupational Safety and Health Administration (OSHA), the Federal Trade Commission (FTC) and the Consumer Product 
Safety Commission (CPSC). We are also subject to anti -corruption laws and regulations, such as the U. S. Foreign Corrupt 
Practices Act, and antitrust and competition laws and regulations that govern our dealings with suppliers, customers,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 13}"
,,"competitors and government officials.  
In addition, many foreign jurisdictions in which we do business have regulation s and regulatory bodies that govern similar 
aspects of our operations and products, in some cases to an even more significant degree. We are also subject to expanding la ws 
and regulations related to environmental protection and other sustainability -relate d matters, non -financial reporting and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 13}"
,,"diligence, labor and employment, trade, taxation and data privacy and protection, including the European Union’s General Data  
Protection Regulation (GDPR) and similar regulations in states within the United States an d in countries around the world.  
The Company has in place compliance programs and internal and external experts to help guide our business in complying with 
these and other existing laws and regulations that apply to us around the globe; and we have made, and plan to continue","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 13}"
,,"making, necessary expenditures for compliance with these laws and regulations. We also expect that our many suppliers, 
consultants and other third parties working on our behalf share our commitment to compliance, and we have policies and 
procedures in place to manage these relationships, though they inherently involve a lesser degree of control over operations and 
governance. We do not expect that the Company’s expenditures for compliance with current government regulations, including","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 13}"
,,"current environmental regulations, will have a material effect on our total capital expenditures, earnings or competitive pos ition 
in fiscal year 2024  as compared to prior periods.  
Human Capital . Our employees are a key source of competitive advantage. Their actions, guided by our Purpose, Values and 
Principles (PVPs), are critical to the long -term success of our business. We aim to retain our talented employees by offering","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 13}"
,,"competitive compensati on and benefits, strong career development and a respectful and inclusive culture that provides equal 
opportunity for all.  
Our Board of Directors, through the Compensation and Leadership Development Committee (C&LD Committee), provides 
oversight of the Co mpany’s policies and strategy relating to talent including diversity, equality and inclusion as well as the 
Company’s compensation principles and practices. The C&LD Committee also evaluates and approves the Company’s","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 13}"
,,"compensation plans, policies and progr ams applicable to our senior executives.  
Employees  
As of June 30, 2023 , the Company had approximately 107,000 employees, an increase of 1% versus the prior year due 
primarily to business growth. The total number of employees is an estimate of total Compan y employees excluding interns, co -
ops, contractors and employees of joint ventures. 49% of our employees are in manufacturing roles and 27% of our employees","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 13}"
,,"are located in the United States. 41% of our global employees are women and 30% of our U.S. employe es identify as 
multicultural.  
Training and Development  
We focus on attracting, developing and retaining skilled and diverse talent, both from universities and the broader market. W e 
recruit from among the best universities across markets in which we compe te and are generally able to select from the top","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 13}"
,,"talent. We focus on developing our employees by providing a variety of job experiences, training programs and skill 
development opportunities. Given our develop -from -within model for staffing most of our s enior leadership positions, it is 
particularly important for us to ensure holistic growth and full engagement of our employees.  
Diversity, Equality and Inclusion  
As a consumer products company, we believe that it is important for our workforce to reflect the diversity of our consumers","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 13}"
,,"worldwide. We also seek to foster an inclusive work environment where each individual can bring their authentic self, which 
helps drive innovation and enables us to better serve our consumers. We aspire to achieve equal gende r representation globally 
and at key management and leadership levels. Within the U.S. workforce, our aspiration is to achieve 40% multicultural 
representation overall as well as at management and leadership levels.  
Compensation and Benefits","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 13}"
,,"Compensation and Benefits  
Market -compet itive compensation and reward programs are critical elements of our employee value equation to attract and 
retain the best talent. Our total rewards programs are based on the principles of paying for performance, paying competitivel y 
versus peer companies  that we compete with for talent in the marketplace and focusing on long -term success through a","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 13}"
,,"combination of short -term and long -term incentive programs. We also offer competitive benefit programs, including retirement 
plans and health insurance in line with local country practices with flexibility to accommodate the needs of a diverse workforce.  
Sustainability . Environmental sustainability is integrated into our business strategy to offer consumers irresistibly superior 
products that are more sustainable . Our aim is to deliver balanced top - and bottom -line growth, value creation and key","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 13}"
,,"sustainability objectives. In 2021, the Company announced a 2040 net zero ambition and published a Climate Transition Action 
2        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 13}"
,,"Plan, which describes the Company’s ongoing ef forts toward reducing greenhouse gas emissions across scopes 1 and 2 and 
elements of scope 3. This includes a long -term objective of net zero emissions for scopes 1 and 2, elements of scope 3 and 
interim goals to help us pace our progress. The Company has  also declared goals towards using renewable electricity for our 
operations, reducing use of virgin petroleum -based plastic in packaging, increasing the recyclability or reusability of packaging,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,"responsible sourcing of key forest -based commodities, improv ing efficiency of water usage in our operations and driving a 
global portfolio of water restoration projects to address water scarcity.  
We use the standards and guidelines of the Global Reporting Initiative, Sustainability Accounting Standards Board (SAS B) 
industry specific standards and the Task Force on Climate -related Financial Disclosures (TCFD) to inform our sustainability","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,"and related disclosures included in this Annual Report, our Proxy Statement and our sustainability reports. The “materiality”  
thresholds in those standards and guidelines may differ from the concept of “materiality” for purposes of the federal securitie s 
laws and disclosures required by the Commission’s rules in this Annual Report. References to our sustainability reports and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,"websi te are for informational purposes only and neither the sustainability reports nor the other information on our website is 
incorporated by reference into this Annual Report on Form 10 -K. Additional detailed information on our sustainability efforts 
can be found on our website at https://pginvestor.com/esg.  
Item 1A. Risk Factors.  
We discuss our expectations regarding future performance, events and outcomes, such as our business outlook and objectives in","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,"this Form 10 -K, as well as in our quarterly and annual reports, current reports on Form 8 -K, press releases and other written and 
oral communications. All statements, except for historical and present factual information, are “forward -looking statements”  
 and are based on financial data an d business plans available only as of the time the statements are made, which may become 
outdated or incomplete. We assume no obligation to update any forward -looking statements as a result of new information,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,"future events or other factors, except to the  extent required by law. Forward -looking statements are inherently uncertain, and 
investors must recognize that events could significantly differ from our expectations.  
The following discussion of “risk factors” identifies significant factors that may adve rsely affect our business, operations, 
financial position or future financial performance. This information should be read in conjunction with Management's","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,"Discussion and Analysis and the Consolidated Financial Statements and related Notes incorporated in  this report. The following 
discussion of risks is not all inclusive but is designed to highlight what we believe are important factors to consider when 
evaluating our expectations. These and other factors could cause our future results to differ from thos e in the forward -looking 
statements and from historical trends, perhaps materially.  
MACROECONOMIC CONDITIONS AND RELATED FINANCIAL RISKS","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,"MACROECONOMIC CONDITIONS AND RELATED FINANCIAL RISKS  
Our business is subject to numerous risks as a result of having significant operations and sales in international markets, 
including foreign currency fluctuations, currency exchange or pricing controls and localized volatility.  
We are a global company, with operations in approximately 70 countries and products sold in approximately 180 countries and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,"territories around the world. We hold assets, incur liabilities, generate sales and pay expenses in a variety of currencies other  
than the U.S. dollar, and our operations outside the U.S. generate more than 50% of our annual net sales. Fluctuations in 
exchan ge rates for foreign currencies have and could continue to reduce the U.S. dollar value of sales, earnings and cash flows","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,"we receive from non -U.S. markets, increase our supply costs (as measured in U.S. dollars) in those markets, negatively impact 
our comp etitiveness in those markets or otherwise adversely impact our business results or financial condition. Further, we have 
a significant amount of foreign currency debt and derivatives as part of our capital markets activities. The maturity cash 
outflows of  these instruments could be adversely impacted by significant appreciation of foreign currency exchange rates","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,"(particularly the Euro), which could adversely impact our overall cash flows. Moreover, discriminatory or conflicting fiscal or 
trade policies in different countries, including changes to tariffs and existing trade policies and agreements, could adversely 
affect our results. See also the Results of Operations and Cash Flow, Financial Condition and Liquidity sections of the MD&A 
and the Consolidated  Financial Statements and related Notes.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,"and the Consolidated  Financial Statements and related Notes.  
We also have businesses and maintain local currency cash balances in a number of countries with currency exchange, import 
authorization, pricing or other controls or restrictions, such as Egypt, Argentina and Pakis tan. Our results of operations, 
financial condition and cash flows could be adversely impacted if we are unable to successfully manage such controls and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,"restrictions, continue existing business operations and repatriate earnings from overseas, or if new o r increased tariffs, quotas, 
exchange or price controls, trade barriers or similar restrictions are imposed on our business.  
Additionally, our business, operations or employees have been and could continue to be adversely affected (including by the 
need t o de-consolidate or even exit certain businesses in particular countries) by geopolitical conflicts, political volatility, trade","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,"controls, labor market disruptions or other crises or vulnerabilities in individual countries or regions. This could include 
political instability, upheaval or acts of war (such as the Russia -Ukraine War) and the related government and other entity 
responses, broad economic instability or sovereign risk related to a default by or deterioration in the creditworthiness of l ocal 
governments, particularly in emerging markets.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,"governments, particularly in emerging markets.  
Uncertain economic or social conditions may adversely impact demand for our products or cause our customers and 
other business partners to suffer financial hardship, which could adversely impact our business.  
Our business could be negatively impacted by reduced demand for our products related to one or more significant local, 
regional or global economic or social disruptions. These disruptions have included and may in the future include: a slow -down,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,The Procter & Gamble Company        3,"{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 14}"
,,"recession o r inflationary pressures in the general economy; reduced market growth rates; tighter credit markets for our 
suppliers, vendors or customers; a significant shift in government policies; significant social unrest; the deterioration of 
economic relations b etween countries or regions; potential negative consumer sentiment toward non -local products or sources; 
or the inability to conduct day -to-day transactions through our financial intermediaries to pay funds to or collect funds from our","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,"customers, vendors a nd suppliers. Additionally, these and other economic conditions may cause our suppliers, distributors, 
contractors or other third -party partners to suffer financial or operational difficulties that they cannot overcome, resulting in 
their inability to pro vide us with the materials and services we need, in which case our business and results of operations could 
be adversely affected. Customers may also suffer financial hardships due to economic conditions such that their accounts","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,"become uncollectible or ar e subject to longer collection cycles. In addition, if we are unable to generate sufficient sales, income 
and cash flow, it could affect the Company’s ability to achieve expected share repurchase and dividend payments.  
Disruptions in credit markets or to o ur banking partners or changes to our credit ratings may reduce our access to 
credit or overall liquidity.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,"credit or overall liquidity.  
A disruption in the credit markets or a downgrade of our current credit rating could increase our future borrowing costs and 
impair our ability to access capital and credit markets on terms commercially acceptable to us, which could adversely affect our 
liquidity and capital resources or significantly increase our cost of capital. In addition, we rely on top -tier banking partners in","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,"key markets arou nd the world, who themselves face economic, societal, political and other risks, for access to credit and to 
facilitate collection, payment and supply chain finance programs. A disruption to one or more of these top -tier partners could 
impact our ability t o draw on existing credit facilities or otherwise adversely affect our cash flows or the cash flows of our 
customers and vendors.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,"customers and vendors.  
Changing political and geopolitical conditions could adversely impact our business and financial results.  
Changes in the polit ical conditions in markets in which we manufacture, sell or distribute our products, as well as changing 
geopolitical conditions, may be difficult to predict and may adversely affect our business and financial results. Results of 
elections, referendums, s anctions or other political processes and pressures in certain markets in which our products are","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,"manufactured, sold or distributed could create uncertainty regarding how existing governmental policies, laws and regulations  
may change, including with respec t to sanctions, taxes, tariffs, import and export controls and the general movement of goods, 
materials, services, capital, data and people between countries. The potential implications of such uncertainty, which includ e,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,"among others, exchange rate fluctu ations, new or increased tariffs, trade barriers and market contraction, could adversely affect 
the Company’s results of operations and cash flows.  
The Company operates a global business with sales, manufacturing, distribution and research and development organizations 
globally that contribute to our overall growth. If geopolitical tensions and trade controls were to increase or disrupt our b usiness","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,"in markets where we have significant sales or operations, including disruptions due to governmental responses  to such conflicts 
(such as the imposition of sanctions, retaliatory tariffs, increased business licensing requirements or limitations on profit s), such 
disruptions could adversely impact our business, financial condition, results of operations and cash fl ows.  
The war between Russia and Ukraine has adversely impacted and could continue to adversely impact our business and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,"financial results.  
The war between Russia and Ukraine has negatively impacted, and the situation it generates may continue to negatively  impact, 
our operations. Beginning in March 2022, the Company reduced its product portfolio, discontinued new capital investments and 
suspended media, advertising and promotional activity in Russia. Future impacts to the Company are difficult to predict du e to","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,"the high level of uncertainty as to how the overall situation will evolve. Within Ukraine, there is a possibility of physical  
damage and destruction of our two manufacturing facilities, our distribution centers or those of our customers. We may not b e 
able to operate our manufacturing sites and source raw materials from our suppliers or ship finished products to our customer s.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,"Within Russia, we may reduce further or discontinue our operations due to sanctions and export controls and counter -sanctions,  
monetary, currency or payment controls, restrictions on access to financial institutions, supply and transportation challenge s or 
other circumstances and considerations. Ultimately, these could result in loss of assets or impairments of our manufacturing 
plants and fixed assets or write -downs of other operating assets and working capital.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,"The war between Russia and Ukraine could also amplify or affect the other risk factors set forth in this Part I, Item 1A, 
including, but not limited to, foreign exchan ge volatility, disruptions to the financial and credit markets, energy supply and 
supply chain disruptions, increased risks of an information security or operational technology incident, cost fluctuations an d 
commodity cost increases and increased costs t o ensure compliance with global and local laws and regulations. The occurrence","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,"of any of these risks, combined with the increased impact from the war between Russia and Ukraine, could adversely impact 
our business and financial results.  
More broadly, ther e could be additional negative impacts to our net sales, earnings and cash flows should the situation worsen, 
including, among other potential impacts, economic recessions in certain neighboring countries or globally due to inflationar y","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,"pressures, energy a nd supply chain cost increases or the geographic proximity of the war relative to the rest of Europe.  
BUSINESS OPERATIONS RISKS  
Our business results depend on our ability to manage disruptions in our global supply chain.  
Our ability to meet our customers’ needs and achieve cost targets depends on our ability to maintain key manufacturing and 
supply arrangements, including execution of supply chain optimizations and certain sole supplier or sole manufacturing plant","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,4        The Procter & Gamble Company,"{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 15}"
,,"arrangem ents. The loss or disruption of such manufacturing and supply arrangements, including for issues such as labor 
disputes or controversies, loss or impairment of key manufacturing sites, discontinuity or disruptions in our internal inform ation 
and data syst ems or those of our suppliers, cybersecurity incidents, inability to procure sufficient raw or input materials 
(including water, recycled materials and materials that meet our labor standards), significant changes in trade policy, natur al","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,"disasters, incre asing severity or frequency of extreme weather events due to climate change or otherwise, acts of war or 
terrorism, disease outbreaks or other external factors over which we have no control, have at times interrupted and could, in  the 
future, interrupt pr oduct supply and, if not effectively managed and remedied, could have an adverse impact on our business, 
financial condition, results of operations or cash flows.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,"financial condition, results of operations or cash flows.  
Our businesses face cost fluctuations and pressures that could affect our business results.  
Our costs are subject to fluctuations, particularly due to changes in the prices of commodities (including certain petroleum - 
derived materials like resins and paper -based materials like pulp) and raw and packaging materials and the costs of labor,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,"transpo rtation (including trucks and containers), energy, pension and healthcare. Inflation pressures could also result in 
increases in these input costs. Therefore, our business results depend, in part, on our continued ability to manage these 
fluctuations thr ough pricing actions, cost saving projects and sourcing decisions, while maintaining and improving margins and 
market share. Failure to manage these fluctuations and to anticipate consumer reaction to our management of these fluctuation s","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,"could adversely im pact our results of operations or cash flows.  
The ability to achieve our business objectives depends on how well we can compete with our local and global 
competitors in new and existing markets and channels.  
The consumer products industry is highly compet itive. Across all of our categories, we compete against a wide variety of global 
and local competitors. As a result, we experience ongoing competitive pressures in the environments in which we operate,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,"which may result in challenges in maintaining sales a nd profit margins. To address these challenges, we must be able to 
successfully respond to competitive factors and emerging retail trends, including pricing, promotional incentives, product 
delivery windows and trade terms. In addition, evolving sales cha nnels and business models may affect customer and consumer 
preferences as well as market dynamics, which, for example, may be seen in the growing consumer preference for shopping","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,"online, ease of competitive entry into certain categories and growth in hard discounter channels. Failure to successfully respond 
to competitive factors and emerging retail trends and effectively compete in growing sales channels and business models, 
particularly e -commerce and mobile or social commerce applications, could negative ly impact our results of operations or cash 
flows.  
A significant change in customer relationships or in customer demand for our products could have a significant impact","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,"on our business.  
We sell most of our products via retail customers, which include mass merchandisers, e -commerce (including social commerce) 
channels, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty  
stores (including airport duty -free stores), high -frequency stores, pharmac ies, electronics stores and professional channels. Our","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,"success depends on our ability to successfully manage relationships with our retail trade customers, which includes our abili ty 
to offer trade terms that are mutually acceptable and are aligned with o ur pricing and profitability targets. Continued concentration 
among our retail customers could create significant cost and margin pressure on our business, and our business performance co uld","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,"suffer if we cannot reach agreement with a key customer on trade terms and principles. Our business could also be negatively 
impacted if a key customer were to significantly reduce the inventory level of or shelf space allocated to our products as a result 
of increased offerings of other branded manufacturers, private l abel brands and generic non -branded 
products or for other reasons, significantly tighten product delivery windows or experience a significant business disruption .","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,"If the reputation of the Company or one or more of our brands erodes significantly, it could  have a material impact on 
our financial results.  
The Company's reputation, and the reputation of our brands, form the foundation of our relationships with key stakeholders an d 
other constituencies, including consumers, customers and suppliers. The quality  and safety of our products are critical to our","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,"business. Many of our brands have worldwide recognition and our financial success directly depends on the success of our 
brands. The success of our brands can suffer if our marketing plans or product initiat ives do not have the desired impact on a 
brand's image or its ability to attract consumers. Our results of operations or cash flows could also be negatively impacted if the 
Company or one of our brands suffers substantial harm to its reputation due to a si gnificant product recall, product -related","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,"litigation, defects or impurities in our products, product misuse, changing consumer perceptions of certain ingredients, nega tive 
perceptions of packaging (such as plastic and other petroleum -based materials), lack  of recyclability or other environmental 
impacts, concerns about actual or alleged labor or equality and inclusion practices, privacy lapses or data breaches, allegat ions","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,"of product tampering or the distribution and sale of counterfeit products. Additiona lly, negative or inaccurate postings or 
comments on social media or networking websites about the Company or one of its brands could generate adverse publicity that 
could damage the reputation of our brands or the Company. If we are unable to effectively m anage real or perceived issues, 
including concerns about safety, quality, ingredients, efficacy, environmental or social impacts or similar matters, sentimen ts","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,"toward the Company or our products could be negatively impacted, and our results of operations o r cash flows could suffer. Our 
Company also devotes time and resources to citizenship efforts that are consistent with our corporate values and are designed  to 
strengthen our business and protect and preserve our reputation, including programs driving ethi cs and corporate responsibility, 
strong communities, equality and inclusion and environmental sustainability. While the Company has many programs and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,The Procter & Gamble Company        5,"{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 16}"
,,"initiatives to further these goals, our ability to achieve these goals is impacted in part by the actions and efforts of third parties 
including local and other governmental authorities, suppliers, vendors and customers. Consumer or broader stakeholder 
perceptions of these programs and initiatives widely vary and could adversely affect our business. If these p rograms are not 
executed as planned or suffer negative publicity, the Company's reputation and results of operations or cash flows could be","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 17}"
,,"adversely impacted.  
We rely on third parties in many aspects of our business, which creates additional risk.  
Due to the scale and scope of our business, we must rely on relationships with third parties, including our suppliers, contract 
manufacturers, distributors, contractors, commercial banks, joint venture partners and external business partners, for certai n 
function s. If we are unable to effectively manage our third -party relationships and the agreements under which our third -party","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 17}"
,,"partners operate, our results of operations and cash flows could be adversely impacted. Further, failure of these third parti es to 
meet t heir obligations to the Company or substantial disruptions in the relationships between the Company and these third 
parties could adversely impact our operations and financial results. Additionally, while we have policies and procedures for 
managing these  relationships, they inherently involve a lesser degree of control over business operations, governance and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 17}"
,,"compliance, thereby potentially increasing our financial, legal, reputational and operational risk.  
A significant information security or operationa l technology incident, including a cybersecurity breach, or the failure of 
one or more key information or operations technology systems, networks, hardware, processes and/or associated sites 
owned or operated by the Company or one of its service providers could have a material adverse impact on our business 
or reputation.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 17}"
,,"or reputation.  
We rely extensively on information and operational technology (IT/OT) systems, networks and services, including internet and 
intranet sites, data hosting and processing facilities and tech nologies, physical security systems and other hardware, software 
and technical applications and platforms, many of which are managed, hosted, provided and/or used by third parties or their","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 17}"
,,"vendors, to assist in conducting our business. The various uses of  these IT/OT systems, networks and services include, but are 
not limited to:  
•ordering and managing materials from suppliers;
•converting materials to finished products;
•shipping products to customers;
•marketing and selling products to consumers;
•collecting, transferring, storing and/or processing customer, consumer, employee, vendor, investor and other stakeholder","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 17}"
,,"information and personal data, including such data from persons covered by an expanding landscape of privacy and data
regulations, such  as citizens of the European Union who are covered by the General Data Protection Regulation (GDPR),
residents of California covered by the California Consumer Privacy Act (CCPA), citizens of China covered by the Personal
Information Protection Law (PIPL) and citizens of Brazil covered by the General Personal Data Protection Law (LGPD);","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 17}"
,,"•summarizing and reporting results of operations, including financial reporting;
•managing our banking and other cash liquidity systems and platforms;
•hosting, processing and sharing, as appropriate, confidential and proprietary research, business plans and financial
information;
•collaborating via an online and efficient means of global business communications;
•complying with regulatory, legal and tax requirement s;
•providing data security; and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 17}"
,,"•providing data security; and
•handling other processes necessary to manage our business.
Numerous and evolving information security threats, including advanced persistent cybersecurity threats, pose a risk to the 
security of our services, systems, networ ks and supply chain, as well as to the confidentiality, availability and integrity of our 
data and of our critical business operations. In addition, because the techniques, tools and tactics used in cyber -attacks","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 17}"
,,"frequently change and may be difficult to detect for periods of time, we may face difficulties in anticipating and implementing 
adequate preventative measures or fully mitigating harms after such an attack.  
Our IT/OT databases and systems and our third -party providers’ databases and systems have been, and will likely continue to 
be, subject to advanced computer viruses or other malicious codes, ransomware, unauthorized access attempts, denial of servic e","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 17}"
,,"attacks, phishing, social engineering, hacking and other cyber -attacks. Such attacks may origi nate from outside parties, hackers, 
criminal organizations or other threat actors, including nation states. In addition, insider actors - malicious or otherwise - could 
cause technical disruptions and/or confidential data leakage. We cannot guarantee that our security efforts or the security efforts","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 17}"
,,"of our third -party providers will prevent material breaches, operational incidents or other breakdowns to our or our third -party 
providers’ IT/OT databases or systems.  
A breach of our data security systems or fa ilure of our IT/OT databases and systems may have a material adverse impact on our 
business operations and financial results. If the IT/OT systems, networks or service providers we rely upon fail to function","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 17}"
,,"properly or cause operational outages or aberrat ions, or if we or one of our third -party providers suffer significant unavailability 
of key operations, or inadvertent disclosure of, lack of integrity of, or loss of our sensitive business or stakeholder infor mation, 
6        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 17}"
,,"including personal information, due to  any number of causes, including catastrophic events, natural disasters, power outages, 
computer and telecommunications failures, improper data handling, viruses, phishing attempts, cyber -attacks, malware and 
ransomware attacks, security breaches, security  incidents or employee error or malfeasance, and our business continuity plans 
do not effectively address these failures on a timely basis, we may suffer interruptions in our ability to manage operations and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 18}"
,,"be exposed to reputational, competitive, opera tional, financial and business harm as well as litigation and regulatory action. If 
our critical IT systems or back -up systems or those of our third -party vendors are damaged or cease to function properly, we 
may have to make a significant investment to r epair or replace them.  
In addition, if a ransomware attack or other cybersecurity incident occurs, either internally or at our third -party technology","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 18}"
,,"service providers, we could be prevented from accessing our data or systems, which may cause interruption s or delays in our 
business operations, cause us to incur remediation costs, subject us to demands to pay a ransom or damage our reputation. In 
addition, such events could result in unauthorized disclosure of confidential information or stakeholder informa tion, including 
personal information, and we may suffer financial and reputational damage because of lost or misappropriated information","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 18}"
,,"belonging to us or to our partners, our employees, customers and suppliers. Additionally, we could be exposed to potent ial 
liability, litigation, governmental inquiries, investigations or regulatory enforcement actions; and we could be subject to 
payment of fines or other penalties, legal claims by our suppliers, customers or employees and significant remediation costs.  
Periodically, we also upgrade our IT/OT systems or adopt new technologies. If such a new system or technology does not","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 18}"
,,"function properly or otherwise exposes us to increased cybersecurity breaches and failures, it could affect our ability to or der 
materia ls, make and ship orders and process payments in addition to other operational and information integrity and loss issues. 
The costs and operational consequences of responding to the above items and implementing remediation measures could be 
significant and  could adversely impact our results of operations and cash flows.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 18}"
,,"We must successfully manage the demand, supply and operational challenges associated with the effects of any future 
disease outbreak, including epidemics, pandemics or similar widespread pub lic health concerns.  
Our business may be negatively impacted by the fear of exposure to or actual effects of a disease outbreak, epidemic, pandemi c 
or similar widespread public health concern. These impacts may include, but are not limited to:","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 18}"
,,"•Significant reductions in demand or significant volatility in demand for one or more of our products, which may be caused
by, among other things: the temporary inability of consumers to purchase our products due to illness, quarantine or other
travel restrictions or f inancial hardship, shifts in demand away from one or more of our more discretionary or higher priced
products to lower priced products, or stockpiling or similar pantry -loading activity. If prolonged, such impacts can further","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 18}"
,,"increase the difficulty of bus iness or operations planning and may adversely impact our results of operations and cash
flows; or
•Significant changes in the political conditions in markets in which we manufacture, sell or distribute our products,
including quarantines, import/export r estrictions, price controls, or governmental or regulatory actions, closures or other
restrictions that limit or close our operating and manufacturing facilities, restrict our employees’ ability to travel or per form","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 18}"
,,"necessary business functions, or otherwi se prevent our third -party partners, suppliers or customers from sufficiently
staffing operations.
Despite efforts to manage and remedy these impacts, their ultimate impact also depends on factors beyond our knowledge or 
control, including the duration an d severity of any such outbreak as well as third -party actions taken to contain its spread and 
mitigate its public health effects.  
BUSINESS STRATEGY & ORGANIZATIONAL RISKS","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 18}"
,,"BUSINESS STRATEGY & ORGANIZATIONAL RISKS  
Our ability to meet our growth targets depends on successful product, marketing and operations innovation and 
successful responses to competitive innovation, evolving digital marketing and selling platforms and changing consumer 
habits.  
We are a consumer products company that relies on continued global demand for our brands and products. Achieving our","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 18}"
,,"business results depends, in part, on successfully developing, introducing and marketing new products and on making 
significant improvements to our equipme nt and manufacturing processes. The success of such innovation depends on our ability 
to correctly anticipate customer and consumer acceptance and trends, to obtain, maintain and enforce necessary intellectual 
property protections and to avoid infringing u pon the intellectual property rights of others and to continue to deliver efficient","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 18}"
,,"and effective marketing across evolving media and mobile platforms with dynamic and increasingly more restrictive privacy 
requirements. We must also successfully respond t o technological advances made by, and intellectual property rights granted to, 
competitors, customers and vendors. Failure to continually innovate, improve and respond to competitive moves, platform 
evolution and changing consumer habits could compromise o ur competitive position and adversely impact our financial","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 18}"
,,"condition, results of operations or cash flows.  
We must successfully manage ongoing acquisition, joint venture and divestiture activities.  
As a company that manages a portfolio of consumer brands,  our ongoing business model includes a certain level of acquisition, 
joint venture and divestiture activities. We must be able to successfully manage the impacts of these activities, while at th e same","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 18}"
,,"time delivering against our business objectives. Specif ically, our financial results have been, and in the future could be, 
adversely impacted by the dilutive impacts from the loss of earnings associated with divested brands or dissolution of joint 
ventures. Our results of operations and cash flows have been,  and in the future could also be, impacted by acquisitions or joint 
The Procter & Gamble Company        7","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 18}"
,,"venture activities, if: 1) changes in the cash flows or other market -based assumptions cause the value of acquired assets to fall 
below book value, or 2) we are not able to deliver the exp ected cost and growth synergies associated with such acquisitions and 
joint ventures, including as a result of integration and collaboration challenges, which could also result in an impairment o f 
goodwill and intangible assets.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 19}"
,,"goodwill and intangible assets.  
Our business results depend  on our ability to successfully manage productivity improvements and ongoing 
organizational change, including attracting and retaining key talent as part of our overall succession planning.  
Our financial projections assume certain ongoing productivity improvements and cost savings, including staffing adjustments 
and employee departures. Failure to deliver these planned productivity improvements and cost savings, while continuing to","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 19}"
,,"invest i n business growth, could adversely impact our results of operations and cash flows. Additionally, successfully executing 
organizational change, management transitions at leadership levels of the Company and motivation and retention of key 
employees is crit ical to our business success. Factors that may affect our ability to attract and retain sufficient numbers of 
qualified employees include employee morale, our reputation, competition from other employers and availability of qualified","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 19}"
,,"individuals. Our succ ess depends on identifying, developing and retaining key employees to provide uninterrupted leadership 
and direction for our business. This includes developing and retaining organizational capabilities in key growth markets wher e 
the depth of skilled or e xperienced employees may be limited and competition for these resources is intense as well as 
continuing the development and execution of robust leadership succession plans.  
LEGAL & REGULATORY RISKS","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 19}"
,,"LEGAL & REGULATORY RISKS  
We must successfully manage compliance with current and expanding laws and regulations, as well as manage new and 
pending legal and regulatory matters in the U.S. and abroad.  
Our business is subject to a wide variety of laws and regulations across the countries in which we do business, including tho se 
laws and regulations involving intellectual property, product liability, product composition or formulation, packaging content or","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 19}"
,,"corporate responsibility for packaging and product disposal, marketing, antitrust and competition, privacy, data protection, 
environmen tal (including increasing focus on the climate, water and waste impacts of consumer packaged goods companies' 
operations and products), employment, healthcare, anti -bribery and anti -corruption (including interactions with health care 
professionals and gove rnment officials as well as corresponding internal controls and record -keeping requirements), trade","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 19}"
,,"(including tariffs, sanctions and export controls), tax, accounting and financial reporting or other matters. In addition, in creasing 
governmental and socie tal attention to environmental, social and governance (ESG) matters, including expanding mandatory 
and voluntary reporting, diligence and disclosure on topics such as climate change, waste production, water usage, human 
capital, labor and risk oversight,  could expand the nature, scope and complexity of matters that we are required to control,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 19}"
,,"assess and report. These and other rapidly changing laws, regulations, policies and related interpretations as well as increa sed 
enforcement actions by various gove rnmental and regulatory agencies, create challenges for the Company, may alter the 
environment in which we do business, may increase the ongoing costs and complexities of compliance including by requiring 
investments in technology or other compliance syste ms, and may ultimately result in the need to cease manufacturing, sales or","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 19}"
,,"other business activities in certain jurisdictions, which could adversely impact our results of operations and cash flows. If  we 
are unable to continue to meet these challenges and  comply with all laws, regulations, policies and related interpretations, it 
could negatively impact our reputation and our business results. Additionally, we are currently, and in the future may be,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 19}"
,,"subject to a number of inquiries, investigations, clai ms, proceedings and requests for information from governmental agencies 
or private parties, the adverse outcomes of which could harm our business. Failure to successfully manage these new or pendin g 
regulatory and legal matters and resolve such matters wi thout significant liability or damage to our reputation may materially 
adversely impact our financial condition, results of operations and cash flows. Furthermore, if new or pending legal or","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 19}"
,,"regulatory matters result in fines or costs in excess of the amo unts accrued to date, that may also materially impact our results of 
operations and financial position.  
Changes in applicable tax laws and regulations and resolutions of tax disputes could negatively affect our financial 
results.  
The Company is subject to  taxation in the U.S. and numerous foreign jurisdictions. Changes in the various tax laws can and do","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 19}"
,,"occur. For example, in December 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as 
the Tax Cuts and Jobs Act (the U.S . Tax Act). The changes included in the U.S. Tax Act were broad and complex. Under the 
current U.S. presidential administration, comprehensive federal income tax reform has been proposed, including an increase in  
the U.S. Federal corporate income tax rate,  elimination of certain investment incentives and an increase in U.S. taxation of non -","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 19}"
,,"U.S. earnings. While these proposals are controversial, likely to change during the legislative process and may prove difficu lt to 
enact as proposed in the current closel y divided U.S. Congress, their impact could nonetheless be significant.  
Additionally, longstanding international tax norms that determine each country’s jurisdiction to tax cross -border international 
trade are subject to potential evolution. An outgrowth o f the original Base Erosion and Profit Shifting (BEPS) project is a","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 19}"
,,"project undertaken by the approximately 140 member countries of the expanded Organisation for Economic Co -operation and 
Development (OECD) Inclusive Framework focused on ""Addressing the C hallenges of the Digitalization of the Economy."" The 
breadth of this project extends beyond pure digital businesses and, as proposed, would likely impact a large portion of 
multinational businesses by potentially redefining jurisdictional taxation rights i n market countries and establishing a global","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 19}"
,,"minimum tax. In December 2022, the European Union (EU) approved a directive requiring member states to incorporate a 15% 
global minimum tax into their respective domestic laws effective for fiscal years beginnin g on or after December 31, 2023. In 
8        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 19}"
,,"addition, several non -EU countries have recently proposed and/or adopted legislation consistent with the global minimum tax 
framework. Important details of these minimum tax developments are still to be determined and, i n some cases, enactment and 
timing remain uncertain.  
While it is too early to assess the overall impact of these potential changes, as these and other tax laws and related regula tions","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 20}"
,,"are revised, enacted and implemented, our financial condition, results  of operations and cash flows could be materially 
impacted.  
Furthermore, we are subject to regular review and audit by both foreign and domestic tax authorities. While we believe our ta x 
positions will be sustained, the final outcome of tax audits and rel ated litigation, including maintaining our intended tax","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 20}"
,,"treatment of divestiture transactions such as the fiscal 2017 Beauty Brands transaction with Coty, may differ materially from  the 
tax amounts recorded in our Consolidated Financial Statements, which could adversely impact our results of operations and 
cash flows.  
Item 1B. Unresolved Staff Comments.  
None.  
Item 2. Properties.  
In the U.S., we own and operate 24 manufacturing sites located in 18 different states. In ad dition, we own and operate 80","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 20}"
,,"manufacturing sites in 34 other countries. Many of the domestic and international sites manufacture products for multiple 
businesses. Beauty  products are manufactured at 23 of these locations; Grooming  products at 17; Health C are products at 20; 
Fabric & Home Care  products at 37; and Baby, Feminine & Family Care  products at 37. We own our Corporate  headquarters in 
Cincinnati, Ohio. We own or lease our principal regional general offices in Switzerland, Panama, Singapore, China and the","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 20}"
,,"United Arab Emirates. We own or lease our principal regional shared service centers in Costa Rica, the United Kingdo m and 
the Philippines. Management believes that the Company's sites are adequate to support the business and that the properties an d 
equipment have been well maintained.  
Item 3. Legal Proceedings.  
The Company is subject, from time to tim e, to certain legal proceedings and claims arising out of our business, which cover a","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 20}"
,,"wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental iss ues, 
patent and trademark matters, labor and employment  matters and tax. In addition , SEC regulations require that we disclose 
certain environmental proceedings arising under Federal, State or local law when a governmental authority is a party and such  
proceeding involves potential monetary sanction s that the Company reasonably believes will exceed a certain threshold ($1","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 20}"
,,"million or more). There are no relevant matters to disclose under this Item for this period. See Note 13 to our Consolidated 
Financial Statements for information on certain legal pr oceedings for which there are contingencies.  
This item should be read in conjunction with the Company's Risk Factors in Part I, Item 1A for additional information.  
Item 4. Mine Safety Disclosure.  
Not applicable.  
The Procter & Gamble Company        9","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 20}"
,,"INFORMATION ABOUT OUR EXECUTIVE OFFICERS  
The names, ages and positions held by the Executive Officers of the Company on August  4, 2023 , are:  
Name   Position   Age  First Elected  to 
Officer  Position  
       Jon R. Moeller   Chairman of the Board, President and Chief Executive 
Officer   59  2009 (1) 
       
Shailesh Jejurikar   Chief Operating Officer   56  2018 (2) 
       Andre Schulten   Chief Financial Officer   52  2021 (3)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 21}"
,,"Gary A. Coombe   Chief Executive Officer - Grooming   59  2014 (4) 
       
Jennifer L. Davis   Chief Executive Officer - Health Care   52  2022 (5) 
       
Ma. Fatima D. Francisco   Chief Executive Officer - Baby, Feminine and Family Care 
and Executive Sponsor for Gender Equality   55  2018 (6) 
       
R. Alexandra Keith   Chief Executive Officer - Beauty and Executive Sponsor for 
Corporate Sustainability   55  2017 (7)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 21}"
,,"Corporate Sustainability   55  2017 (7) 
       
Sundar Raman   Chief Executive Officer - Fabric and Home Care   48  2021 (8) 
       
Victor Aguilar   Chief Research, Development and Innovation Officer   56  2020 (9) 
       
Marc S. Pritchard   Chief Brand Officer   63  2008  (( ) 
       
Balaji Purushothaman   Chief Human Resources Officer   54  2023 (10) 
       Susan Street Whaley   Chief Legal Officer and Secretary   49  2022 (11)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 21}"
,,"All the Executive Officers named above have been employed by the Company for more than the past five years.  
(1) Mr. Moeller previously served as President and Chief Executive Officer (2021 - 2022), Vice Chairman, Chief Operating Officer and Chief Financial  
Officer (2019 - 2021), Vice Chairman and Chief Financial Officer (2017 - 2019) and as Chief Financial Officer (2009 - 2017).","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 21}"
,,"(2) Mr. Jejurikar previously served as Chief Executive Officer - Fabric and Home Care (2019 - 2021), President - Global Fabric, Home C are and P&G 
Professional (2018 - 2019), and President - Global Fabric Care and Brand -Building Officer Global Fabric & Home Care (2015 - 2018). 
(3) Mr. Schulten previously served as Senior Vice President - Baby Care, North America (2018 - 2021) and Senior Vice President - Finance & Accounting, 
Global Baby, Feminine and Family Care (2014 - 2018).","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 21}"
,,"Global Baby, Feminine and Family Care (2014 - 2018). 
(4) Mr. Coombe previously served as President - Europe Selling & Market Operations (2014 - 2018). 
(5) Ms. Davis previously served as President - Feminine Care (2019 - 2022) , President - Global Feminine Care (2018 - 2019), and Vice President - Feminine 
Care, North America and Brand Franchise Leader, Tampax (2016 - 2018).","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 21}"
,,"(6) Ms. Francisco previously served as Chief Executive Officer - Baby and Feminine Care (2019 - 2021), Preside nt - Global Baby Care and Baby & Feminine 
Care Sector (2018 - 2019), and President - Global Feminine Care (2015 - 2018). 
(7) Ms. Keith previously served as Chief Executive Officer - Beauty (2017 - 2022). 
(8) Mr. Raman previously served as President - Home Care and  P&G Professional (2020 - 2021), President - Fabric Care, North America and P&G","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 21}"
,,"Professional (2019 - 2020), and Vice President - Fabric Care, North America (2015 - 2019). 
(9) Mr. Aguilar previously served as Senior Vice President - Research & Development, Cor porate Function Research & Development (2020), Senior Vice 
President - Research & Development, Corporate Function Research & Development and Global Fabric Care (2019), and Senior Vice President - Research 
& Development Global Fabric Care; and Sector Leader , Research & Development Global Fabric and Home Care (2014 - 2019).","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 21}"
,,"(10) Mr. Purushothaman previously served as Senior Vice President - Human Resources, Global Total Rewards, Employee and Labor Relations and Corporate 
Services (2020 - 2022) and as Senior Vice P resident - Human Resources, Beauty, Grooming, and Family Care (2015 - 2020). 
(11) Ms. Whaley previously served as Senior Vice President and General Counsel - North America, Practice Groups and Sector Business Units (2019 - 2022),","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 21}"
,,"and Vice President and General Counsel - North America, Global Go -To-Market and Practice Groups, and Global Business Units (2016 - 2019). 
 
10        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 21}"
,,"PART II  
Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Se curities.  
ISSUER PURCHASES OF EQUITY SECURITIES  
PeriodTotal  Number of  
Shares  Purchased (1) Average Price Paid 
per Share (2) Total Number of 
Shares  Purchased  as  
Part of Publicly Announced 
Plans or Programs (3) Approximate  Dollar  Value of 
Shares that May Yet Be 
Purchased Under Our Share 
Repurchase Program
4/1/2023 - 4/30/2023  — — — (3)
5/1/2023 - 5/31/2023  — — — (3)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 22}"
,,"5/1/2023 - 5/31/2023  — — — (3) 
6/1/2023 - 6/30/2023  914,324  $149.95  — (3)
Total  914,324  $149.95  — (3) 
(1)All transactions are reported on a trade date basis and were made in the open market with large financial institutions. This table excludes
shares withheld from employees to satisfy minimum tax withholding requirements on opti on exercises and other equity -based
transactions. The Company administers cashless exercises through an independent third party and does not repurchase stock in","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 22}"
,,"connection with cashless exercises.
(2)Average price paid per share for open market transactions  excludes commission.
(3)On April 21, 2023, the Company stated that in fiscal year 2023  the Company expected  to reduce outstanding shares through direct share
repurchases at a value of $7.4 to $8.0 billion, notwithstanding any purchases under the Company's compensation and benefit pl ans. The","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 22}"
,,"share repurchases were authorized pursuant to a resolution issued by th e Company's Board of Directors and were financed through a
combination of operating cash flows and issuance of debt. The total value of the shares purchased under the share repurchase plan was
$7.4 billion. The share repurchase plan ended on June 30, 2023 .
Additional information required by this item can be found in Part III, Item  12 of this Form 10 -K.
SHAREHOLDER RETURN PERFORMANCE GRAPHS  
Market and Dividend Information","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 22}"
,,"Market and Dividend Information  
P&G has been paying a dividend for 133 consecutive years since its incorporation in 189 0 and has increased its dividend for 67 
consecutive years since 1956. Over the past ten years, the dividend has increased at an annual compound average rate of 5%. 
Nevertheless, as in the past, further dividends will be considered after reviewing dividend yields, profitability and cash flow","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 22}"
,,"expectations and financing needs and will be declared at the discretion of the Company's Board of Directors.
(in dollars; split -adjusted)  1956 1963 1973 1983 1993 2003 2013 2023 
Dividends per share  $ 0.01 $ 0.02 $ 0.05 $ 0.14 $ 0.28 $ 0.82 $ 2.29 $ 3.68 
The Procter & Gamble Company        11","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 22}"
,,"Common Stock Information  
P&G trades on the New York Stock Exchange under the stoc k symbol PG. As of June  30, 2023, there were approximately five 
million common stock shareowners, including shareowners of record, participants in P&G stock ownership plans and beneficial 
owners with accounts at banks and brokerage firms.  
Shareholder Retur n 
The following graph compares the cumulative total return of P&G’s common stock for the five -year period ended June 30,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 23}"
,,"2023 , against the cumulative total return of the S&P 500 Stock Index (broad market comparison) and the S&P 500 Consumer 
Staples Index (line of business comparison). The graph and table assume $100 was invested on June 30, 2018 , and that all 
dividends were reinvested . 
Cumulative Value of $100 Investment, through June 30  
Company Name/Index  2018  2019  2020  2021  2022  2023  
P&G  $ 100  $ 145  $ 162  $ 188  $ 205  $ 222 
S&P 500  100 110 119 167 149 179","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 23}"
,,"S&P 500  100 110 119 167 149 179 
S&P 500 Consumer Staples  100 116 121 149 159 169 
Item 6. Intentionally Omitted.  
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations .
Forward -Looking Statements  
Certain statements in this report, other than purely historical  information, including estimates, projections, statements relating to 
our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 23}"
,,"“forward -looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section  27A of the 
Securities Act of 1933 and Section  21E of the Securities Exchange Act of 1934. Forward -looking statements may appear 
throughout this report, including without limitation, the following sections: “Management's Discussion and Analysis,” “Risk 
Factors” and ""Notes 4, 8 and 13 to the Consolidated Financial Statements."" These forward -looking statements generally are","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 23}"
,,"identified by the wor ds “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” 
“plan,” “may,” “ should,” “will,” “would,” “will be,” “will continue,” “will likely result” and similar expressions. Forward - 
looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may  
 cause results to differ materially from those expressed or implied in the forward -looking statements. We undertake no","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 23}"
,,"obligation to update or revise publ icly any forward -looking statements, whether because of new information, future events or 
otherwise, except to the extent required by law.
12        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 23}"
,,"Risks and uncertainties to which our forward -looking statements are subject include, without limitation: (1) the abil ity to 
successfully manage global financial risks, including foreign currency fluctuations, currency exchange or pricing controls an d 
localized volatility; (2) the ability to successfully manage local, regional or global economic volatility, including redu ced 
market growth rates, and to generate sufficient income and cash flow to allow the Company to effect the expected share","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 24}"
,,"repurchases and dividend payments; (3) the ability to manage disruptions in credit markets or to our banking partners or 
changes t o our credit rating; (4) the ability to maintain key manufacturing and supply arrangements (including execution of 
supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business 
due to various factors, including ones outside of our control, such as natural disasters, acts of war (including the Russia -Ukraine","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 24}"
,,"War) or terrorism or disease outbreaks; (5) the ability to successfully manage cost fluctuations and pressures, including pri ces 
of commod ities and raw materials and costs of labor, transportation, energy, pension and healthcare; (6) the ability to stay on 
the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing 
consumer habits , evolving digital marketing and selling platform requirements and technological advances attained by, and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 24}"
,,"patents granted to, competitors; (7) the ability to compete with our local and global competitors in new and existing sales 
channels, including by s uccessfully responding to competitive factors such as prices, promotional incentives and trade terms for 
products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and br and 
equity by successfully  managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 24}"
,,"packaging content, supply chain practices or similar matters that may arise; (10) the ability to successfully manage the fina ncial, 
legal, reputational and  operational risk associated with third -party relationships, such as our suppliers, contract manufacturers, 
distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third -party","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 24}"
,,"information and opera tional technology systems, networks and services and maintain the security and functionality of such 
systems, networks and services and the data contained therein; (12) the ability to successfully manage uncertainties related to 
changing political and geop olitical conditions and potential implications such as exchange rate fluctuations and market 
contraction; (13) the ability to successfully manage current and expanding regulatory and legal requirements and matters","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 24}"
,,"(including, without limitation, those laws  and regulations involving product liability, product and packaging composition, 
intellectual property, labor and employment, antitrust, privacy and data protection, tax, the environment, due diligence, ris k 
oversight, accounting and financial reporting) a nd to resolve new and pending matters within current estimates; (14) the ability 
to manage changes in applicable tax laws and regulations; (15) the ability to successfully manage our ongoing acquisition,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 24}"
,,"divestiture and joint venture activities, in each ca se to achieve the Company’s overall business strategy and financial objectives, 
without impacting the delivery of base business objectives; (16) the ability to successfully achieve productivity improvement s 
and cost savings and manage ongoing organizationa l changes while successfully identifying, developing and retaining key","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 24}"
,,"employees, including in key growth markets where the availability of skilled or experienced employees may be limited; (17) th e 
ability to successfully manage the demand, supply and oper ational challenges, as well as governmental responses or mandates, 
associated with a disease outbreak, including epidemics, pandemics or similar widespread public health concerns; (18) the 
ability to manage the uncertainties, sanctions and economic effect s from the war between Russia and Ukraine; and (19) the","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 24}"
,,"ability to successfully achieve our ambition of reducing our greenhouse gas emissions and delivering progress towards our 
environmental sustainability priorities. A detailed discussion of risks and u ncertainties that could cause actual results and events 
to differ materially from those projected herein is included in the section titled ""Economic Conditions and Uncertainties"" an d the 
section titled ""Risk Factors"" (Part I, Item 1A) of this Form 10 -K. 
Purpose, Approach and Non -GAAP Measures","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 24}"
,,"Purpose, Approach and Non -GAAP Measures  
The purpose of Management's Discussion and Analysis (MD&A) is to provide an understanding of Procter & Gamble's 
financial condition, results of operations and cash flows by focusing on changes in certain key measures from year to year. The 
MD&A is provided as a supplement to, and should be read in conjunction with, our Consolidated Financial Statements and 
accompanying Notes. The MD&A is organized in the following sections:  
•Overview
•Summary of 2023  Results","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 24}"
,,"•Overview
•Summary of 2023  Results
•Economic Conditions and Uncertainties
•Results of Operations
•Segment Results
•Cash Flow, Financial Condition and Liquidity
•Critical  Accounting Policies and Estimates
•Other Information
Throughout the MD&A we refer to measures used by management to evaluate pe rformance, including unit volume growth, net 
sales, net earnings, diluted net earnings per common share (diluted EPS) and operating cash flow. We also refer to a number o f","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 24}"
,,"financial measures that are not defined under accounting principles generally accept ed in the United States of America (U.S. 
GAAP), consisting of organic sales growth, core earnings per share (Core EPS), adjusted free cash flow and adjusted free cash  
flow productivity. Organic sales growth is net sales growth excluding the impacts of acqu isitions and divestitures and foreign 
exchange from year -over-year comparisons. Core EPS is diluted EPS excluding certain items that are not judged by","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 24}"
,,"management to be part of the Company's sustainable results or trends.  Adjusted free cash flow is operating cash flow less 
The Procter & Gamble Company        13","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 24}"
,,"capital spending and excluding payments for the transitional tax resulting from  the U.S. Tax Act. Adjusted free cash flow 
productivity is the ratio of adjusted free cash flow to net earnings excluding c ertain one -time items. We believe these m easures 
provide our investors with additional information about our underlying results and trends as well as insight to some of the 
metrics used to evaluate management. The explanation at the end of the MD&A provid es more details on the use and the","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 25}"
,,"derivation of these measures as well as reconciliations to the most directly comparable U.S. GAAP measure.  
Management also uses certain market share and market consumption estimates to evaluate performance relative to com petition 
despite some limitations on the availability and comparability of share and consumption information. References to market 
share and consumption in the MD&A are based on a combination of vendor -purchased traditional brick -and-mortar and online","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 25}"
,,"data in key markets as well as internal estimates. All market share references represent the percentage of sales of our products  
in dollar terms on a constant currency basis relative to all product sales in the category. The Company measures quarter and 
fiscal year -to-date market shares through the most recent period for which market share data is available, which typically 
reflects a lag time of one or two months as compared to the end of the reporting period. Management also uses unit volume","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 25}"
,,"growth to eva luate drivers of changes in net sales. Organic volume growth reflects year -over-year changes in unit volume 
excluding the impacts of acquisitions, divestitures and certain one -time items, if applicable, and is used to explain changes in 
organic sales.  
OVERVIEW  
Procter & Gamble is a global leader in the fast -moving consumer goods industry, focused on providing branded consumer","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 25}"
,,"packaged goods of superior quality and value to our consumers around the world. Our products are sold in appro ximately 180 
countries and territories primarily through mass merchandisers, e -commerce (including social commerce) channels, grocery 
stores, membership club stores, drug stores, department stores, distributors, wholesalers, specialty beauty stores (includ ing 
airport duty -free stores), high -frequency stores, pharmacies, electronics stores and professional channels. We also sell direct to","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 25}"
,,"individual consumers. We have on -the-ground operations in approximately 70 countries.  
Our market environment is highly c ompetitive with global, regional and local competitors. In many of the markets and industry 
segments in which we sell our products, we compete against other branded products, as well as retailers' private -label brands. 
Additionally, many of the product seg ments in which we compete are differentiated by price tiers (referred to as super -","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 25}"
,,"premium, premium, mid -tier and value -tier products). We believe we are well positioned in the industry segments and markets  
in which we operate, often holding a leadership or significant market share position.  
Organizational Structure  
Our organizational structure is comprised of Sector Business Units (SBUs), Enterprise Markets (EMs), Corporate Functions 
(CF) and Global Business Services (GBS).  
Sector Business Units","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 25}"
,,"Sector Business Units  
The Comp any's ten product categories are organized into five SBUs and five reportable segments (under U.S. GAAP): Beauty; 
Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The SBUs are responsible for global brand 
strategy, product upgra des and innovation, marketing plans and supply chain. They have direct profit responsibility for markets","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 25}"
,,"(referred to as Focus Markets) representing the large majority of the Company's sales and earnings and are also responsible f or 
innovation plans, suppl y plans and operating frameworks to drive growth and value creation in the remaining markets (referred 
to as Enterprise Markets). Throughout the MD&A, we reference business results by region, which are comprised of North 
America, Europe, Greater China, Lat in America, Asia Pacific and India, Middle East and Africa (IMEA).","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 25}"
,,14        The Procter & Gamble Company,"{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 25}"
,,"The following provides additional detail on our reportable segments and the ten product categories and brand composition 
within each segment.  
Reportable Segments  % of  
Net Sales (1) % of Net  
Earnings (1) Product Categories (Sub -Categories)  Major Brands  
Beauty  18% 21% Hair Care ( Conditioners, Shampoos, Styling Aids, 
Treatments ) Head & Shoulders, Herbal 
Essences, Pantene, Rejoice  
Skin and Personal Care ( Antiperspirants and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 26}"
,,"Skin and Personal Care ( Antiperspirants and 
Deodorants, Personal Cleansing, Skin Care ) Olay, Old Spice, Safeguard, 
Secret, SK -II 
Grooming (2) 8% 10% Grooming ( Appliances, Female Blades & Razors, 
Male Blades & Razors, Pre - and Post -Shave 
Products, Other Grooming ) Braun, Gillette, Venus  
Health Care  14% 14% Oral Care ( Toothbrushes, Toothpastes, Other Oral 
Care ) Crest, Oral -B 
Personal Health Care ( Gastrointestinal, Pain Relief, 
Rapid Diagnostics, Respiratory, Vitamins/Minerals/","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 26}"
,,"Rapid Diagnostics, Respiratory, Vitamins/Minerals/  
Supplements, Other Personal Health Care ) Metamucil, Neurobion, 
Pepto -Bismol, Vicks  
Fabric & Home 
Care  35% 32% Fabric Care ( Fabric Enhancers, Laundry Additives, 
Laundry Detergents ) Ariel, Downy, Gain, Tide  
Home Care ( Air Care, Dish Care, P&G Professional, 
Surface Care ) Cascade, Dawn, Fairy, 
Febreze, Mr. Clean, Swiffer  
Baby, Feminine & 
Family Care  25% 23% Baby Care ( Baby Wipes, Taped Diapers and Pants ) Luvs, Pampers","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 26}"
,,"Feminine Care ( Adult Incontinence, Feminine Care ) Always, Always Discreet, 
Tampax  
Family Care ( Paper Towels, Tissues, Toilet Paper ) Bounty, Charmin, Puffs  
(1)Percent of Net sales and Net earnings for the fiscal year ended June  30, 2023 (excluding results held in Corporate).
(2)Effective July 1, 2022, the Grooming Sector Business Unit completed the full integration of its Shave Care and Appliances categories to","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 26}"
,,"cohesively serve consumers' grooming needs. This transition included the integration of the management team, strategic decisi on-
making, innovation plans, financial targets, budgets and internal ma nagement reporting.
 Organization Design:  
Sector Business Units 
Beauty : We are a global market leader amongst the beauty categories in which we compete, including hair care and skin and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 26}"
,,"personal care. We are a global market leader in the retail hair care m arket with nearly 20% global market share primarily behind 
our Pantene and Head  & Shoulders brands. In skin and personal care, we offer a wide variety of products, ranging from 
deodorants to personal cleansing to skin care, such as our Olay brand, which i s one of the top facial skin care brands in the 
world with nearly 5% global market share.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 26}"
,,"world with nearly 5% global market share. 
Grooming : We are the global market leader in the blades and razors market. Our global blades and razors market share is more 
than 60%, primarily behind our Gillette  and Venus brands. Our appliances, such as electric shavers and epilators, are sold 
primarily under the Braun brand in a number of markets around the world where we compete against both global and regional","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 26}"
,,"competitors. We hold nearly 25% of the male electr ic shavers market and over 50% of the female epilators market.
Health Care : We compete in oral care and personal health care. In oral care, there are several global competitors in the market, 
and we have the number two market share position with nearly 20%  global market share behind our Crest and Oral -B brands. In 
personal health care, we are a global market leader among the categories in which we compete, including respiratory","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 26}"
,,"treatments, digestive wellness, vitamins and analgesics behind our Vicks, Metam ucil, Pepto -Bismol and Neurobion brands. 
Fabric & Home Care : This segment is comprised of a variety of fabric care products, including laundry detergents, additives 
and fabric enhancers; and home care products, including dishwashing liquids and detergents, surface cleaners and air 
fresheners. In fabric care, we g enerally have the number one or number two market share position in the markets in which we","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 26}"
,,"compete and are the global market leader with over 35% global market share, primarily behind our Tide, Ariel and Downy 
brands. Our global home care market share is  about 25% across the categories in which we compete, primarily behind our 
Cascade, Dawn, Febreze and Swiffer brands. 
Baby, Feminine & Family Care : In baby care, we are a global market leader and compete mainly in taped diapers, pants and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 26}"
,,"baby wipes, with more than 20% global market share. We have the number one or number two market share position in the 
markets in which we compete, primarily behind our Pampers brand . We are a global market leader in the feminine care category 
with over 25% global market sh are, primarily behind our Always and Tampax brands. We also compete in the adult 
incontinence category in certain markets behind Always Discreet, with over 10% market share in the key markets in which we","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 26}"
,,"compete. Our family care business is predominantly a North American business comprised primarily of the Bounty paper towel 
and Charmin toilet paper brands. North America market shares are over 40% for Bounty and over 25% for Charmin.
The Procter & Gamble Company        15","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 26}"
,,"Enterprise Markets  
Enterprise Markets are responsible for sales and profit delivery in specific countries, supported by SBU -agreed innovation and 
supply chain plans, along with scaled services like planning, distribution and customer management. 
Corporate Functions  
Corporate Functions provides com pany -level strategy and portfolio analysis, corporate accounting, treasury, tax, external 
relations, governance, human resources, information technology and legal services. 
Global Business Services","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 27}"
,,"Global Business Services  
Global Business Services provides scaled services in techn ology, process and data tools to enable the SBUs, the EMs and CF to 
better serve consumers and customers. The GBS organization is responsible for providing world -class services and solutions  
that drive value for P&G. 
Strategic Focus  
Procter & Gamble aspir es to serve the world’s consumers better than our best competitors in every category and in every","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 27}"
,,"country in which we compete and, as a result, deliver total shareholder return in the top one -third of our peer group.  Delivering 
and sustaining leadership l evels of shareholder value creation requires balanced top - and bottom -line growth and strong cash 
generation. 
The Company competes in daily -use product categories where performance plays a significant role in the consumer's choice of","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 27}"
,,"brands, and therefore,  play to P&G's strengths. Our focused portfolio of businesses consists of ten product categories where  
P&G has leading market positions, strong brands and consumer -meaningful product technologies. 
Within these categories, our strategic choices are focused  on delighting and winning with consumers. Our consumers are at the 
center of everything we do. We win with consumers by delivering irresistible superiority across five key vectors - product","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 27}"
,,"performance, packaging, brand communication, retail execution and  value. Winning with consumers around the world and  
against our best competitors requires superior innovation. Innovation has always been, and continues to be, P&G’s 
lifeblood.  Superior products delivered with superior execution drive market growth, value  creation for retailers and build share 
growth for P&G.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 27}"
,,"growth for P&G. 
Ongoing productivity improvement is crucial to delivering our balanced top - and bottom -line growth, cash generation and value 
creation objectives. Productivity improvement enables investments to stren gthen the superiority of our brands via product and 
packaging innovation, more efficient and effective supply chains, equity and awareness -building brand advertising and other","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 27}"
,,"programs and expansion of sales coverage and R&D programs. Productivity improvem ents also enable us to mitigate  
challenging cost environments (including periods of increasing commodity and negative foreign exchange impacts). Our 
objective is to drive productivity improvements across all elements of the statement of earnings and balan ce sheet, including  
cost of goods sold, marketing and promotional spending, overhead costs and capital spending.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 27}"
,,"We act with agility and are constructively disrupting our highly competitive industry and the way we do business, including  
how we innovate,  communicate and leverage new technologies, to create more value. 
We are improving operational effectiveness and organizational culture through enhanced clarity of roles and responsibilities,  
accountability and incentive compensation programs.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 27}"
,,"accountability and incentive compensation programs. 
Additionally , within this strategy of superiority, productivity, constructive disruption and organization, we have declared four 
focus areas to strengthen our performance going forward. These are 1) leveraging environmental sustainability as an additiona l 
driver of su perior performing products and packaging innovations, 2) increasing digital acumen to drive consumer and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 27}"
,,"customer preference, reduce cost and enable rapid and efficient decision making, 3) developing next -level supply chain 
capabilities to enable flexibil ity, agility, resilience and a new level of productivity and 4) delivering employee value equation  
for all gender identities, races, ethnicities, sexual orientations, ages and abilities for all roles to ensure we continue to  attract, 
retain and develop th e best talent.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 27}"
,,"retain and develop th e best talent. 
We believe this strategy is right for the long -term health of the Company and our objective of delivering total shareholder return 
in the top one -third of our peer group. 
The Company expects the delivery of the following long -term growth alg orithm will result in total shareholder returns in the  
top third of the competitive, fast -moving consumer goods peer group:","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 27}"
,,"• Organic sales growth above market growth rates in the categories and geographies in which we compete;  
• Core EPS growth of mid -to-high single digits; and  
• Adjusted free cash flow productivity of 90% or greater.  
While periods of significant macroeconomic pressures may cause short -term results to deviate from the long -term growth 
algorithm, we intend to maintain a disciplined approach to i nvesting in our business. 
16        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 27}"
,,"SUMMARY OF 2023 RESULTS
Amounts in millions, except per share amounts 2023  2022  Change vs. 
Prior Year  
Net sales  $ 82,006  $ 80,187  2 % 
Operating income  18,134  17,813  2 % 
Net earnings  14,738  14,793  — % 
Net earnings attributable to Procter & Gamble  14,653  14,742  (1) % 
Diluted net earnings per common share  5.90 5.81 2 % 
Core earnings per share  5.90 5.81 2 % 
Cash flow from operating activities  16,848  16,723  1 %","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 28}"
,,"Cash flow from operating activities  16,848  16,723  1 % 
•Net sales increased 2% to $82.0 billion  versus the prior year. The net sales growth was driven by a mid -single -digit
increase in Health Care, low single -digit increases in Fabric & Home Care, Baby, Feminine & Family Care and Beauty,
partially offset by a low single -digit decrease in Grooming. Organic sales, which excludes the impact of acquisitions and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 28}"
,,"divestitures and foreign exchange, increased 7%. Organic sales increased high single digits in Health Care and Fabric &
Home Care and mid-single  digits in Baby, Feminine & Family Care, Beauty and  Grooming.
•Operating income increased $321 million, or 2%, to $18.1 billion  versus year ago due to the increase in net sales, partially
offset by a modest decrease in operating margin.
•Net earnings decreased modestly by $55 million to $14.7 billion versus year ago as the increase in operating income was","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 28}"
,,"more than fully offset by a higher effective tax rate. Foreign exchange impacts reduced net earnings by approximately $1.4
billion .
•Net earnings attributable to Procter & Gamble decreased $89 million, or 1%, to $14.7 billion  versus the prior year due
primarily to the decrease in net earnings.
•Diluted EPS increased 2% to $5.90  as the decrease in net earnings was more than offset by a re duction in shares
outstanding.
•Cash flow from operating activities was $16.8 billion .","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 28}"
,,"•Cash flow from operating activities was $16.8 billion .
oAdjusted free cash flow, which is operating cash flow less  capital expenditures and certain other impacts, was $14.0
billion.
oAdjusted free cash flow productivity, which is the ratio of adjusted free cash flow to net earnings, was 95%.
ECONOMIC CONDITIONS AND UNCERTAINTIES  
We discuss expectations regarding future performance, events and outcomes, such as our business outlook and objectives, in","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 28}"
,,"annual and quarterly reports, press releases and other written and oral communications. All such statements, except for 
historical and present factual infor mation, are ""forward -looking statements"" and are based on financial data and our business 
plans available only as of the time the statements are made, which may become out -of-date or incomplete. We assume no 
obligation to update any forward -looking stateme nts as a result of new information, future events or other factors, except as","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 28}"
,,"required by law. Forward -looking statements are inherently uncertain and investors must recognize that events could be 
significantly different from our expectations. For more inf ormation on risk factors that could impact our results, please refer to 
“Risk Factors” in Part I, Item 1A of this Form 10 -K. 
Global Economic Conditions. Our products are sold in numerous countries across North America, Europe, Latin America,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 28}"
,,"Asia, Austral ia and Africa, with more than half our sales generated outside the United States. Our largest international markets 
are Greater China, the United Kingdom, Canada, Japan and Germany  and collectively comprise more than 20% of our net sales 
in fiscal 2023 . As such, we are exposed to and impacted by global macroeconomic factors, geopolitical tensions, U.S. and 
foreign government policies and foreign exchange fluctuations. We are also exposed to market risks from operating in","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 28}"
,,"challenging environments including  unstable economic, political and social conditions, civil unrest, natural disasters, debt and 
credit issues and currency controls or fluctuations. These risks can reduce our net sales or erode our operating margins and 
consequently reduce our net earnings  and cash flows.  
Changes in Costs. Our costs are subject to fluctuations, particularly due to changes in commodity and input material prices,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 28}"
,,"transportation costs, other broader inflationary impacts and our own productivity efforts. We have significant exp osures to 
certain commodities and input materials, in particular certain oil -derived materials like resins and paper -based materials like 
pulp. Volatility in the market price of these commodities and input materials has a direct impact on our costs. Disruptions in our","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 28}"
,,"manufacturing, supply and distribution operations due to energy shortages, natural disasters, labor or freight constraints ha ve 
impacted our costs and could do so in the future. New or increased legal or regulatory requirements, along with i nitiatives to 
meet our sustainability goals, could also result in increased costs due to higher material costs and investments in facilitie s and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 28}"
,,"equipment. We strive to implement, achieve and sustain cost improvement plans, including supply chain optimiza tion and 
general overhead and workforce optimization. Increased pricing in response to certain inflationary or cost increases may also  
offset portions of the cost impacts; however, such price increases may impact product consumption. If we are unable to m anage 
cost impacts through pricing actions and consistent productivity improvements, it may adversely impact our net sales, gross","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 28}"
,,"margin, operating margin, net earnings and cash flows.  
The Procter & Gamble Company        17","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 28}"
,,"Foreign Exchange. We have significant translation and transaction expos ure to the fluctuation of exchange rates. Translation 
exposures relate to exchange rate impacts of measuring income statements of foreign subsidiaries that do not use the U.S. dol lar 
as their functional currency. Transaction exposures relate to 1) the impa ct from input costs that are denominated in a currency","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"other than the local reporting currency and 2) the revaluation of transaction -related working capital balances denominated in 
currencies other than the functional currency. In the past three years, wea kening of certain foreign currencies versus the U.S. 
dollar has resulted in significant foreign exchange impacts leading to lower net sales, net earnings and cash flows. Certain","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"countries that recently had and are currently experiencing significant exchang e rate fluctuations include Argentina, Brazil, the 
United Kingdom, Japan, Russia and Turkey. These fluctuations have significantly impacted our historical net sales, net earnin gs 
and cash flows and could do so in the future. Increased pricing in response t o certain fluctuations in foreign currency exchange","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"rates may offset portions of the currency impacts but could also have a negative impact on the consumption of our products, 
which would negatively affect our net sales, gross margin, operating margin, net  earnings and cash flows.  
Government Policies. Our net sales, gross margin, operating margin, net earnings and cash flows could be affected by changes 
in U.S. or foreign government legislative, regulatory or enforcement policies. For example, our net earni ngs and cash flows","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"could be affected by any future legislative or regulatory changes in U.S. or non -U.S. tax policy, including changes resulting 
from the current work being led by the OECD/G20 Inclusive Framework focused on ""Addressing the Challenges of the 
Digitalization of the Economy."" The breadth of the OECD project extends beyond pure digital businesses and, as proposed, is 
likely to impact most large multinational businesses by both redefining jurisdictional taxation rights and establishing a 15%","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"global minimum tax. Our net sales, gross margin, operating margin, net earnings and cash flows may also be impacted by 
changes in U.S. and foreign government policies related to environmental and climate change matters. Additionally, we attempt  
to carefull y manage our debt, currency and other exposures in certain countries with currency exchange, import authorization 
and pricing controls, such as Egypt, Argentina and Pakistan. Further, our net sales, gross margin, operating margin, net earn ings","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"and cash fl ows could be affected by changes to international trade agreements in North America and elsewhere. Changes in 
government policies in the above areas might cause an increase or decrease in our net sales, gross margin, operating margin, net 
earnings and cash  flows.  
Russia -Ukraine War . The war between Russia and Ukraine has negatively impacted our operations. Our Ukraine business","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"includes two manufacturing sites and accounted for less than 1% of consolidated net sales and consolidated net earnings in th e 
fisca l year ended June 30, 2023. Net assets of our Ukraine business accounted for less than 1% of consolidated net assets as of 
June 30, 2023. Our Russia business includes two manufacturing sites. Beginning in March 2022, the Company reduced its 
product portfolio, discontinued new capital investments and suspended media, advertising and promotional activity in Russia.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"The Russia business accounted for approximately 2% of consolidated net sales and consolidated net earnings in the fiscal year  
ended  June 30, 2023. Net assets of our Russia business accounted for less than 2% of consolidated net assets as of June 30, 
2023.  
Future impacts to the Company are difficult to predict due to the high level of uncertainty related to the war's duration,  
 evolu tion and ultimate resolution. Within Ukraine, there is a possibility of physical damage and destruction of our two","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"manufacturing facilities. We may not be able to operate our manufacturing sites and source raw materials from our suppliers o r 
ship finished products to our customers.  
Within Russia, we may not be able to continue our reduced operations at current levels due to sanctions and counter -sanctions, 
monetary, currency or payment controls, legislative restrictions or policies, restrictions on access to financial institutions and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"supply and transportation challenges. Our suppliers, distributors and retail customers are also impacted by the war and their  
 ability to successfully maintain their operations could also impact our operations or negatively im pact the sales of our products. 
More broadly, there could be additional negative impacts to our net sales, earnings and cash flows should the situation escal ate","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"beyond its current scope, including, among other potential impacts, economic recessions in cer tain neighboring countries or 
globally due to inflationary pressures and supply chain cost increases or the geographic proximity of the war relative to the  rest 
of Europe.  
For additional information on risk factors that could impact our business results, please refer to “Risk Factors” in Part I, Item 
1A of this Form 10 -K. 
RESULTS OF OPERATIONS","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"1A of this Form 10 -K. 
RESULTS OF OPERATIONS  
The key metrics included in the discussion of our consolidated results of operations include net sales, gross margin, selling , 
general and adminis trative costs (SG&A), operating margin, other non -operating items, income taxes and net earnings. The 
primary factors driving year -over-year changes in net sales include overall market growth in the categories in which we","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"compete, product initiatives, com petitive activities (the level of initiatives, pricing and other activities by competitors), 
marketing spending, retail executions (both in -store and online) and acquisition and divestiture activity, all of which drive 
changes in our underlying unit volu me, as well as our pricing actions (which can also impact volume), changes in product and 
geographic mix and foreign exchange impacts on sales outside the U.S.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"For most of our categories, our cost of products sold and SG&A are variable in nature to some ex tent. Accordingly, our 
discussion of these operating costs focuses primarily on relative margins rather than the absolute year -over-year changes in total 
costs. The primary drivers of changes in gross margin are input costs (energy and other commodities),  pricing impacts, 
geographic mix (for example, gross margins in North America are generally higher than the Company average for similar","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"products), product mix (for example, the Beauty segment has higher gross margins than the Company average), foreign 
18        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 29}"
,,"exchange rate fluctuations (in situations where certain input costs may be tied to a different functional currency than the 
underlying sales), the impacts of manufacturing savings projects and reinvestments (for example, product or package 
improvements) and,  to a lesser extent, scale impacts (for costs that are fixed or less variable in nature). The primary components 
of SG&A are marketing -related costs and non -manufacturing overhead costs. Marketing -related costs are primarily variable in","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 30}"
,,"nature, although we  may achieve some level of scale benefit over time due to overall growth and other marketing efficiencies. 
While overhead costs are variable to some extent, we generally experience more scale -related impacts for these costs due to our 
ability to leverage o ur organization and systems' infrastructures to support business growth. The main drivers of changes in 
SG&A as a percentage of net sales are overhead and marketing cost savings, reinvestments (for example, increased","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 30}"
,,"advertising), inflation, foreign exch ange fluctuations and scale impacts.  
For a detailed discussion of the fiscal 2022 year -over-year changes, please refer to the MD&A in Part II, Item 7 of the 
Company's Form 10 -K for the fiscal year ended June 30, 2022 . 
Net Sales  
Net sales increased 2% to $82.0 billion  in fiscal 2023 . The increase in net sales was driven by higher pricing of 9% and a","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 30}"
,,"favorable mix o f 1%, partially offset by unfavorable foreign exchange of 5% and a 3% decrease in unit volume versus the prior 
year. Favorable mix was driven by a higher proportion of sales in North America (with higher than Company -average selling 
prices) and decline in Europe (with lower than Company -average selling prices). Excluding the impacts of foreign exchange 
and acquisitions and divestitures, organic sales grew 7%.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 30}"
,,"and acquisitions and divestitures, organic sales grew 7%.  
Net sales increased mid -single digits in Health Care, increased low single digits in Fabric & Home Care, Baby, Feminine & 
Family Care and Beauty and decreased low single digits in Grooming. On a regional basis, volume decreased double digits in 
Europe, mid -single digits in Greater China and low single digits in Asia Pacific, IMEA and North America. Volume increased 
low single digits in Latin America.  
Operating Costs","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 30}"
,,"low single digits in Latin America.  
Operating Costs  
Comparisons as a percentage of net sales; fiscal years ended June 30  2023  2022  Basis Point Change  
Gross margin  47.9 %  47.4 %  50 bps  
Selling, general and administrative expense  25.7 %  25.2 %  50 bps  
Operating margin  22.1 %  22.2 %  (10) bps
Earnings before income taxes  22.4 %  22.4 %  0 bps
Net earnings  18.0 %  18.4 %  (40) bps
Net earnings attributable to Procter & Gamble  17.9 %  18.4 %  (50) bps","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 30}"
,,"Gross margin increased 50 basis points to 47.9%  of net sales. The increase in gross margin was due to:  
•a 430 basis -point increase from higher pricing and
•a 150 basis -point increase from manufacturing productivity savings.
These increases were partially offset by 
•320 basis points of increased commodity and input material costs,
•a 110 basis -point decline from unfavorable mix due to the launch and growth of premium products (which have lower than","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 30}"
,,"Company -average gross margins) and the disproportionate decline of the super -premium SK -II brand,
•a 50 basis -point decline from unfavorable foreign exchange impacts,
•30 basis points due to capacity start -up costs and other manufacturing impacts and
•20 basis points of product and packaging investments.
Total SG&A increased 4% to $21.1 billion due primarily to an increase in overhead costs and other net operating costs. SG&A","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 30}"
,,"as a percentage of net sales increased 50 basis poi nts to 25.7% due to an increase in overhead and other net operating costs as a 
percentage of net sales, partially offset by a decrease in marketing spending as a percentage of net sales.  
•Marketing spending as a percentage of net sales decreased 40 basis p oints due to the positive scale impacts of the net sales
increase and increased productivity savings, partially offset by increased media reinvestments.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 30}"
,,"•Overhead costs as a percentage of net sales increased 40 basis points due to wage inflation and other c ost increases,
partially offset by the positive scale impacts of the net sales increase and productivity savings.
•Other net operating expenses as a percentage of net sales increased 60 basis points due primarily to higher foreign
exchange transactional c harges.
Productivity -driven cost savings delivered 90 basis points of benefit to SG&A as a percentage of net sales.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 30}"
,,"Operating margin decreased 10 basis points to 22.1%  as the increase in gross margin was more than fully offset by the incre ase 
in SG&A as a percentage of net sales as discussed above.
The Procter & Gamble Company        19","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 30}"
,,"Non-Operating Items  
• Interest expense was $756  million, an increase of $317 million versus the prior year due to higher interest rates and an 
increase in short -term debt in the current year.  
• Interest income was $307  million, an increase of $256 million versus the prior year due to higher interest rates.  
• Other non -operating income increased $98 million to $668 million due primarily to a prior year unrealized loss on equity","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 31}"
,,"investments and a current year gain on divestiture of minor brands.  
Income Taxes  
The effective tax rate increased 190 basis points versus the prior year period to 19.7% d ue to:  
• a 100 basis -point increase from lower excess tax benefits of share -based compensation,  
• a 50 basis -point increase from discrete impacts related to uncertain tax positions and  
• a 40 basis -point increase primarily from lower current year deductions for foreign -derived intangible income versus prior 
year.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 31}"
,,"year.  
Net Earnings  
Operating income increased $321 million, or 2 %, to $18.1 billion  due to the increase in net sales, partially offset by a modest 
decrease in operating margin, both of which are discussed above.  
Earnings before income taxes increased $358 million, or 2%, to $18.4 billion  due primarily to the increase in operating income . 
Net earnings declined modestly by $55 million to $14.7 billion due to the increase in earnings before income taxes, more than","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 31}"
,,"fully offset by the increase in the effective income tax rate discussed above. Foreign exchange impacts reduced net earnings by 
approximately $1.4 billion  due to a weakening of certain currencies against the U.S. dollar. This impact includes both  
transactional charges and translational impacts from converting earnings from foreign subsidiaries to U.S. dolla rs. 
Net earnings attributable to Procter & Gamble decreased $89 million, or 1%, to $14.7 billion .","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 31}"
,,"Diluted EPS increased $0.09, or 2%, to $5.90  as the decrease in net earnings was more than fully offset by a reduction in shares 
outstanding.  
SEGMENT RESULTS  
Segment results reflect information on the same basis we use for internal management reporting and performance evaluation.  
The results of these reportable segments do not include certain non -business unit specific costs which are reported in our","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 31}"
,,"Corporate  segment and are included as part of our Corporate segment discussion. Additionally, we apply blended statutory tax 
rates in the segments. Eliminations to adjust segment results to arrive at our consolidated effective tax rate are included i n 
Corporate. Se e Note 2 to the Consolidated Financial Statements for additional information on items included in the Corporate 
segment.   
 Net Sales Change Drivers 2023 vs. 2022 (1) 
 Volume with 
Acquisitions & 
Divestitures   Volume 
Excluding","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 31}"
,,"Volume with 
Acquisitions & 
Divestitures   Volume 
Excluding 
Acquisitions & 
Divestitures   Foreign 
Exchange   Price   Mix  Other (2)  Net Sales 
Growth  
Beauty  (1) %  (2) %  (5) %  8 %  (1) %  1 %  2 % 
Grooming  (3) %  (3) %  (7) %  9 %  (2) %  — %  (3) % 
Health Care  (1) %  (1) %  (4) %  5 %  4 %  — %  4 % 
Fabric & Home Care  (4) %  (4) %  (5) %  11 %  1 %  — %  3 % 
Baby, Feminine & Family Care  (3) %  (3) %  (4) %  8 %  1 %  — %  2 % 
TOTAL COMPANY  (3)%  (3)%  (5)%  9 %  1 %  — %  2 %","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 31}"
,,"TOTAL COMPANY  (3)%  (3)%  (5)%  9 %  1 %  — %  2 % 
(1) Net sales percentage changes are approximations based on quantitative formulas that are consistently applied. 
(2) Other includes the sales mix impact from acquisitions and divestitures and rounding impacts necessary to reconcile volume to net sales.   
BEAUTY  
($ millions)  2023  2022  Change vs. 2022  
Volume  N/A  N/A  (1)%  
Net sales  $15,008   $14,740   2% 
Net earnings  $3,178   $3,160   1% 
% of net sales  21.2%   21.4%   (20) bps","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 31}"
,,"% of net sales  21.2%   21.4%   (20) bps  
Beauty net sales increased 2% to  $15.0 billion  as the positive impacts of higher pricing of 8% and benefit from acquisitions of 
1% were partially offset  by unfavorable foreign exchange of 5%, unfavorable mix of 1% (due primarily to the decline of the 
super -premium SK -II brand, which has higher than segment -average selling prices) and a 1% decrease in unit volume .  
20        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 31}"
,,"Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 6% . Global market share of 
the Beauty segment increased 0.3 points . 
•Hair Care net sales increased low single digits . Positive impacts of higher pricing (driven by all regions) and benefit from
acquisitions were partially offset by the negative impacts of unfavorable foreign exchange and a decrease in unit volume.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 32}"
,,"Mix had a neutral impact on net sales. The volume decrea se was driven primarily by declines in Europe (due to portfolio
reduction in Russia and increased pricing), Greater China (due to market contraction and pandemic -related disruptions) and
Asia Pacific (due to increased pricing). Organic sales increased high  single digits driven by 20% growth in Latin America
and double -digit growth in Europe and North America, partially offset by a mid -single -digit decline in Greater China .","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 32}"
,,"Global market share of the hair care category decreased more than half a point .
•Skin and Personal Care net sales increased low single digits . Positive impacts of higher pricing (across all regions), a unit
volume increase and a benefit from acquisitions were partially offset by the negative impacts from unfavorable mix (due
primarily to t he decline of the super -premium SK -II brand) and unfavorable foreign exchange. The volume increase was","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 32}"
,,"driven primarily by growth in North America, Latin America and Greater China (all due to innovation) , partially offset by a
decline in Asia Pacific (due to the decline of the super -premium SK -II brand in the travel retail channel). Organic sales
increased mid -single digits  as more than 20% increases in Latin America and Europe and a double -digit increase in North
America were partially offset by a double -digit decrease  in Asia Pacific. Global market share of the skin and personal care","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 32}"
,,"category increased nearly a point .
Net earnings increased 1% to $3.2 billion due to the increase in net sales, partially offset by a 20 basis -point decrease in net 
earnings ma rgin. Net earnings margin decreased due to a reduction in gross margin, partially offset by a reduction in SG&A as a 
percentage of net sales. The gross margin reduction was driven by negative product mix (due to the decline of the super -","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 32}"
,,"premium SK -II bran d), increased commodity costs and unfavorable foreign exchange, partially offset by increased pricing. 
SG&A as a percentage of net sales decreased primarily due to a decrease in marketing spending.  
GROOMING  
($ millions) 2023  2022  Change vs.  2022  
Volume  N/A N/A (3)%  
Net sales  $6,419  $6,587  (3)%  
Net earnings  $1,461  $1,490  (2)%  
% of net sales  22.8%  22.6%  20 bps","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 32}"
,,"% of net sales  22.8%  22.6%  20 bps  
Grooming net sales decreased 3% to $6.4 billion driven by unfavorable foreign exchange of 7%, a 3% decrease in unit volume 
and unfavorable mix of 2% (due to decline of appliances, which have higher than segment -average selling prices), partially 
offset by  higher pricing of 9% (driven by all regions). The volume decrease was primarily driven by decreases in Europe (due","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 32}"
,,"to portfolio reduction in Russia and increased pricing) and North America (due to market contraction and increased pricing). 
Excluding the impact of acquisitions and divestitures and foreign exchange, organic sales increased 5% driven by growth in all 
regions led by a more than 20% growth in Latin America and a double -digit growth in Asia Pacific. Global market share of the 
Grooming segment i ncreased 1 point.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 32}"
,,"Grooming segment i ncreased 1 point.  
Net earnings decreased 2% to $1.5 billion due to the decrease in net sales, partially offset by a 20 basis -point increase in net 
earnings margin. Net earnings margin increased as a decrease in gross margin was more than fully offset by a decrease in 
SG&A as a percentage of net sales. The gross margin decrease was driven by unfavorable product mix (due to a","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 32}"
,,"disproportionate decline of higher gross margin appliances such as premium shavers), commodity cost increases and 
unfavorable foreig n exchange, partially offset by higher pricing and productivity savings. SG&A as a percentage of net sales 
decreased due primarily to a decrease in marketing spending.  
HEALTH CARE  
($ millions) 2023 2022 Change vs. 2022
Volume  N/A N/A (1)%  
Net sales  $11,226  $10,824  4% 
Net earnings  $2,125  $2,006  6% 
% of net sales  18.9%  18.5%  40 bps","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 32}"
,,"% of net sales  18.9%  18.5%  40 bps  
Health Care net sales increased 4% to  $11.2 billion  driven by higher pricing of 5% and favorable mix of 4% (due to growth in 
North America and the Personal Health Care category, both of which have higher than segment -average selling prices), partially 
offset by unfavorable foreign exchange of 4% and a 1% decrease in unit volume. Excluding the impact of foreign  exchange and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 32}"
,,"acquisitions and divestitures, organic sales increased 8% . Global market share of the Health Care segment decreased 0.2 points .
The Procter & Gamble Company        21","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 32}"
,,"•Oral Care net sales decreased low single digits . Negative impacts of unfavorable foreign exchange and a unit volum e
decrease were partially offset by increased pricing (driven primarily by North America and Europe) and favorable premium
product mix. Volume decline was primarily driven by Europe (due to portfolio reduction in Russia and increased pricing),
North Ameri ca (due to increased pricing) and Greater China (due to market contraction, especially in the power brush","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 33}"
,,"market). Organic sales increased low single digits  driven by a more than 20% growth in Latin America and a low single - 
digit growth in North America. Global market share of the oral care category was unchanged .
•Personal Health Care net sales increased double digits . Positive impacts of favorable mix (due to the disproportionate
growth of North America and respiratory products, both of which have higher  than category -average selling prices), higher","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 33}"
,,"pricing (driven primarily by North America, Europe and Latin America) and a unit volume increase were partially offset by
unfavorable foreign exchange. Volume increase was primarily driven by growth in North A merica (due to innovation and a
stronger respiratory season) and Latin America, partially offset by a decline in IMEA (versus a prior year impacted by
pandemic -related consumption increases in certain markets ). Organic sales increased mid -teens driven by a  high teens","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 33}"
,,"increase in North America,  a mid -teens increase in Europe  and a low teens  increase in Latin America. Global market share
of the personal health care category was unchanged .
Net earnings increased 6% to  $2.1 billion  due to the increase in net sales and a 40 basis -point increase in net earnings margin. 
Net earnings margin increased as a decrease in gross margin was more than fully offset by a decrease in SG&A as a percentage","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 33}"
,,"of net sales. The decrease in gross margin was driven by unfavorable product mix (due to the growth of products such as 
manual brushes, which have lower gross margins ) and increased commodity and input material costs, partially offset by 
increased pricing. SG&A as a percentage of net sales decrea sed due to the positive scale impacts of the net sales increase and 
lower marketing spending, partially offset by increased overhead spending.  
FABRIC & HOME CARE  
($ millions)  2023 2022 Change vs. 2022","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 33}"
,,"FABRIC & HOME CARE  
($ millions)  2023 2022 Change vs. 2022  
Volume  N/A N/A (4)%  
Net sales  $28,371  $27,556  3% 
Net earnings  $4,828  $4,386  10% 
% of net sales  17.0%  15.9%  110 bps  
Fabric & Home Care net sales increased 3% to  $28.4 billion  driven by higher pricing of 11% and favorable mix of 1% (due to a 
disproportionate volume d ecline in Europe , which has lower than segment -average selling prices), partially offset by","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 33}"
,,"unfavorable foreign exchange of 5% and a 4% decrease in unit volume . Excluding the impact of foreign exchange and 
acquisitions  and divestitures, organic sales increased 8% . Global market share of the Fabric & Home Care segment was 
unchanged.  
•Fabric Care net sales increased low single digits . Positive impacts of higher pricing (driven by all regions) and favorable
geographic mix ( due to decline in Europe, which has lower than category -average selling prices) were partially offset by","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 33}"
,,"unfavorable foreign exchange and a decrease in unit volume. The volume decrease was primarily driven by declines in
Europe (due to increased pricing an d portfolio reduction in Russia), North America (due to increased pricing and market
contraction) and Greater China (due to portfolio reductions and market contraction) . Organic sales increased high single
digits  driven by more than 20% increases in Latin America and IMEA, high single -digit increases in Asia Pacific and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 33}"
,,"Europe and a low single -digit increase in North America. Global market share of the fabric care category decreased nearly
a point .
•Home Care net sales increased mid -single digits . Positive  impacts of higher pricing (driven primarily by Europe and North
America) and favorable product mix were partially offset by unfavorable foreign exchange and a decrease in unit volume.
The volume decrease was driven by declines in Europe (due to market con traction and increased pricing ) and North","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 33}"
,,"America ( due to market contraction).  Organic sales increased high single digits  driven by a mid -teens growth in Europe
and a high single -digit growth in North America. Global market share of the home care category increased more than a
point .
Net earnings increased 10% to  $4.8 billion  due to the increase in net sales and a 110 basis -point increase in net earnings margin.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 33}"
,,"Net earnings margin increased due to an increase in gross margin, partially offset by an increase in SG&A as a percentage of net 
sales. The gross margin increase was driven by increased pricing, partially offset by an increase in commodity and input 
mater ial costs, unfavorable foreign exchange and unfavorable product mix. SG&A as a percentage of net sales increased due to 
an increase in media spending, partially offset by the positive scale effects of the net sales increase.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 33}"
,,22        The Procter & Gamble Company,"{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 33}"
,,"BABY, FEMININE & FAMILY CARE  
($ millions)  2023  2022  Change vs. 2022  
Volume  N/A N/A (3)%  
Net sales  $20,217  $19,736  2% 
Net earnings  $3,545  $3,266  9% 
% of net sales  17.5%  16.5%  100 bps  
Baby, Feminine & Family Care net sales increased 2% to  $20.2 billion  as the positive impacts of higher pricing of 8% and 
favorable mix of 1% (due to a higher proportion of sales in North America, which has higher than segment -average selling","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 34}"
,,"prices) were partially offset by unfavorable foreign exchange of 4% and a 3% decr ease in unit volume . Excluding the impact of 
foreign exchange and acquisitions and divestitures, organic sales increased 6% . Global market share of the Baby, Feminine & 
Family Care segment was unchanged . 
•Baby Care net sales decreased low single digits. Negative impacts of a decrease in unit volume and unfavorable foreign","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 34}"
,,"exchange were partially offset by higher pricing (across all regions) and favorable product and geographic mix (due to a
higher proportio n of sales in North America). The volume decrease was driven primarily by declines in Europe (due to
increased pricing and portfolio reduction in Russia), North America (due to increased pricing) and Greater China. Organic
sales increased mid -single digits  driven by a more than 30% growth in Latin America, high single -digit growth in IMEA","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 34}"
,,"and mid -single -digit growth in North America and Europe, partially offset by a double -digit decline in Greater China.
Global market share of the baby care category was u nchanged.
•Feminine Care net sales increased mid -single digits. Positive impacts of higher pricing (driven by all regions) and
favorable product and geographic mix (due to a decline in Europe, which has lower than category -average selling prices)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 34}"
,,"were part ially offset by unfavorable foreign exchange and a decrease in unit volume. The volume decrease was driven
primarily by declines in Europe (due to portfolio reduction in Russia and increased pricing) and IMEA (due to increased
pricing). Organic sales incre ased double digits driven by growth in all regions led by a mid -teens increase in Europe and a
double -digit increase in North America. Market share of the feminine care category increased nearly half a point.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 34}"
,,"•Net sales in Family Care, which is predominantl y a North American business, increased low single digits driven by higher
pricing. Unit volume had a neutral impact on net sales. Organic sales increased mid -single digits. North America's share of
the family care category decreased nearly half a point.
Net earnings increased 9% to  $3.5 billion  due to the increase in net sales and a 100 basis -point increase in net earnings margin.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 34}"
,,"Net earnings margin increased primarily due to an increase in gross margin and a modest decrease in SG&A as a percentage of 
net sales. Gross margin increased due to increased pricing, partially offset by an increase in commodity and input material 
costs. SG&A as a percentage of net sales decreased due to the positive scale effects of the net sales increase partially offset by 
an increase in other operating expense.  
CORPORATE  
($ millions)  2023 2022 Change vs. 2022  
Net sales  $765  $744  3%","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 34}"
,,"Net sales  $765  $744  3% 
Net earnings/(loss)  $(399)  $485  N/A 
Corporate includes certain operating and non -operating activities not allocated to specific business segments. These include but 
are not limited to incidental businesses managed at the corporate level, gains and losses related to certain divested brands or 
businesses, impacts from various financing and investing activities, impacts related to employee benefits, asset impairments and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 34}"
,,"restructuring activities including manufacturing and workforce optimization. Corporate also includes reconciling items to adj ust 
the accounting policies used within the reportable segments to U.S. GAAP. The most notable ongoing reconciling item is 
income taxes, which adjusts the blended statutory rates that are reflected in the reportable segments to the overall Company 
effectiv e tax rate.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 34}"
,,"effectiv e tax rate.  
Corporate net sales increased 3% to  $765 million  due to an increase in net sales of the incidental businesses managed at the 
corporate level. Corporate net earnings decreased $884 million to a loss of $399 million primarily due to higher interest 
expense, lower excess tax benefits of share -based compen sation and higher foreign exchange transactional charges, partially 
offset by the increase in net sales of the incidental businesses and higher interest income.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 34}"
,,"Restructuring Program to Deliver Productivity and Cost Savings  
The Company ha s historically had an ongoing restructuring program with annual spending in the range of $250 to $500 million. 
Savings generated from the Company's restructuring program are difficult to estimate, given the nature of the activities, the  
timing of the exec ution and the degree of reinvestment. In fiscal 2023 , the Company incurred before tax restructuring costs","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 34}"
,,"within the range of our historical annual ongoing level of $250 to $500 million.
The Procter & Gamble Company        23","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 34}"
,,"Restructuring accruals of $174 million as of June  30, 2023, are clas sified as current liabilities. Approximately 87% of the 
restructuring charges incurred in fiscal 2023  either have been or will be settled with cash. Consistent with our policies for 
ongoing restructuring -type activities, the resulting charges are funded b y and included within Corporate for segment reporting.  
In addition to our restructuring programs, we have additional ongoing savings efforts in our supply chain, marketing and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 35}"
,,"overhead areas that yield additional benefits to our operating margins.  
CASH FLOW, FINANCIAL CONDITION AND LIQUIDIT Y 
We believe our financial condition continues to be of high quality, as evidenced by our ability to generate substantial cash from 
operations and to readily access capital markets at competitive rates.  
Operating cash flow provides the primary source of ca sh to fund operating needs and capital expenditures. Excess operating","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 35}"
,,"cash is used first to fund shareholder dividends. Other discretionary uses include share repurchases and acquisitions to 
complement our portfolio of businesses, brands and geographies. As necessary, we may supplement operating cash flow with 
debt to fund these activities. The overall cash position of the Company reflects our strong business results and a global cas h 
management strategy that takes into account liquidity management, econom ic factors and tax considerations.  
Cash Flow Analysis","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 35}"
,,"Cash Flow Analysis  
($ millions) 2023 2022
Net cash provided by operating activities  $ 16,848  $ 16,723  
Net cash used in investing activities  (3,500)  (4,424)  
Net cash used in financing activities  (12,146)  (14,876)  
Adjusted Free Cash Flow  14,011  13,792  
Adjusted Free Cash Flow Productivity  95 %  93 % 
Operating Cash Flow  
Operating cash flow was $16.8 billion  in 2023 , a 1% increase versus the prior year. Net earnings, adjusted for non -cash items","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 35}"
,,"(depreciation and amortization, share -based compensation, deferred income taxes and gain on sale of assets) generated 
approximately $17.5 billion  of operating cash flow. Working cap ital and other impacts used $656 million  of operating cash 
flow as summarized below.  
•An increase in Accounts receivable used $307 million  of cash primarily due to sales growth. The number of days sales
outstanding increased approximately 1 day versus prior year.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 35}"
,,"outstanding increased approximately 1 day versus prior year.
•Higher inventory used $119 million  of cash due to increased safety stock levels to strengthen supply chain sufficiency.
Inventory days on hand was flat versus year ago.
•Accounts payable and Accrued and other liabilities provided $313 million of cash, primarily driven by increases in taxes
payable and accrued compensation expense, partially offset by a reduction in trade payables. Th e reduction in trade","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 35}"
,,"payables was due to lower supply chain payables from a decrease in commodity and transportation costs, partially offset by
the impact of extended payment terms with suppliers (see Extended Payment Terms and Supply Chain Financing below).
Days payable outstanding decreased approximately 3 days versus prior year.
•Other net operating assets and liabilities used $543 million  of cash primarily driven by pension -related contributions.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 35}"
,,"Adjusted Free Cash Flow. We view adjusted free cash flow as an important non -GAAP measure because it is a factor 
impacting the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investments. It  is 
defined as operating cash flow less capital expenditures and excluding  payments for the transitional tax resulting from the U.S. 
Tax Act. Adjusted free cash flow is one of the measures used to evaluate senior management and determine their at -risk","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 35}"
,,"compensation.  
Adjusted free cash flow was $14.0 billion  in 2023 , an increase of 2% versus the prior year. The increase was primarily driven 
by the increase in operating cash flows  as discussed above. Adjusted free cash flow productivity, defined as the ratio of adjusted 
free cash flow to net earnings, was 95% in 2023 .  
Extended Payment Terms and Supply Chain Financing . Beginning in fiscal 2014, in response to evolving market practices,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 35}"
,,"the Company began a program to negotiate extended payment terms with its suppliers. At the same time, the Company initiated 
a Supply Chain Finance program (the ""SCF"") with a number of global financial institutions (the ""SCF Banks""). Under the SCF, 
qualifying suppliers may elect to sell their receivables from the Company to an SCF Bank. These participating suppliers 
negotiate their rece ivables sales arrangements directly with the respective SCF Bank. While the Company is not party to those","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 35}"
,,"agreements, the SCF Banks allow the participating suppliers to utilize the Company’s creditworthiness in establishing credit 
spreads and associated co sts. This generally provides the suppliers with more favorable terms than they would be able to secure 
on their own. The Company has no economic interest in a supplier’s decision to sell a receivable. Once a qualifying supplier 
elects to participate in the  SCF and reaches an agreement with an SCF Bank, they elect which individual Company invoices","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 35}"
,,"they sell to the SCF bank. However, all the Company’s payments to participating suppliers are paid to the SCF Bank on the 
invoice due date, regardless of whether the individual invoice is sold by the supplier to the SCF Bank. The SCF Bank pays the 
supplier on the invoice due date for any invoices that were not previously sold to the SCF Bank under the SCF.  
24        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 35}"
,,"The terms of the Company’s payment obligation are not impac ted by a supplier’s participation in the SCF. Our payment terms 
with our suppliers for similar services and materials within individual markets are consistent between suppliers that elect t o 
participate in the SCF and those that do not participate. Accordi ngly, our average days outstanding are not significantly 
impacted by the portion of suppliers or related input costs that are included in the SCF. In addition, the SCF is available t o both","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 36}"
,,"material suppliers, where the underlying costs are largely include d in Cost of goods sold, and to service suppliers, where the 
underlying costs are largely included in SG&A. As of June 30, 2023 , approximately 3% of our global suppliers have elected to 
participate in the SCF. Payments to those suppliers during fiscal year  2023 were approximately $18 billion,  which equals 
approximately 29% of our total Cost of goods sold and SG&A for the year. For participating suppliers, we believe substantiall y","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 36}"
,,"all of their receivables with the Company are sold to the SCF Banks. According ly, we would expect that at each balance sheet 
date, a similar proportion of amounts originally due to suppliers would instead be payable to SCF Banks. All outstanding 
amounts related to suppliers participating in the SCF are recorded within Accounts paya ble in our Consolidated Balance Sheets, 
and the associated payments are included in operating activities within our Consolidated Statements of Cash Flows. As of","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 36}"
,,"June 30, 2023  and 2022 , the amounts due to suppliers participating in the SCF and included in Accounts payable were 
approximately $6 billion.  
Although difficult to project due to market and other dynamics, we anticipate incremental cash flow benefits from the extende d 
payment terms with suppliers could increase at a slower rate in fiscal 2024 . Futu re changes in our suppliers’ financing policies","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 36}"
,,"or economic developments, such as changes in interest rates, general market liquidity or the Company’s credit -worthiness 
relative to participating suppliers, could impact suppliers’ participation in the SCF  and/or our ability to negotiate extended 
payment terms with our suppliers. However, any such impacts are difficult to predict.  
Investing Cash Flow  
Net investing activities used $3.5 billion  of cash in 2023 , primarily due to capital spending and acquisitio ns.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 36}"
,,"Capital Spending. Capital expenditures, primarily to support capacity expansion, innovation and cost efficiencies, were $3.1 
billion  in 2023 . Capital spending as a percentage of net sales decreased 20 basis points to 3.7%  in 2023 .  
Acquisitions. Acqui sition activity used cash of $765 million  in 2023 , primarily related to a Beauty acquisition.  
Financing Cash Flow  
Net financing activities consumed $12.1 billion of cash in 2023, mainly due to dividends to shareholders and treasury stock","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 36}"
,,"purchases, partially offset by a net debt increase and the impact of stock options and other.  
Dividend Payments. Our first discretionary use of cash is dividend payments. Dividends per common share increased 4% to 
$3.6806  per share in 2023 . Total dividend payments to common and preferred shareholders were $9.0 billion  in 2023 . In April 
2023, the Board of Directors declared a 3% increase in our quarterly dividend from $0.9133 to $0.9407 per share on Common","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 36}"
,,"Stock and Series A and B Employee Stock Ownership Pl an (ESOP) Convertible Class  A Preferred Stock. This is the 67th 
consecutive year that our dividend has increased. We have paid a dividend for 133 consecutive years, every year since our 
incorporation in 1890.  
Long -Term and Short -Term Debt. We maintain debt  levels we consider appropriate after evaluating a number of factors, 
including cash flow expectations, cash requirements for ongoing operations, investment and financing plans (including","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 36}"
,,"acquisitions and share repurchase activities) and the overall cost o f capital. Total debt was $34.6 billion  as of June 30, 2023 . We 
generated $2.9 billion from net debt issuances in  short -term debt and long -term debt markets.  
Treasury Purchases. Total share repurchases were $7.4 billion  in 2023 . 
Impact of Stock Options an d Other. The exercise of stock options and other financing activities generated $1.3 billion  of cash 
in 2023 .  
Liquidity","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 36}"
,,"in 2023 .  
Liquidity  
At June 30, 2023 , our current liabilities exceeded current assets by $13.1 billion , largely due to short -term borrowings under our 
commercial paper program. We anticipate being able to support our short -term liquidity and operating needs largely through 
cash generated from operations. The Company regularly assesses its cash needs and the available sources to fund these needs.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 36}"
,,"As of June 30, 2023 , the Company had $5.1 billion of cash and cash equivalents related to foreign subsidiaries, primarily in 
various European and Asian countries . We did not have material cash and cash equivalents related to any country subject to 
exchange controls  that significantly restrict our ability to access or repatriate the funds. Under current law, we do not expect","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 36}"
,,"restrictions or taxes on repatriation of cash held outside of the U.S. to have a material effect on our overall liquidity, fi nancial 
condition o r the results of operations for the foreseeable future.  
We utilize short - and long -term debt to fund discretionary items, such as acquisitions and share repurchases. We have strong 
short - and long -term debt ratings, which have enabled and should continue to enable us to refinance our debt as it becomes due","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 36}"
,,"at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial 
institutions that, if needed, should provide sufficient funding to meet short -term financing requirements.  
On June 30, 2023 , our short -term credit ratings were P -1 (Moody's) and A -1+ (Standard  & Poor's), while our long -term credit 
ratings were Aa3 (Moody's) and AA - (Standard  & Poor's), all with a stable outlook.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 36}"
,,"We maintain bank credi t fac ilities to support our ongoing commercial paper program. The current facility is an $8.0 billion 
facility split between a $3.2 billion five -year facility and a $4.8 billion 364 -day facility, which expire in November 2027 and 
The Procter & Gamble Company        25","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 36}"
,,"November 2023, respective ly. Both facilities can be extended for certain periods of time as specified in the terms of the credit 
agreement. These facilities are currently undrawn and we anticipate that they will remain undrawn. These credit facilities do  not 
have cross -default or ratings triggers, nor do they have material adverse events clauses, except at the time of signing. In addition","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 37}"
,,"to these credit facilities, we have an automatically effective registration statement on Form S -3 filed with the SEC that is  
available for regis tered offerings of short - or long -term debt securities. For additional details on debt, see Note 10 to the 
Consolidated Financial Statements.  
Guarantees and Other Off -Balance Sheet Arrangements  
We do not have guarantees or other off -balance sheet financing arrangements, including variable interest entities, which we","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 37}"
,,"believe could have a material impact on our financial condition or liquidity.  
Contractual Commitments  
The following table provides information on the amount and payable date of our contractual commitments as of June 30, 2023 . 
($ millions)  Total  Less Than 1 Year   1-3 Years   3-5 Years   After 5 Years  
RECORDED LIABILITIES           
Total debt  $ 35,248    $ 10,316    $ 5,328    $ 5,899    $ 13,705   
Leases   911    222    322    171    196","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 37}"
,,"Leases   911    222    322    171    196  
U.S. Tax Act transitional charge (1)  1,575     421    1,154     —    —  
OTHER           
Interest payments relating to long -term debt   5,727     713    1,245     946    2,823   
Minimum pension funding (2)  591    192    399    —    —  
Purchase obligations (3)  2,989     1,169     976    482    362  
TOTAL CONTRACTUAL COMMITMENTS  $ 47,041    $ 13,033    $ 9,424    $ 7,498    $ 17,086","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 37}"
,,"(1) Represents the U.S. federal tax liability associated with the repatriation provisions of the U.S. Tax Act.  
(2) Represents future pension payments to comply with local funding requirements. These future pension payments assume the Compan y 
continues to meet its future statutory funding requirements. Considering the current economic environment in which the Compan y  
operates, the Company believes its cash flows are adequate to meet the future statutory funding requirements. The projected payments","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 37}"
,,"beyond fiscal year 2026 are not currently determinable. 
(3) Primarily reflects future contractual payments under various take -or-pay arrangements entered into as part of the normal course of  
business. Commitments made under take -or-pay obligations represent minimum commitments with suppliers and are in line with  
expected usage. This includes service contracts for information technology, human resources management and facilities managem ent","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 37}"
,,"activities that have been outsourced. While the amounts listed represent contractual obligations, we do not believe it is lik ely that the full 
contractual amount would be paid if the underlying contracts were canceled prior to maturity. In such cases, we generally are  able to 
negotiate new contracts or cancellation penalties, resulting in a reduced payment. The amounts do not incl ude other contractual purchase","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 37}"
,,"obligations that are not take -or-pay arrangements. Such contractual purchase obligations are primarily purchase orders at fair value that 
are part of normal operations and are reflected in historical operating cash flow trend s. We do not believe such purchase obligations will 
adversely affect our liquidity position.  
CRITICAL ACCOUNTING POLICIES AND ESTIMATES  
In preparing our financial statements in accordance with U.S. GAAP, there are certain accounting poli cies that may require a","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 37}"
,,"choice between acceptable accounting methods or may require substantial judgment or estimation in their application. These 
include revenue recognition, income taxes, certain employee benefits and goodwill and intangible assets. We b elieve these 
accounting policies, and others set forth in Note 1 to the Consolidated Financial Statements, should be reviewed as they are 
integral to understanding the results of operations and financial condition of the Company.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 37}"
,,"The Company has discussed the selection of critical  accounting policies  and the effect of estimates with the Audit Committee of 
the Company's Board of Directors.  
Revenue Recognition  
Our revenue is primarily generated from the sale of finished product to customers. Those sales predo minantly contain a single 
performance obligation and revenue is recognized at a single point in time when ownership, risks and rewards transfer, which","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 37}"
,,"can be on the date of shipment or the date of receipt by the customer. Trade promotions, consisting prim arily of customer  
pricing allowances, in -store merchandising funds, advertising and other promotional activities and consumer coupons, are  
offered through various programs to customers and consumers.  Sales are recorded net of trade promotion spending, wh ich is 
recognized as incurred at the time of the sale.  Amounts accrued for trade promotions at the end of a period require estimation,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 37}"
,,"based on contractual terms, sales volumes and historical utilization and redemption rates.  The actual amounts paid may be  
different from such estimates.  These differences, which have historically not been significant, are recognized as a change in 
management estimate in a subsequent period.  
Income Taxes  
Our annual tax rate is determined based on our income, statutory tax rat es and the tax impacts of items treated differently for tax","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 37}"
,,"purposes than for financial reporting purposes. Also inherent in determining our annual tax rate are judgements and  
26        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 37}"
,,"assumptions regarding the recoverability of certain deferred tax balances, prim arily net operating loss and other carryforwards, 
and our ability to uphold certain tax positions.  
Realization of net operating losses and other carryforwards is dependent upon generating sufficient taxable income in the 
appropriate jurisdiction prior to t he expiration of the carryforward periods, which involves business plans, planning","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 38}"
,,"opportunities and expectations about future outcomes. Although realization is not assured, management believes it is more 
likely than not that our deferred tax assets, net  of valuation allowances, will be realized.  
We operate in multiple jurisdictions with complex tax policy and regulatory environments. In certain of these jurisdictions, we 
may take tax positions that management believes are supportable but are potentially subject to successful challenge by the","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 38}"
,,"applicable taxing authority. These interpretational differences with the respective governmental taxing authorities can be  
 impacted by the local economic and fiscal environment.  
A core operating principle is that our  tax structure is based on our business operating model, such that profits are earned in line 
with the business substance and functions of the various legal entities in the jurisdictions where those functions are perfor med.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 38}"
,,"However, because of the complexi ty of transfer pricing concepts, we may have income tax uncertainty related to the 
determination of intercompany transfer prices for our various cross -border transactions. We have obtained and continue to 
prioritize the strategy of seeking advance rulings  with tax authorities to reduce this uncertainty. We estimate that our current 
portfolio of advance rulings reduces this uncertainty with respect to over 70% of our global earnings. We evaluate our tax","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 38}"
,,"positions and establish liabilities in accordance wit h the applicable accounting guidance on uncertainty in income taxes. We 
review these tax uncertainties considering changing facts and circumstances, such as the progress of tax audits, and adjust t hem 
accordingly. We have several audits in process in vario us jurisdictions. Although the resolution of these tax positions is 
uncertain, based on currently available information, we believe that the ultimate outcomes will not have a material adverse","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 38}"
,,"effect on our financial position, results of operations or cas h flows.  
Because there are several estimates and assumptions inherent in calculating the various components of our tax provision, cert ain 
future events such as changes in tax legislation, geographic mix of earnings, completion of tax audits or earnings rep atriation 
plans could have an impact on those estimates and our effective tax rate. See Note 5 to the Consolidated Financial Statements","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 38}"
,,"for additional details on the Company's income taxes.  
Employee Benefits  
We sponsor various postretirement benefits thro ughout the world. These include pension plans, both defined contribution plans 
and defined benefit plans, and other postretirement benefit (OPRB) plans consisting primarily of health care and life insuran ce 
for retirees. For accounting purposes, the define d benefit pension and OPRB plans require assumptions to estimate the net","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 38}"
,,"projected and accumulated benefit obligations, including the following variables: discount rate; expected salary increases; 
certain employee -related factors, such as turnover, retire ment age and mortality; expected return on assets; and health care cost 
trend rates. These and other assumptions affect the annual expense and net obligations recognized for the underlying plans. O ur","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 38}"
,,"assumptions reflect our historical experiences and manag ement's best judgment regarding future expectations. As permitted by 
U.S. GAAP, the net amount by which actual results differ from our assumptions is deferred. If this net deferred amount exceed s 
10% of the greater of plan assets or liabilities, a portion of the deferred amount is included in expense for the following year.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 38}"
,,"The cost or benefit of plan changes, such as increasing or decreasing benefits for prior employee service (prior service cost ), is 
deferred and included in expense on a straight -line ba sis over the average remaining service period of the employees expected 
to receive benefits.  
The expected return on plan assets assumption impacts our defined benefit expense since many of our defined benefit pension","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 38}"
,,"plans and our primary OPRB plan are partially funded. The process for setting the expected rates of return is described in No te 
8 to the Consolidated Financial Statements. For 2023 , the average return on assets assumptions for pension plan assets and 
OPRB assets was 5.9%  and 8.4% , respectively. A change in the rate of return of 100 basis points for both pension and OPRB 
assets would impact annual after -tax benefit/expense by approximately $135 million.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 38}"
,,"Since pension and OPRB liabilities are measured on a discounted basis, the discount rate impacts our plan obligations and 
expenses. Discount rates used for our U.S. defined benefit pens ion and OPRB plans are based on a yield curve constructed from 
a portfolio of high -quality bonds for which the timing and amount of cash outflows approximate the estimated payouts of the 
plan. For our international plans, the discount rates are set by benc hmarking against investment grade corporate bonds rated AA","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 38}"
,,"or better. The average discount rate on the defined benefit pension plans of 4.2%  represents a weighted average of local rates in 
countries where such plans exist. A 100 basis -point change in the d iscount rate would impact annual after -tax benefit expense 
by approximately $130 million. The average discount rate on the OPRB plan of 5.6%  reflects the higher interest rates generally","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 38}"
,,"applicable in the U.S., which is where most of the plan participants receive benefits. A 100 basis -point change in the discount 
rate would impact annual after -tax OPRB expense by approximately $30 million. See Note 8 to the Consolidated Financial 
Statements for additional details on our defined benefit pension and OPRB pla ns. 
Goodwill and Intangible Assets  
Significant judgment is required to estimate the fair value of our goodwill reporting units and intangible assets. Accordingl y, we","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 38}"
,,"typically obtain the assistance of third -party valuation specialists for significant goodw ill reporting units and intangible assets. 
Determining the useful life of an intangible asset also requires judgment. Certain brand intangible assets are expected to ha ve 
indefinite lives based on their history and our plans to continue to support and buil d the acquired brands. Other acquired 
The Procter & Gamble Company        27","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 38}"
,,"intangible assets (e.g., certain brands, customer relationships, patents and technologies) are expected to have determinable 
useful lives. Our assessment as to brands that have an indefinite life and those that have a determinable life is based on a 
number of factors including competitive environment, market share, brand history, underlying product life cycles, operating 
plans and the macroeconomic environment of the countries in which the brands are sold. Determina ble-lived intangible assets","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 39}"
,,"are amortized to expense over their estimated lives. An impairment assessment for determinable -lived intangibles is only 
required when an event or change in circumstances indicates that the carrying amount of the asset may not  be recoverable.  
Goodwill and indefinite -lived intangible assets are not amortized but are tested at least annually for impairment. We use the 
income method to estimate the fair value of these assets, which is based on forecasts of the expected future cas h flows","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 39}"
,,"attributable to the respective assets. If the resulting fair value is less than the asset's carrying value, that difference r epresents an 
impairment. Our annual impairment testing for goodwill and indefinite -lived intangible assets occurs during t he three months 
ended December 31.  
Most of our goodwill reporting units have fair value cushions that significantly exceed their underlying carrying values. In","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 39}"
,,"connection with the Grooming operating segment integration as described further in Note 2, we c oncluded that the Shave Care 
and Appliances categories now operate as one reporting unit for goodwill impairment testing. Based on our annual impairment 
testing during the three months ended December 31, 2022, our Grooming reporting unit goodwill has a fai r value cushion of 
over 30%. As of June 30, 2023, the carrying value of the Grooming reporting unit goodwill was $12.7 billion.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 39}"
,,"Most of our indefinite -lived intangible assets have fair value cushions that significantly exceed their underlying carrying val ue. 
Based on our annual impairment testing during the three months ended December 31, 2022, the Gillette indefinite -lived 
intangible asset's fair value exceeded its carrying value by approximately 5%. As of June 30, 2023, the carrying value of the  
Gillett e indefinite -lived intangible asset was $14.1 billion. W hile we have concluded that no triggering event has occurred","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 39}"
,,"during the fiscal year ended June 30, 2023, the Gillette indefinite -lived intangible asset is most susceptible to future impairment 
risk. Adverse changes in the business or in the macroeconomic environment, including foreign currency devaluation, increasing 
global inflation, market contraction from an economic recession and the Russia -Ukraine War, could reduce the underlying cash","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 39}"
,,"flows used to estimate the fair value of the Gillette indefinite -lived intangible asset and trigger a future impairment charge. 
Further reduction of the Gillette business activities in Russia could reduce the estimated fair value by up to 5%.  
The most significant a ssumptions utilized in the determination of the estimated fair value of the Gillette indefinite -lived 
intangible asset are the net sales growth rates (including residual growth rates), discount rate and royalty rates.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 39}"
,,"Net sales growth rates could be nega tively impacted by reductions or changes in demand for our Gillette products, which may 
be caused by, among other things: changes in the use and frequency of grooming products, shifts in demand away from one or 
more of our higher priced products to lower priced products or potential supply chain constraints. In addition, relative global 
and country/regional macroeconomic factors, including the Russia -Ukraine War, could result in additional and prolonged","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 39}"
,,"devaluation of other countries’ currencies relative to the U.S. dollar. The residual growth rates represent the expected rate at 
which the Gillette brand is expected to grow beyond the shorter -term business planning period. The residual growth rates 
utilized in our fair value estimates are consistent with  the brand operating plans and approximates expected long -term category 
market growth rates. The residual growth rates depend on overall market growth rates, the competitive environment, inflation,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 39}"
,,"relative currency exchange rates and business activities t hat impact market share. As a result, the residual growth rates could be 
adversely impacted by a sustained deceleration in category growth, grooming habit changes, devaluation of currencies against 
the U.S. dollar or an increased competitive environment.  
The discount rate, which is consistent with a weighted average cost of capital that is likely to be expected by a market","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 39}"
,,"participant, is based upon industry required rates of return, including consideration of both debt and equity components of t he 
capita l structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the 
equity and debt markets or other country specific factors, such as further devaluation of currencies against the U.S. dollar.  Spot 
rates a s of the fair value measurement date are utilized in our fair value estimates for cash flows outside the U.S.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 39}"
,,"The royalty rates are driven by historical and estimated future profitability of the underlying Gillette business. The royalt y rate 
may be impact ed by significant adverse changes in long -term operating margins.  
We performed a sensitivity analysis for the Gillette indefinite -lived intangible asset as part of our annual impairment testing 
during the three months ended December 31, 2022, utilizing re asonably possible changes in the assumptions for the discount","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 39}"
,,"rate, the short -term and residual growth rates and the royalty rates to demonstrate the potential impacts to the estimated fair 
values. The table below provides, in isolation, the estimated fair value impacts related to a 25 basis -point increase in the 
discount rate, a 25 basis -point decrease in our shorter -term and residual growth rates, or a 50 basis -point decrease in our royalty 
rates, which may result in an impairment of the Gillette indefinite -lived intangible asset.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 39}"
,,"Approximate Percent Change in Es timated Fair Value  
+25 bps 
Discount Rate  -25 bps  
Growth Rate  -50 bps 
Royalty Rate  
Gillette indefinite -lived intangible asset  (6)%  (6)%  (4)%  
See Note 4 to the Consolidated Financial Statements for additional discussion on goodwill and intangible assets.
28        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 39}"
,,"New Accounting Pronouncements  
Refer to Note 1 to the Consolidated Financial Statements for recently ado pted accounting pronouncements and recently issued 
accounting pronouncements not yet adopted as of June 30, 2023 . 
OTHER INFORMATION  
Hedging and Derivative Financial Instruments  
As a multinational company with diverse product offerings, w e are exposed to market risks, such as changes in interest rates,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 40}"
,,"currency exchange rates and commodity prices. We evaluate exposures on a centralized basis to take advantage of natural 
exposure correlation and netting. We leverage the Company's diversifie d portfolio of exposures as a natural hedge and prioritize 
operational hedging activities over financial market instruments. To the extent we choose to further manage volatility within  
our financing operations, as discussed below, we enter into various fi nancial transactions which we account for using the","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 40}"
,,"applicable accounting guidance for derivative instruments and hedging activities. These financial transactions are governed b y 
our policies covering acceptable counterparty exposure, instrument types and other hedging practices. See Note 9 to the 
Consolidated Financial Statements for a discussion of our accounting policies for derivative instruments.  
Derivative positions are monitored using techniques including market valuation, sensitivity analysis and v alue-at-risk modeling.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 40}"
,,"The tests for interest rate, currency rate and commodity derivative positions discussed below are based on the RiskManager ™ 
value -at-risk model using a one -year horizon and a 95% confidence level. The model incorporates the impact of  correlation (the 
degree to which exposures move together over time) and diversification (from holding multiple currency, commodity and 
interest rate instruments) and assumes that financial returns are normally distributed. Estimates of volatility and cor relations of","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 40}"
,,"market factors are drawn from the RiskMetrics ™ dataset as of June 30, 2023 . In cases where data is unavailable in 
RiskMetrics ™, a reasonable proxy is included.  
Our market risk exposures relative to interest rates, currency rates and commodity  prices, as discussed below, have not changed 
materially versus the previous reporting period. In addition, we are not aware of any facts or circumstances that would 
significantly impact such exposures in the near term.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 40}"
,,"significantly impact such exposures in the near term.  
Interest Rate Exposure on Financial Instruments. Interest rate swaps are used to manage exposures to interest rates on 
underlying debt obligations. Certain interest rate swaps denominated in foreign currencies are designated to hedge exposures to 
currency exchange rate movements on our inves tments in foreign operations. These currency interest rate swaps are designated 
as hedges of the Company's foreign net investments.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 40}"
,,"as hedges of the Company's foreign net investments.  
Based on our interest rate exposure as of and during the fiscal year ended June 30, 2023 , including derivative and other 
instruments sensitive to interest rates, we believe a near -term change in interest rates, at a 95% confidence level based on 
historical interest rate movements, would not materially affect our financial statements.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 40}"
,,"Currency Rate Exposure on Financial Instrum ents. Because we manufacture and sell products and finance operations in a 
number of countries throughout the world, we are exposed to the impact on revenue and expenses of movements in currency 
exchange rates. Corporate policy prescribes the range of allo wable hedging activity. To manage the exchange rate risk 
associated with the financing of our operations, we primarily use forward contracts and currency swaps with maturities of les s 
than 18 months.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 40}"
,,"than 18 months.  
Based on our currency rate exposure on derivative and other instruments as of and during the fiscal year ended June 30, 2023 , 
we believe, at a 95% confidence level based on historical currency rate movements, the impact on such instruments of a near -
term change in currency rates would not materially affect our financial statements.  
Commodity Price Exposure on Financial Instruments. We use raw materials that are subject to price volatility caused by","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 40}"
,,"weather, supply conditions, political and economic variables and other unpredictable factors.  We may use futures, options and 
swap contracts to manage the volatility related to the above exposures. During the fiscal years ended June  30, 2023 and 2022, 
we did not have any financial commodity hedging activity.   
Measures Not Defined By U.S. GAAP  
In accordance with the SEC's Regulation S -K Item 10(e), the following provides definitions of the non -GAAP measures and the","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 40}"
,,"reconciliation to the most closely related GAAP measure. We believe that these measures provide useful perspective on 
underlying bu siness trends (i.e., trends excluding non -recurring or unusual items) and results and provide a supplemental 
measure of year -on-year results. The non -GAAP measures described below are used by management in making operating 
decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors, as they","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 40}"
,,"provide supplemental information about business performance and provide investors a view of our business results through the 
eyes of management. These measures  are also used to evaluate senior management and are a factor in determining their at -risk 
compensation. These non -GAAP measures are not intended to be considered by the user in place of the related GAAP measures 
but rather as supplemental information to o ur business results. These non -GAAP measures may not be the same as similar","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 40}"
,,"measures used by other companies due to possible differences in method and in the items or events being adjusted. These 
measures include:  
Organic Sales Growth. Organic sales growt h is a non -GAAP measure of sales growth excluding the impacts of acquisitions, 
divestitures and foreign exchange from year -over-year comparisons. We believe this measure provides investors with a 
The Procter & Gamble Company        29","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 40}"
,,"supplemental understanding of underlying sales trends by pro viding sales growth on a consistent basis. This measure is used in 
assessing the achievement of management goals for at -risk compensation.  
The following tables provide a numerical reconciliation of organic sales growth to reported net sales growth:  
Fiscal year ended June  30, 2023  Net Sales Growth  Foreign Exchange 
Impact  Acquisition & 
Divestiture  
Impact/Other (1) Organic Sales 
Growth  
Beauty  2 % 5 % (1) % 6 %","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 41}"
,,"Growth  
Beauty  2 % 5 % (1) % 6 % 
Grooming  (3) % 7 % 1 % 5 % 
Health Care  4 % 4 % — % 8 % 
Fabric & Home Care  3 % 5 % — % 8 % 
Baby, Feminine & Family Care  2 % 4 % — % 6 % 
TOTAL COMPANY  2 % 5 % — % 7 % 
(1) Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures and rounding impac ts 
necessary to reconcile net sales to organic sales.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 41}"
,,"necessary to reconcile net sales to organic sales. 
Adjusted Free Cash Flow. Adjusted free cash flow is defined as operating cash flow less capital spending and excluding  
payments for the transitional tax resulting from the U.S. Tax Act. Adjusted free cash flow represents the cash t hat the Company 
is able to generate after taking into account planned maintenance and asset expansion. We view adjusted free cash flow as an","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 41}"
,,"important measure because it is one factor used in determining the amount of cash available for dividends, share re purchases, 
acquisitions and other discretionary investments. 
The following table provides a numerical reconciliation of adjusted free cash flow ($ millions): 
 Operating Cash Flow  Capital Spending  Adjustments to 
Operating Cash Flow(1) Adjusted Free 
Cash  Flow 
2023  $ 16,848   $ (3,062)  $ 225  $ 14,011   
2022  $ 16,723   $ (3,156)  $ 225  $ 13,792","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 41}"
,,"2022  $ 16,723   $ (3,156)  $ 225  $ 13,792   
(1) Adjustments to Operating Cash Flow include transitional tax payments resulting from the U.S. Tax Act of $225 in 2023  and 2022 . 
Adjusted Free Cash Flow Productivity. Adjusted free cash flow productivity is defined as the ratio of adjusted free cash flow  
to net earnings. We view adjusted free cash flow productivity as a useful measure to help investors understand P&G’s ability to","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 41}"
,,"generate cash. Adjusted free cash flow productivity is used by management in making operating decisions, in allocating  
financial resources and for budget planning purposes. This measure is used in assessing the achievement of management goals 
for at -risk compensation.  
The following table provides a numerical reconciliation of adjusted free cash flow productivity ($ millions): 
 Adju sted Free  
Cash Flow  Net Earnings  Adjusted Free  
Cash  Flow Productivity  
2023 $ 14,011   $ 14,738   95 %","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 41}"
,,"Cash  Flow Productivity  
2023 $ 14,011   $ 14,738   95 % 
2022 $ 13,792   $ 14,793   93 % 
Core EPS. Core EPS is a measure of the Company's diluted EPS excluding items that are not judged by management to be part 
of the Company's sustainable results or trends. Management views this non -GAAP measure as a useful supplemental measure  
of Company performance over time. This measure is also used in assessing the achievement of management goals for at -risk","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 41}"
,,"compensation. For the fiscal years ended June 30, 2023  and 2022 , there were no adjustments to or reconciling items for diluted 
EPS. 
Item 7A. Quantitative and Qualitative Disclosures About Market Risk.  
The information required by this item is incorporated by reference to the section entitled Other Information in the MD&A and 
Note 9 to the Consolidated Financial Statements.  
30        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 41}"
,,"Item 8. Financial Statements and Supplementary Data.  
MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING 
Management is responsible for establishing and maintaining adequate internal control over financial reporting of The Procter  & 
Gamble Company (as defined in Rule 13a -15(f) under the Securities Exchange Act of 1934, as amended). Our internal control 
over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 42}"
,,"prepa ration of financial statements for external purposes in accordance with generally accepted accounting principles in the 
United States of America.  
Strong internal controls is an objective that is reinforced through our Worldwide Business Conduct Manual , whi ch sets forth our 
commitment to conduct business with integrity, and within both the letter and the spirit of the law. Our people are deeply","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 42}"
,,"committed to our Purpose, Values and Principles, which unite us in doing what’s right. Our system of internal contr ols includes 
written policies and procedures, segregation of duties and the careful selection and development of employees. Additional key  
elements of our internal control structure include our Global Leadership Council, which is actively involved in overs ight of the","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 42}"
,,"business strategies, initiatives, results and controls, our Disclosure Committee, which is responsible for evaluating disclos ure 
implications of significant business activities and events, our Board of Directors, which provides strong and effec tive corporate 
governance, and our Audit Committee, which reviews critical accounting policies and estimates, financial reporting and intern al 
control matters.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 42}"
,,"control matters.  
Global Internal Audit performs audits of internal controls over financial reporting as well as b roader financial, operational and 
compliance audits around the world, provides training and continually improves our internal control processes. The Company’s 
internal control over financial reporting also includes a robust Control Self -Assessment Program that is conducted annually on","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 42}"
,,"critical financial reporting areas of the Company. Management takes the appropriate action to correct any identified control 
deficiencies.  
Because of its inherent limitations, any system of internal control over financial rep orting, no matter how well designed, may 
not prevent or detect misstatements due to the possibility that a control can be circumvented or overridden or that misstatem ents","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 42}"
,,"due to error or fraud may occur that are not detected. Also, because of changes in c onditions, internal control effectiveness may 
vary over time.  
Management assessed the effectiveness of the Company's internal control over financial reporting as of June 30, 2023 , using 
criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 42}"
,,"the Tr eadway Commission (COSO) and concluded that the Company maintained effective internal control over financial 
reporting as of June 30, 2023 , based on these criteria.  
Deloitte  & Touche LLP, an independent registered public accounting firm, has audited the e ffectiveness of the Company's internal 
control over financial reporting as of June 30, 2023 , as stated in their report which is included herein.  
/s/ Jon R. Moeller  
(Jon R. Moeller)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 42}"
,,"/s/ Jon R. Moeller  
(Jon R. Moeller)  
Chairman of the Board, President and Chief Executive Officer  
/s/ Andre Schulten  
(Andre Schulten)  
Chief Financial Officer  
August 4, 2023  
The Procter & Gamble Company        31","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 42}"
,,"REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM  
To the shareholders and the Board of Directors of The Procter & Gamble Company  
Opinion on the Financial Statements  
We have audited the accompanying Consolidated Balance Sheets of The Procter & Gamble Company and subsidiaries (the 
""Company"") as of June 30, 2023 and 2022, the related Consolidated Statements of Earnings, Comprehensive Income,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 43}"
,,"Sharehol ders’ Equity and Cash Flows, for each of the three years in the period ended June 30, 2023, and the related notes 
(collectively referred to as the ""financial statements""). In our opinion, the financial statements present fairly, in all mat erial 
respects, t he financial position of the Company as of June 30, 2023 and 2022, and the results of its operations and its cash flows","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 43}"
,,"for each of the three years in the period ended June 30, 2023, in conformity with accounting principles generally accepted in  the 
United  States of America.  
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) 
(PCAOB), the Company's internal control over financial reporting as of June 30, 2023, based on criteria established in Internal","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 43}"
,,"Control — Integrated Framework (2013)  issued by the Committee of Sponsoring Organizations of the Treadway Commission 
and our report dated August 4, 2023, expressed an unqualified opinion on the Company's internal control over financial  
 reporti ng. 
Basis for Opinion  
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 43}"
,,"the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are 
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable  
rules and regulations of the Securities and Exchange Commission and the PCAOB.  
We conducted our audits in accordance  with the standards of the PCAOB. Those standards require that we plan and perform the","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 43}"
,,"audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to  
error or fraud. Our audits included perform ing procedures to assess the risks of material misstatement of the financial 
statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included 
examining, on a test basis, evidence regarding the amou nts and disclosures in the financial statements. Our audits also included","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 43}"
,,"evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall 
presentation of the financial statements. We believe that ou r audits provide a reasonable basis for our opinion.  
Critical Audit Matter  
The critical audit matter communicated below is a matter arising from the current -period audit of the financial statements that","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 43}"
,,"was communicated or required to be communicated to th e audit committee and that (1) relates to accounts or disclosures that are 
material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The 
communication of critical audit matters does not alter in any  way our opinion on the financial statements, taken as a whole, and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 43}"
,,"we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on  the 
accounts or disclosures to which it relates.  
Intangible As sets — Gillette Indefinite Lived Intangible Asset — Refer to Notes 1 and 4 to the financial statements  
Critical Audit Matter Description  
The Company’s evaluation of the Gillette indefinite lived intangible asset (the ""Gillette Brand"") for impairment involv es the","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 43}"
,,"comparison of the fair value to its carrying value. The Company estimates fair value using the income method, which is based 
on the present value of estimated future cash flows attributable to the respective asset. This requires management to make 
significant estimates and assumptions related to forecasts of future net sales and earnings, including growth rates beyond a 10-
year time period, royalty rates, and discount rate. Changes in the assumptions could have a significant impact on either the fair","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 43}"
,,"value, the amount of any impairment charge, or both. The Company performed their annual impairment assessment of the 
Gillette Brand as of December 31, 2022. Because the estimated fair value exceeds the carrying value, no impairment was 
recorded. As of June 30, 2023, the carrying value of the Gillette Brand was $14.1 billion.  
We identified the Company’s impairment evaluation of the Gillette Brand as a critical audit matter because of the significant","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 43}"
,,"judgments made by management to estimate the fair value  of the indefinite lived intangible asset. A high degree of auditor 
judgment and an increased extent of effort was required when performing audit procedures to evaluate the reasonableness of 
management’s estimates and assumptions related to the forecasts o f future net sales and earnings as well as the selection of 
royalty rates and discount rate, including the need to involve our fair value specialists.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 43}"
,,"How the Critical Audit Matter Was Addressed in the Audit  
Our audit procedures related to forecasts of fu ture net sales and earnings and the selection of the royalty rates and discount rate 
for the Gillette Brand included the following, among others:  
•We tested the effectiveness of controls over the Gillette Brand, including those over the determination of fa ir value, such as
controls related to management’s development of forecasts of future net sales and earnings, and the selection of royalty","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 43}"
,,"rates and discount rate.
•We evaluated management’s ability to accurately forecast net sales and earnings by comparing  actual results to
management’s historical forecasts.
32        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 43}"
,,"•We evaluated the reasonableness of management’s forecast of net sales and earnings by comparing the forecasts to:
•Historical net sales and earnings.
•Underlying analysis detailing business strategies a nd growth plans.
•Internal communications to management and the Board of Directors.
•Forecasted information included in analyst and industry reports for the Company and certain of its peer companies.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 44}"
,,"•With the assistance of our fair value specialists, we evaluated the net sales and earnings growth rates, royalty rates, and
discount rate by:
•Testing the source information underlying the determination of net sales and earnings growth rates, royalty rates, and
discount rate and the mathematica l accuracy of the calculations.
•Developing a range of independent estimates for the discount rate and comparing the discount rate selected by
management to that range.
/s/ Deloitte & Touche LLP","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 44}"
,,"management to that range.
/s/ Deloitte & Touche LLP  
Cincinnati, Ohio  
August 4, 2023  
We have served as the Company’s auditor since 1890.  
The Procter & Gamble Company        33","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 44}"
,,"REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM  
To the shareholders and the Board of Directors of The Procter & Gamble Company  
Opinion on Internal Control over Financial Reporting  
We have audited the internal control over financial reporting of The Procter & Gamble Company and subsidiaries (the 
""Company"") as of June 30, 2023, based on criteria established in Internal Control — Integrated Framework (2013)  issued by","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 45}"
,,"the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, 
in all material respects, effective internal control over financial reporting as of June 30, 2023, ba sed on criteria established in 
Internal Control — Integrated Framework (2013)  issued by COSO.  
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 45}"
,,"(PCAOB), the consolidated financial statem ents as of and for the year ended June 30, 2023, of the Company and our report 
dated August 4, 2023, expressed an unqualified opinion on those financial statements.  
Basis for Opinion 
The Company's management is responsible for maintaining effective inter nal control over financial reporting and for its 
assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Repor t","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 45}"
,,"on Internal Control over Financial Reporting. Our responsibility is to express a n opinion on the Company’s internal control 
over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be  
independent with respect to the Company in accordance with the U.S. federal securitie s laws and the applicable rules and 
regulations of the Securities and Exchange Commission and the PCAOB.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 45}"
,,"We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the 
audit to obtain reasonable a ssurance about whether effective internal control over financial reporting was maintained in all 
material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk 
that a material weakness exis ts, testing and evaluating the design and operating effectiveness of internal control based on the","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 45}"
,,"assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audi t 
provides a reasonable basis fo r our opinion.  
Definition and Limitations of Internal Control over Financial Reporting 
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the 
reliability of financial reporting and the pr eparation of financial statements for external purposes in accordance with generally","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 45}"
,,"accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures 
that (1) pertain to the maintenance of record s that, in reasonable detail, accurately and fairly reflect the transactions and 
dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to pe rmit 
preparation of financial statements in accord ance with generally accepted accounting principles, and that receipts and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 45}"
,,"expenditures of the company are being made only in accordance with authorizations of management and directors of the 
company; and (3) provide reasonable assurance regarding preventi on or timely detection of unauthorized acquisition, use, or 
disposition of the company’s assets that could have a material effect on the financial statements.  
Because of its inherent limitations, internal control over financial reporting may not prevent o r detect misstatements. Also,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 45}"
,,"projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate 
because of changes in conditions, or that the degree of compliance with the policies or procedures m ay deteriorate.  
/s/ Deloitte & Touche LLP  
Cincinnati, Ohio  
August 4, 2023  
34        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 45}"
,,"Consolidated Statements of Earnings  
Amounts in millions except per share amounts; fiscal years ended June  30 2023 2022 2021
NET SALES  $ 82,006  $ 80,187  $ 76,118  
Cost of products sold  42,760  42,157  37,108  
Selling, general and administrative expense  21,112  20,217  21,024  
OPERATING INCOME  18,134  17,813  17,986  
Interest expense  (756)   (439)   (502)  
Interest income  307 51 45 
Other non -operating income, net  668 570 86 
EARNINGS BEFORE INCOME TAXES  18,353  17,995  17,615","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 46}"
,,"EARNINGS BEFORE INCOME TAXES  18,353  17,995  17,615  
Income taxes  3,615  3,202  3,263  
NET EARNINGS  14,738  14,793  14,352  
Less: Net earnings attributable to noncontrolling interests  85 51 46 
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE  $ 14,653  $ 14,742  $ 14,306  
NET EARNINGS PER COMMON SHARE (1) 
Basic  $ 6.07 $ 6.00 $ 5.69 
Diluted  $ 5.90 $ 5.81 $ 5.50 
(1)Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter &","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 46}"
,,"Gamble.
Consolidated Statements of Comprehensive Income  
Amounts in millions; fiscal years ended June 30 2023 2022 2021
NET EARNINGS  $ 14,738  $ 14,793  $ 14,352  
OTHE R COMPREHENSIVE INCOME/(LOSS), NET OF TAX  
Foreign currency translation (net of tax (benefit)/expense of $(197) , $515  and 
$(266) , respectively)  (71)  (1,450)   1,023  
Unrealized gains/(losses) on investment securities  
(net of tax (benefit)/expense of $(2), $1 and $5, respectively)  (7)  5 16","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 46}"
,,"Unrealized gains on defined benefit postretirement plans  
(net of tax expense of $9, $1,022  and $445 , respectively)  40 2,992  1,386  
TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX  (38)  1,547  2,425  
TOTAL COMPREHENSIVE INCOME  14,700  16,340  16,777  
Less: Comprehensive income attributable to noncontrolling interests  78 43 50 
TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO
PROCTER & GAMBLE  $ 14,622  $ 16,297  $ 16,727  
The Procter & Gamble Company        35","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 46}"
,,"The Procter & Gamble Company        35
See accompanying Notes to Consolidated Financial Statements.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 46}"
,,"Consolidated Balance Sheets  
Amounts in millions except stated values; as of June 30 2023 2022
Assets  
CURRENT ASSETS  
Cash and cash equivalents  $ 8,246  $ 7,214  
Accounts receivable  5,471  5,143  
INVENTORIES  
Materials and supplies  1,863  2,168  
Work in process  956 856 
Finished goods  4,254  3,900  
Total inventories  7,073  6,924  
Prepaid expenses and other current assets  1,858  2,372  
TOTAL CURRENT ASSETS  22,648  21,653  
PROPERTY, PLANT AND EQUIPMENT, NET  21,909  21,195","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 47}"
,,"PROPERTY, PLANT AND EQUIPMENT, NET  21,909  21,195  
GOODWILL  40,659  39,700  
TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET  23,783  23,679  
OTHER NONCURRENT ASSETS  11,830  10,981  
TOTAL ASSETS  $ 120,829  $ 117,208  
Liabilities and Shareholders' Equity  
CURRENT LIABILITIES  
Accounts payable  $ 14,598  $ 14,882  
Accrued and other liabilities  10,929  9,554  
Debt due within one year  10,229  8,645  
TOTAL CURRENT LIABILITIES  35,756  33,081  
LONG -TERM DEBT  24,378  22,848","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 47}"
,,"LONG -TERM DEBT  24,378  22,848  
DEFERRED INCOME TAXES  6,478  6,809  
OTHER NONCURRENT LIABILITIES  7,152  7,616  
TOTAL LIABILITIES  73,764  70,354  
SHAREHOLDERS' EQUITY  
Convertible Class  A preferred stock, stated value $1 per share ( 600 shares authorized)  819 843 
Non-Voting Class B preferred stock, stated value $1 per share ( 200 shares authorized)  — — 
Common stock, stated value $1 per share ( 10,000  shares authorized; shares issued:
2023 - 4,009.2 , 2022 - 4,009.2 ) 4,009  4,009","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 47}"
,,"2023 - 4,009.2 , 2022 - 4,009.2 ) 4,009  4,009  
Additional paid -in capital  66,556  65,795  
Reserve for ESOP debt retirement  (821)   (916)  
Accumulated other comprehensive loss  (12,220)   (12,189)  
Treasury stock (shares held:  2023 - 1,647.1 ; 2022 - 1,615.4 ) (129,736)   (123,382)  
Retained earnings  118,170  112,429  
Noncontrolling interest  288 265 
TOTAL SHAREHOLDERS' EQUITY  47,065  46,854  
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY  $ 120,829  $ 117,208","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 47}"
,,"36        The Procter & Gamble Company
See accompanying Notes to Consolidated Financial Statements.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 47}"
,,"Consolidated Statements of Shareholders' Equity  
Dollars in millions except per 
share amounts;
shares in thousandsCommon StockPreferred 
Stock  Additional 
Paid -In 
Capital  Reserve 
for ESOP 
Debt 
Retirement  Accumulated  
Other  
Comprehens
ive 
Income/  
(Loss)  Treasury 
Stock  Retained 
Earnings  Noncont
rolling 
Interest  Total 
Sharehol
ders' 
Equity  Shares Amount
BALANCE JUNE 30, 2020   2,479,746  $4,009  $897  $64,194  ($1,080)   ($16,165)    ($105,573)    $100,239  $357   $46,878","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 48}"
,,"Net earnings  14,306  46  14,352  
Other comprehensive 
income/(loss)  2,421  4 2,425  
Dividends and dividend 
equivalents ( $3.2419  per 
share):  
 Common  (8,020)     (8,020)   
 Preferred  (271)    (271)   
Treasury stock purchases  (81,343)  (11,009)     (11,009)
Employee stock plans  28,001  650 1,586  2,236  
Preferred stock conversions  3,302  (27) 4 23 — 
ESOP debt impacts  74 120 194 
Noncontrolling interest, net  (131) (131)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 48}"
,,"Noncontrolling interest, net  (131) (131)  
BALANCE JUNE 30, 2021   2,429,706  $4,009  $870  $64,848  ($1,006)   ($13,744)    ($114,973)    $106,374  $276   $46,654  
Net earnings  14,742  51  14,793  
Other comprehensive 
income/(loss)  1,555  (8) 1,547
Dividends and dividend 
equivalents ( $3.5227  per 
share):  
 Common  (8,514)     (8,514)   
 Preferred  (281)    (281)   
Treasury stock purchases  (67,088)  (10,003)     (10,003)
Employee stock plans  28,042  945 1,571  2,516","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 48}"
,,"Employee stock plans  28,042  945 1,571  2,516  
Preferred stock conversions  3,217  (27) 4 23 — 
ESOP debt impacts  90 108 198 
Noncontrolling interest, net  (2)  (54)  (56)  
BALANCE JUNE 30, 2023   2,393,877  $4,009  $843  $65,795  ($916)   ($12,189)    ($123,382)    $112,429  $265   $46,854  
Net earnings  14,653  85  14,738  
Other comprehensive 
income/(loss)  (31)  (7) (38) 
Dividends and dividend 
equivalents ( $3.6806  per 
share):  
 Common  (8,742)    (8,742)  
 Preferred  (282) (282)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 48}"
,,"share):  
 Common  (8,742)    (8,742)  
 Preferred  (282) (282)
Treasury stock purchases  (52,021
)  (7,353)    (7,353)
Employee stock plans  17,424  758 978 1,736
Preferred stock conversions  2,840  (24) 3 21 — 
ESOP debt impacts  95 112 207 
Noncontrolling interest, net  — (55) (55)
BALANCE JUNE 30, 2023  2,362,120 $4,009  $819    $66,556  ($821)   ($12,220)  ($129,736)  $118,170 $288   $47,065
The Procter & Gamble Company        37
See accompanying Notes to Consolidated Financial Statements.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 48}"
,,"Consolidated Statements of Cash Flows  
Amounts in millions; fiscal years ended June  30 2023 2022 2021
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF YEAR  $ 7,214  $ 10,288  $ 16,181  
OPERATING ACTIVITIES  
Net earnings  14,738  14,793  14,352  
Depreciation and amortization  2,714  2,807  2,735  
Loss on early extinguishment of debt  — — 512 
Share -based compensation expense  545 528 540 
Deferred income taxes  (453) (402) (258)  
Loss/(gain) on sale of assets  (40) (85) (16)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 49}"
,,"Loss/(gain) on sale of assets  (40) (85) (16) 
Change in accounts receivable  (307) (694) (342)  
Change in inventories  (119)  (1,247) (309)  
Change in accounts payable and accrued and other liabilities  313 1,429 1,391  
Change in other operating assets and liabilities  (1,107)   (635) (369)
Other  564 229 135
TOTAL OPERATING ACTIVITIES  16,848  16,723  18,371  
INVESTING ACTIVITIES  
Capital expenditures  (3,062)   (3,156)   (2,787)  
Proceeds from asset sales  46 110 42","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 49}"
,,"Proceeds from asset sales  46 110 42 
Acquisitions, net of cash acquired  (765) (1,381) (34) 
Other investing activity  281 3 (55) 
TOTAL INVESTING ACTIVITIES  (3,500)   (4,424)   (2,834)  
FINANCING ACTIVITIES  
Dividends to shareholders  (8,999)   (8,770)   (8,263)  
Additions to short -term debt with original maturities of more than three months  17,168  10,411  7,675  
Reductions in short -term debt with original maturities of more than three months  (13,031)   (11,478)   (7,577)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 49}"
,,"Net additions/(reductions) to other short -term debt  (3,319)   917 (3,431)  
Additions to long -term debt  3,997  4,385  4,417  
Reductions in long -term debt (1) (1,878)   (2,343)   (4,987)  
Treasury stock purchases  (7,353)   (10,003)   (11,009)  
Impact of stock options and other  1,269  2,005  1,644  
TOTAL FINANCING ACTIVITIES  (12,146)   (14,876)   (21,531)  
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS 
AND RESTRICTED CASH  (170) (497) 101","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 49}"
,,"AND RESTRICTED CASH  (170) (497) 101 
CHAN GE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH  1,032  (3,074)   (5,893)  
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF YEAR  $ 8,246  $ 7,214  $ 10,288  
SUPPLEMENTAL DISCLOSURE  
Cash payments for interest  $ 721 $ 451 $ 531 
Cash payments for income taxes  4,278  3,818  3,822  
(1)Includes early extinguishment of debt costs of $512 in 2021.
38        The Procter & Gamble Company
See accompanying Notes to Consolidated Financial Statements.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 49}"
,,"Notes to Consolidated Financial Statements  
NOTE 1  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Nature of Operations  
The Procter  & Gamble Company's (the ""Company,"" ""Procter & Gamble,"" ""we"" or ""us"") business is focused on providing 
branded consumer  packaged goods of superior quality and value. Our products are sold in approximately 180 countries and 
territories primarily through mass merchandisers, e -commerce (including social commerce) channels, grocery stores,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 50}"
,,"membership club stores, drug stores,  department stores, distributors, wholesalers, specialty beauty stores (including airport 
duty-free stores), high -frequency stores, pharmacies, electronics stores and professional channels. We also sell direct to 
consumers. We have on -the-ground operation s in approximately 70 countries.  
Basis of Presentation  
The Consolidated Financial Statements include the Company and its controlled subsidiaries. Intercompany transactions are 
eliminated.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 50}"
,,"eliminated.  
Because of a lack of control over Venezuelan subsidiaries caused by  a number of currency and other operating controls and 
restrictions, our Venezuelan subsidiaries are not consolidated for any year presented. We account for those subsidiaries at c ost, 
less impairments, plus or minus observable price changes.  
Beginning in fiscal year 2022, the Company began to present increases and reductions in short -term debt with maturities of","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 50}"
,,"more than three months separately within the Consolidated Statements of Cash Flows. The presentation for the fiscal year 
ended June 30, 2021, ha s been revised to align with the current period presentation. This change had no impact on total 
financing activities, and we have concluded the change is not material.  
Use of Estimates  
Preparation of financial statements in conformity with accounting pri nciples generally accepted in the United States of America","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 50}"
,,"(U.S. GAAP) requires management to make estimates and assumptions that affect the amounts reported in the Consolidated 
Financial Statements and accompanying disclosures. These estimates are based o n management's best knowledge of current 
events and actions the Company may undertake in the future. Estimates are used in accounting for, among other items, 
consumer and trade promotion accruals, restructuring reserves, pensions, postretirement benefits,  stock options, valuation of","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 50}"
,,"acquired intangible assets, useful lives for depreciation and amortization of long -lived assets, future cash flows associated with 
impairment testing for goodwill, indefinite -lived intangible assets and other long -lived assets,  deferred tax assets and liabilities, 
uncertain income tax positions and contingencies. Actual results may ultimately differ from estimates, although management","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 50}"
,,"does not generally believe such differences would materially affect the financial statements in any individual year. However, 
regarding ongoing impairment testing of goodwill and indefinite -lived intangible assets, significant deterioration in future cash 
flow projections or other assumptions used in estimating fair values versus those anticipated at the time of the initial valuations, 
could result in impairment charges that materially affect the financial statements in a given year.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 50}"
,,"Revenue Recognition  
Our revenue is primarily generated from the sale of finished product to customers. Th ose sales predominantly contain a single 
performance obligation and revenue is recognized at a single point in time when ownership, risks and rewards transfer, which 
can be on the date of shipment or the date of receipt by the customer. A provision for pa yment discounts and product return","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 50}"
,,"allowances is recorded as a reduction of sales in the same period the revenue is recognized. The revenue recorded is presente d 
net of sales and other taxes we collect on behalf of governmental authorities. The revenue inc ludes shipping and handling costs, 
which generally are included in the list price to the customer.  
Trade promotions, consisting primarily of customer pricing allowances, merchandising funds and consumer coupons, are","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 50}"
,,"offered through various programs to cu stomers and consumers. Sales are recorded net of trade promotion spending, which is 
recognized as incurred at the time of the sale. Most of these arrangements have terms of approximately one year. Accruals for  
expected payouts under these programs are incl uded as accrued marketing and promotion in the Accrued and other liabilities 
line item in the Consolidated Balance Sheets.  
Cost of Products Sold","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 50}"
,,"Cost of Products Sold  
Cost of products sold is primarily comprised of direct materials and supplies consumed in the manufacturing of  product, as well 
as manufacturing labor, depreciation expense and direct overhead expenses necessary to acquire and convert the purchased 
materials and supplies into finished products. Cost of products sold also includes the cost to distribute products to  customers,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 50}"
,,"inbound freight costs, internal transfer costs, warehousing costs and other shipping and handling activity.  
Selling, General and Administrative Expense  
Selling, general and administrative expense (SG&A) is primarily comprised of marketing expen ses, selling expenses, research 
and development costs, administrative and other indirect overhead costs, depreciation and amortization expense on non -","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 50}"
,,"manufacturing assets and other miscellaneous operating items. Research and development costs are charged t o expense as 
incurred and were $2.0 billion in 2023 and 2022 and $1.9 billion in 2021. Advertising costs, charged to expense as incurred, 
include television, print, radio, digital and in -store advertising expenses and were $8.0 billion in 2023, $7.9 billio n in 2022 and 
The Procter & Gamble Company        39
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 50}"
,,"$8.2 billion in 2021. Non -advertising related components of the Company's total marketing spending reported in SG&A include 
costs associated with consumer promotions, product sampling and sales aids.  
Other Non -Operating Income, Net  
Other non-operating income, net primarily includes divestiture gains, net non -service impacts related to postretirement benefit 
plans, investment income and other non -operating items.  
Currency Translation","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 51}"
,,"Currency Translation  
Financial statements of operating subsidiaries outside th e U.S. generally are measured using the local currency as the functional 
currency. Adjustments to translate those statements into U.S. dollars are recorded in Other comprehensive income (OCI). For 
subsidiaries operating in highly inflationary economies, th e U.S. dollar is the functional currency. Re -measurement adjustments","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 51}"
,,"for financial statements in highly inflationary economies and other transactional exchange gains and losses are reflected in 
earnings.  
Cash Flow Presentation  
The Consolidated Statements o f Cash Flows are prepared using the indirect method, which reconciles net earnings to cash flows 
from operating activities. Cash flows from foreign currency transactions and operations are translated at monthly exchange ra tes","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 51}"
,,"for each period. Cash flows fr om hedging activities are included in the same category as the items being hedged. Cash flows 
from derivative instruments designated as net investment hedges are classified as investing activities. Realized gains and lo sses 
from non -qualifying derivative instruments used to hedge currency exposures resulting from intercompany financing 
transactions are classified as financing activities. Cash flows from other derivative instruments used to manage interest rat es,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 51}"
,,"commodity or other currency exposures are c lassified as operating activities. Cash payments related to income taxes are 
classified as operating activities.  
Investments  
The Company holds minor equity investments in certain companies over which we exert significant influence, but do not 
control th e financial and operating decisions. These are accounted for as equity method investments. Other equity investments","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 51}"
,,"that are not controlled, and over which we do not have the ability to exercise significant influence, and for which there is a 
readily dete rminable market value, are recorded at fair value, with gains and losses recorded through net earnings. Equity 
investments without readily determinable fair values are measured at cost, less impairments, plus or minus observable price 
changes. Equity inves tments are included as Other noncurrent assets in the Consolidated Balance Sheets.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 51}"
,,"The Company also holds highly liquid investments, primarily money market funds and time deposits. Such investments are 
considered cash equivalents and are included within Ca sh and cash equivalents in the Consolidated Balance Sheets.  
Inventory Valuation  
Inventories are valued at the lower of cost or net realizable value. Product -related inventories are maintained on the first -in, 
first-out method. The cost of spare part inven tories is maintained using the average -cost method.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 51}"
,,"Property, Plant and Equipment  
Property, plant and equipment is recorded at cost reduced by accumulated depreciation. Depreciation expense is recognized 
over the assets' estimated useful lives using the s traight -line method. Machinery and equipment includes office furniture and 
fixtures (15 -year life), computer equipment and capitalized software (3 - to 5-year lives) and manufacturing equipment (3 - to 20 -","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 51}"
,,"year lives). Buildings are depreciated over an estima ted useful life of 40 years. Estimated useful lives are periodically reviewed 
and, when appropriate, changes are made prospectively. When certain events or changes in operating conditions occur, asset 
lives may be adjusted and an impairment assessment may  be performed on the recoverability of the carrying amounts.  
Goodwill and Other Intangible Assets","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 51}"
,,"Goodwill and Other Intangible Assets  
Goodwill and indefinite -lived intangible assets are not amortized but are evaluated for impairment annually or more often if 
indicators of a potential impairm ent are present. Our annual impairment testing of goodwill is performed separately from our 
impairment testing of indefinite -lived intangible assets.  
We have acquired brands that have been determined to have indefinite lives. We evaluate several factors t o determine whether","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 51}"
,,"an indefinite life is appropriate, including the competitive environment, market share, brand history, underlying product lif e 
cycles, operating plans and the macroeconomic environment of the countries in which the brands are sold. In addition, when 
certain events or changes in operating conditions occur, an additional impairment assessment is performed and indefinite -lived 
assets may be adjusted to a determinable life.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 51}"
,,"assets may be adjusted to a determinable life.  
The cost of intangible assets with determinable useful lives is amo rtized to reflect the pattern of economic benefits consumed, 
either on a straight -line or accelerated basis over the estimated periods benefited. Patents, technology and other intangible assets 
with contractual terms are generally amortized over their resp ective legal or contractual lives. Customer relationships, brands","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 51}"
,,"and other non -contractual intangible assets with determinable lives are amortized over periods generally ranging from 5 to 30 
years. When certain events or changes in operating conditions o ccur, an impairment assessment is performed and remaining 
lives of intangible assets with determinable lives may be adjusted.  
For additional details on goodwill and intangible assets see Note 4.
40        The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 51}"
,,"Fair Values of Financial Instruments  
Certain financial instruments are required to be recorded at fair value. Changes in assumptions or estimation methods could 
affect the fair value estimates; however, we do not believe any such changes would have a material impact on our financ ial 
condition, results of operations or cash flows. Other financial instruments, including cash equivalents, certain investments and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 52}"
,,"certain short -term debt, are recorded at cost, which approximates fair value. The fair values of long -term debt and financi al 
instruments are disclosed in Note 9.  
New Accounting Pronouncements and Policies  
In September 2022, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2022 -04, 
""Liabilities - Supplier Finance Programs (Subtopic 405 -50): Disclosure of Supplier Finance Program Obligations"". This","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 52}"
,,"guidance requires annual and interim disclosures for entities that use supplier finance programs in connection with the purch ase 
of goods and services. These amendments are effective for fiscal  years beginning after December 15, 2022, except for the 
amendment on rollforward information, which is effective for fiscal years beginning after December 15, 2023. We will adopt 
the guidance effective July 1, 2023. Additional disclosures will be include d in the Notes to the Consolidated Financial","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 52}"
,,"Statements.  
No other new accounting pronouncements issued or effective during the fiscal year or in future years had, or are expected to 
have, a material impact on our Consolidated Financial Statements.  
NOTE 2  
SEGMENT INFORMATION  
Under U.S. GAAP, our operating segments are aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health 
Care, 4) Fabric & Home Care and 5) Baby, Feminine & Family Care. Our five reportable segments are comprised of:","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 52}"
,,"•Beauty : Hair Care (Cond itioners, Shampoos, Styling Aids, Treatments); Skin and Personal Care (Antiperspirants and
Deodorants, Personal Cleansing, Skin Care);
•Grooming : Grooming (Appliances, Female Blades & Razors, Male Blades & Razors, Pre - and Post -Shave Products, Other
Groomin g);
•Health Care : Oral Care (Toothbrushes, Toothpaste, Other Oral Care); Personal Health Care (Gastrointestinal, Pain Relief,
Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care);","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 52}"
,,"•Fabric & Home Care : Fabric Care (Fabri c Enhancers, Laundry Additives, Laundry Detergents); Home Care (Air Care,
Dish Care, P&G Professional, Surface Care); and
•Baby, Feminine & Family Care : Baby Care (Baby Wipes, Taped Diapers and Pants); Feminine Care (Adult Incontinence,
Feminine Care); Fam ily Care (Paper Towels, Tissues, Toilet Paper).
While none of our reportable segments are highly seasonal, components within certain reportable segments, such as Appliances","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 52}"
,,"(Grooming) and Personal Health Care (Health), are seasonal.  
The accounting policie s of the segments are generally the same as those described in Note 1. Differences between these policies 
and U.S. GAAP primarily reflect income taxes, which are reflected in the segments using applicable blended statutory rates. 
Adjustments to arrive at o ur effective tax rate are included in Corporate. In addition, capital expenditures in the segments are on","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 52}"
,,"an accrual basis consistent with the balance sheet. Adjustments to move from an accrual to cash basis, for purposes of the ca sh 
flow statement, are re flected in Corporate.  
Corporate includes certain operating and non -operating activities that are not reflected in the operating results used internally to 
measure and evaluate the businesses, as well as items to adjust management reporting principles to U. S. GAAP. Operating","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 52}"
,,"activities in Corporate include the results of incidental businesses managed at the corporate level. Operating elements also 
include certain employee benefit costs, the costs of certain restructuring -type activities to maintain a compet itive cost structure, 
including manufacturing and workforce optimization, asset impairment charges and other general Corporate items. The non -
operating elements in Corporate primarily include interest expense, certain pension and other postretirement benef it costs,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 52}"
,,"certain acquisition and divestiture gains, interest and investing income and other financing costs.  
Total assets for the reportable segments include those assets managed by the reportable segment, primarily inventory, fixed 
assets and intangib le assets. Other assets, primarily cash, accounts receivable, investment securities and goodwill, are included 
in Corporate.  
The Procter & Gamble Company        41
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 52}"
,,"Our operating segments are comprised of similar product categories. Operating segments that individually accounte d for 5% or 
more of consolidated net sales are as follows:  
% of Net sales by operating segment (1) 
Fiscal years ended June 30  2023 2022 2021 
Fabric Care  23%  23% 22% 
Home Care  12%  12% 12% 
Baby Care  10%  10% 10% 
Skin and Personal Care  9% 9% 10% 
Hair Care  9% 9% 9% 
Family Care  8% 9% 9% 
Grooming (2) 8% 6% 7% 
Oral Care  8% 8% 8% 
Feminine Care  7% 6% 6%","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 53}"
,,"Oral Care  8% 8% 8% 
Feminine Care  7% 6% 6% 
Personal Health Care  6% 6% 5% 
Other (2) —% 2% 2% 
TOTAL  100%  100%  100%  
(1)% of Net sales by operating segment excludes sales recorded in Corporate.
(2)Effective July 1, 2022, the Grooming Sector Business Unit completed the full integration of its Shave Care and Ap pliances categories to 
cohesively serve consumers' grooming needs. This transition included the integration of the management team, strategic decisi on-","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 53}"
,,"making, innovation plans, financial targets, budgets and internal management reporting. For the fiscal y ears ended June 30, 2022 and
2021, Appliances was presented in Other.
Net sales and long -lived assets in the United States and internationally were as follows (in billions):
Fiscal years ended June 30  2023 2022 2021 
NET SALES  
United States  $ 38.7 $ 36.5 $ 33.7 
International  $ 43.3 $ 43.7 $ 42.4 
LONG -LIVED ASSETS (1) 
United States  $ 11.4 $ 10.7 $ 10.1 
International  $ 10.5 $ 10.5 $ 11.6","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 53}"
,,"International  $ 10.5 $ 10.5 $ 11.6 
(1)Long -lived assets consists  of property, plant and equipment.
No country, other than the United States, exceeds 10% of the Company's consolidated net sales or long -lived assets. 
Our largest customer, Walmart Inc. and its affiliates, accounted for consolidated net sales of approximately 15% in 2023, 2022 
and 2021. No other customer represents more than 10% of our consolidated net sales
42        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 53}"
,,"42        The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 53}"
,,"Global Segment Results  Net Sales  Earnings/(Loss)  
Before  
Income Taxes  Net Earnings
/(Loss)  Depreciation  
and 
Amortization  Total  
Assets  Capital  
Expenditures  
BEAUTY  2023  $ 15,008  $ 4,009  $ 3,178  $ 376 $ 6,196  $ 287 
2022  14,740  3,946  3,160  348 6,055  331 
2021  14,417  4,018  3,210  333 5,587  386 
GROOMING  2023  6,419  1,806  1,461  335 20,601  300 
2022  6,587  1,835  1,490  361 20,482  260 
2021  6,440  1,728  1,427  378 20,668  291","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 54}"
,,"2021  6,440  1,728  1,427  378 20,668  291 
HEALTH CARE  2023  11,226  2,759  2,125  352 8,480  466 
2022  10,824  2,618  2,006  376 7,888  410 
2021  9,956  2,398  1,851  372 7,976  364 
FABRIC & HOME CARE  2023  28,371  6,303  4,828  675 8,669  979 
2022  27,556  5,729  4,386  672 8,567  988 
2021  26,014  5,986  4,622  646 8,334  1,006  
BABY, FEMININE & 
FAMILY CARE  2023  20,217  4,623  3,545  804 8,517  994 
2022  19,736  4,267  3,266  826 8,443  932 
2021  18,850  4,723  3,629  846 8,666  814","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 54}"
,,"2021  18,850  4,723  3,629  846 8,666  814 
CORPORATE 2023  765 (1,147)   (399)   172 68,366  36 
2022  744 (400)   485 224 65,773  235 
2021  441 (1,238)   (387)   160 68,076  (74) 
TOTAL COMPANY  2023  $ 82,006  $ 18,353  $ 14,738  $ 2,714  $120,829  $ 3,062  
2022  80,187  17,995  14,793  2,807  117,208  3,156  
2021  76,118  17,615  14,352  2,735  119,307  2,787  
The Procter & Gamble Company        43
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 54}"
,,"NOTE 3  
SUPPLEMENTAL FINANCIAL INFORMATION  
The components of property, plant and equipment were as follows:  
As of June 30  2023 2022 
PROPERTY, PLANT AND EQUIPMENT  
Buildings  $ 8,277  $ 8,087  
Machinery and equipment  36,521  35,098  
Land  867 756 
Construction in progress  2,980  2,756  
TOTAL PROPERTY, PLANT AND EQUIPMENT  48,645  46,697  
Accumulated depreciation  (26,736)   (25,502)  
PROPERTY, PLANT AND EQUIPMENT, NET  $ 21,909  $ 21,195","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 55}"
,,"PROPERTY, PLANT AND EQUIPMENT, NET  $ 21,909  $ 21,195  
Selected components of current and noncurrent liabilities were as follows:  
As of June 30  2023 2022 
ACCRUED AND OTHER LIABILITIES - CURRENT  
Marketing and promotion  $ 3,894  $ 3,878  
Compensation expenses  2,030  1,797  
Taxes payable  828 587 
Derivative liabilities  631 1 
Leases  222 205 
Restructuring reserves  174 147 
Other  3,150  2,939  
TOTAL  $ 10,929  $ 9,554  
OTHER NONCURRENT LIABILITIES  
Pension benefits  $ 3,116  $ 3,139","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 55}"
,,"Pension benefits  $ 3,116  $ 3,139  
U.S. Tax Act transitional tax payable  1,154  1,661  
Other retiree benefits  690 672 
Uncertain tax positions  622 752 
Long term operating leases  595 595 
Derivative liabilities  445 307 
Other  530 490 
TOTAL  $ 7,152  $ 7,616  
RESTRUCTURING PROGRAM  
The Company has historically incurred an ongoing annual level of restructuring -type activities to maintain a competitive cost","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 55}"
,,"structure, including manufacturing and workforce optimization. Before tax costs incurred under ongoing programs have 
generally ra nged from $250 to $500 annually.  
Restructuring costs incurred consist primarily of costs to separate employees, asset -related costs to exit facilities and other 
costs. Employee separation costs relate to severance packages that are primarily voluntary an d the amounts calculated are based","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 55}"
,,"on salary levels and past service periods. Severance costs related to voluntary separations are generally charged to earnings  
when the employee accepts the offer. Asset -related costs consist of both asset write -downs and  accelerated depreciation. Asset 
write -downs relate to the establishment of a new fair value basis for assets held -for-sale or for disposal. These assets are written","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 55}"
,,"down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. 
Charges for accelerated depreciation relate to long -lived assets that will be taken out of service prior to the end of their normal 
service period. These assets relate primarily to manufacturing consolidations and techn ology standardizations. The asset -related","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 55}"
,,"charges will not have a significant impact on future depreciation charges. Other restructuring -type charges primarily include 
asset removal and termination of contracts related to supply chain and overhead optimiz ation. The Company incurred total 
restructuring charges of $329 and $253 for the fiscal years ended June  30, 2023 and 2022. Of the charges incurred for fiscal 
year 2023, $160 were recorded in Costs of products sold, $160 in SG&A and $9 in Other non -operat ing income, net. Of the","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 55}"
,,"44        The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 55}"
,,"charges incurred in fiscal year 2022, $182 were recorded in Costs of products sold, $67 in SG&A, and $4 in Other non - 
operating income, net. The following table presents restructuring activity for the fiscal years ended June  30, 202 3 and 2022:  
Separations  Asset -Related 
Costs  Other  Total  
RESERVE JUNE 30, 2021  $ 176  $ —  $ 102  $ 278 
Cost incurred and charged to expense  88 87 78 253 
Cost paid/settled  (143) (87) (154) (384)
RESERVE JUNE 30, 2022  121 — 26 147","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 56}"
,,"RESERVE JUNE 30, 2022  121 — 26 147 
Cost incurred and charged to expense  175 43 111 329 
Cost paid/settled  (141) (43) (118)  (302)
RESERVE JUNE 30, 2023  $ 155  $ —  $ 19  $ 174 
Consistent with our historical policies for ongoing restructuring -type activities, the restructuring charges are funded by and 
included within Corporate for management and segment reporting. 
However, for information purposes, the following table summarizes the total restructuring costs related to our reportable 
segments:","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 56}"
,,"segments: 
Fiscal years ended June 30  2023 2022 2021 
Beauty  $ 15  $ 11  $ 13 
Grooming  17 14 25 
Health Care  28 32 51 
Fabric & Home Care  87 42 22 
Baby, Feminine & Family Care  21 83 29 
Corporate (1) 161 71 190 
Total Company  $ 329  $ 253  $ 330 
(1)Corporate includes costs related to allocated overheads, including charges related to our Enterprise Markets, Global Business  Services
and Corporate Functions activities.
NOTE 4
GOODWILL AND INTANGIBLE ASSETS","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 56}"
,,"NOTE 4
GOODWILL AND INTANGIBLE ASSETS  
The change in the net carrying amount of goodwill by reportable segment was as follows:  
Beauty  Grooming  Health Care  Fabric & 
Home Care  Baby, 
Feminine & 
Family Care  Total 
Company  
Balance at June  30, 2021  - Net (1) $ 13,257  $ 13,095   $ 8,046   $ 1,873   $ 4,653  $ 40,924  
Acquisitions and divestitures  781 — 1 — — 782 
Translation and other  (742) (524) (458) (65) (217) (2,006)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 56}"
,,"Translation and other  (742) (524) (458) (65) (217) (2,006)
Balance at June  30, 2022  - Net (1) 13,296  12,571  7,589  1,808  4,436  39,700  
Acquisitions and divestitures  405 — — — 33 438 
Translation and other  187 132 129 13 60 521 
Balance at June  30, 2023  - Net (1) $ 13,888   $ 12,703   $ 7,718   $ 1,821   $ 4,529   $ 40,659  
(1)Grooming goodwill balance is net of $7.9 billion accumulated impairment losses.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 56}"
,,"Goodwill and indefinite -lived intangibles are tested for impairment at least annually by comparing the estimated fair values of 
our reporting units and indefinite -lived intangible assets to their respective carrying values. We use the income method to 
estimate the fair value of these assets, which is based on forecasts of the expected future cash flows attributable to the 
respective assets. Significant estimates and assumptions inherent in the valuations reflect a consideration of other marketpl ace","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 56}"
,,"partic ipants and include the amount and timing of future cash flows (including expected growth rates and profitability). 
Significant judgement by management is required to estimate the impact of macroeconomic and other factors on future cash 
flows, including tho se related to the Russia -Ukraine War. Estimates utilized in the projected cash flows include consideration of 
macroeconomic conditions, overall category growth rates, competitive activities, cost containment and margin expansion,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 56}"
,,"Company business plans, th e underlying product or technology life cycles, economic barriers to entry, a brand's relative market 
position and the discount rate applied to the cash flows. Unanticipated market or macroeconomic events and circumstances may 
occur, which could affect the  accuracy or validity of the estimates and assumptions. 
The Procter & Gamble Company        45
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 56}"
,,"We believe the estimates and assumptions utilized in our impairment testing are reasonable and are comparable to those that 
would be used by other marketplace participants. However, actual events and  results could differ substantially from those used 
in our valuations. To the extent such factors result in a failure to achieve the level of projected cash flows initially used  to 
estimate fair value for purposes of establishing or subsequently impairin g the carrying amount of goodwill and related","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 57}"
,,"intangible assets, we may need to record additional non -cash impairment charges in the future. 
Goodwill increased during fiscal 2023 primarily due to an acquisition in the Beauty segment, other minor brand ac quisitions in 
the Baby, Feminine & Family Care segment and currency translation across all reportable segments.
Goodwill decreased during fiscal 2022 due to currency translation across all reportable segments, partially offset by three","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 57}"
,,"acquisitions (Farmac y Beauty, Ouai and TULA) in the Beauty reportable segment. 
Identifiable intangible assets were comprised of: 
2023 2022 
As of June 30Gross Carrying 
Amount  Accumulated  
Amortization  Gross Carrying 
Amount  Accumulated  
Amortization  
INTANGIBLE ASSETS WITH DETERMINABLE LIVES  
Brands  $ 4,352   $ (2,540)   $ 4,299   $ (2,628)  
Patents and technology  2,775  (2,649)   2,769  (2,609)  
Customer relationships  1,847  (1,039)   1,797  (939)  
Other  73 (28)  147 (97)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 57}"
,,"Other  73 (28)  147 (97) 
TOTAL  $ 9,047   $ (6,256)   $ 9,012   $ (6,273)  
INTANGIBLE ASSETS WITH INDEFINITE LIVES  
Brands  20,992  — 20,940  — 
TOTAL INTANGIBLE ASSETS  $ 30,039   $ (6,256)   $ 29,952   $ (6,273)  
Amortization expense of intangible assets was as follows:
Fiscal years ended June 30  2023 2022 2021 
Intangible asset amortization  $ 327 $ 312 $ 318 
Estimated amortization expense over the next five fiscal years is as follows:  
Fiscal years ending June 30  2024 2025 2026 2027 2028","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 57}"
,,"Fiscal years ending June 30  2024 2025 2026 2027 2028 
Estimated amortization expense  $ 340  $ 320  $ 297  $ 287  $ 247 
NOTE 5  
INCOME TAXES  
Income taxes are recognized for the amount of taxes payable for the current year and for the impact of deferred tax assets an d 
liabilities, which represent future tax consequences of events that have been recognized differently in the financial stateme nts","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 57}"
,,"than for tax purposes. Deferred tax assets and liabilities are established using the enacted statutory tax rates and are adju sted for 
any changes in such rates in the period of change.  
We have elected to account for the tax effects of Global Intangible Lo w-Taxed Income (GILTI) as a current period expense 
when incurred.  
Earnings before income taxes consisted of the following:  
Fiscal years ended June 30  2023 2022 2021 
United States  $ 12,107  $ 11,698  $ 10,858","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 57}"
,,"United States  $ 12,107  $ 11,698  $ 10,858  
International  6,246  6,297  6,757  
TOTAL  $ 18,353  $ 17,995  $ 17,615  
46        The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 57}"
,,"Income taxes consisted of the following:  
Fiscal years ended June 30  2023 2022 2021 
CURRENT TAX EXPENSE  
U.S. federal  $ 2,303  $ 1,916  $ 1,663  
International  1,412  1,333  1,534  
U.S. state and local  353 355 324 
TOTAL  4,068  3,604  3,521  
DEFERRED TAX EXPENSE/(BENEFIT)  
U.S. federal  (224)   (320)   (65) 
International and other  (229)   (82)  (193)  
TOTAL  (453)   (402)   (258)  
TOTAL TAX EXPENSE  $ 3,615  $ 3,202  $ 3,263","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 58}"
,,"TOTAL TAX EXPENSE  $ 3,615  $ 3,202  $ 3,263  
A reconciliation of the U.S. federal statutory income tax rate to our actual effective income tax rate is provided below:  
Fiscal years ended June 30  2023 2022 2021 
U.S. federal statutory income tax rate  21.0 %  21.0 %  21.0 % 
Country mix impacts of foreign operations  (0.5) %  (0.3) %  (0.5) % 
State income taxes, net of federal benefit  1.6 %  1.5 %  1.3 % 
Excess tax benefits from the exercise of stock options  (1.0) %  (2.0) %  (1.6) %","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 58}"
,,"Foreign derived intangible income deduction (FDII)  (0.8) %  (1.1) %  (1.0) % 
Changes in uncertain tax positions  0.1 %  (0.4) %  (0.1) % 
Other  (0.7) %  (0.9) %  (0.6) % 
EFFECTIVE INCOME TAX RATE  19.7 %  17.8 %  18.5 % 
Country mix impacts of foreign operations includes the effects of foreign subsidiaries' earnings taxed at rates other than th e 
U.S. statutory rate, the U.S. tax impacts of non -U.S. earnings repatriation and any net impacts of intercompany transactions.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 58}"
,,"Changes in uncertain tax positions represent changes in our net liability related to prior year tax positions. Excess tax ben efits 
from the exercise of stock options reflect the e xcess of actual tax benefits received on employee exercises of stock options and 
other share -based payments (which generally equals the income taxable to the employee) over the amount of tax benefits that 
were calculated and recognized based on the grant d ate fair values of such instruments.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 58}"
,,"Tax benefits credited to shareholders' equity totaled $190 for the fiscal year ended June  30, 2023. This primarily relates to the 
tax effects of net investment hedges. Tax costs charged to shareholders' equity totaled $1,538 for the fiscal year ended June  30, 
2022. This primarily relates to the tax effects of certain adjustments to pension obligations recorded in shareholders' equit y and 
the tax effects of net investment hedges.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 58}"
,,"the tax effects of net investment hedges.  
Prior to the passage of the U.S. Tax Act,  the Company asserted that substantially all of the undistributed earnings of its foreign 
subsidiaries were considered indefinitely invested and, accordingly, no deferred taxes were provided. Pursuant to the provisi ons 
of the U.S. Tax Act, these earnings w ere subjected to a one -time transition tax. This charge included taxes for all U.S. income","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 58}"
,,"taxes and for the related foreign withholding taxes for the portion of those earnings which are no longer considered indefini tely 
invested. We have not provided defe rred taxes on approximately $24 billion of earnings that are considered indefinitely 
invested.  
A reconciliation of the beginning and ending liability for uncertain tax positions is as follows:  
Fiscal years ended June 30  2023 2022 2021 
BEGINNING OF YEAR  $ 583 $ 627 $ 485 
Increases in tax positions for prior years  113 102 157","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 58}"
,,"Increases in tax positions for prior years  113 102 157 
Decreases in tax positions for prior years  (119)   (118)   (34) 
Increases in tax positions for current year  60 53 60 
Settlements with taxing authorities  (108)   (42)  (26) 
Lapse in statute of limitations  (7) (17) (24) 
Currency translation  (7)  (22) 9 
END OF YEAR  $ 515   $ 583   $ 627 
The Procter & Gamble Company        47
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 58}"
,,"Included in the total liability for uncertain tax positions at June  30, 2023, is $354 that, depending on the ultimate resolution,  
could impact the effective tax rate in future periods.  
The Company is present in approximately 70 countries and over 150 taxa ble jurisdictions and, at any point in time, has 30 -40 
jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 59}"
,,"uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the 
underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in  
light of changing facts and circumstances, including progress of tax audits, d evelopments in case law and the closing of statutes","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 59}"
,,"of limitation. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2010 a nd 
forward. We are generally not able to reliably estimate the ultimate settlem ent amounts until the close of the audit. Based on 
information currently available, we anticipate that over the next 12 -month period, audit activity could be completed related to","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 59}"
,,"uncertain tax positions in multiple jurisdictions for which we have accrued e xisting liabilities of approximately $40, including 
interest and penalties.  
We recognize the additional accrual of any possible related interest and penalties relating to the underlying uncertain tax  
position in income tax expense. As of June  30, 2023, 20 22 and 2021, we had accrued interest of $143, $179 and $166 and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 59}"
,,"accrued penalties of $12, $12 and $10, respectively, which are not included in the above table. During the fiscal years ended  
June 30, 2023, 2022 and 2021, we recognized $23, $21 and $38 in i nterest expense and $1, $2 and $6 in penalties expense, 
respectively.  
Deferred income tax assets and liabilities were comprised of the following:  
  
As of June 30  2023  2022 
DEFERRED TAX ASSETS     
Loss and other carryforwards  $ 1,014    $ 914  
Capitalized research & development   930    646","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 59}"
,,"Capitalized research & development   930    646  
Pension and other retiree  benefits   737    740  
Accrued marketing and promotion   421    420  
Stock -based compensation   412    386  
Unrealized loss on financial and foreign exchange transactions   282    138  
Fixed assets   223    209  
Lease liabilities   197    185  
Other   874    862  
Valuation allowances   (403)    (409)  
TOTAL  $ 4,687    $ 4,091   
    
DEFERRED TAX LIABILITIES","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 59}"
,,"TOTAL  $ 4,687    $ 4,091   
    
DEFERRED TAX LIABILITIES     
Goodwill and other intangible assets  $ 5,811    $ 5,783   
Fixed assets   1,556     1,542   
Other retiree benefits   1,101     1,031   
Unrealized gain on financial and foreign exchange transactions   198    439  
Lease right -of-use assets   191    179  
Foreign withholding tax on earnings to be repatriated   96    70  
Other   381    244  
TOTAL  $ 9,334    $ 9,288","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 59}"
,,"Other   381    244  
TOTAL  $ 9,334    $ 9,288   
 Net operating loss carryforwards were $2.9 billion at June  30, 2023, and $2.5 billion at June  30, 2022. If unused, approximately 
$300 will expire between 2023 and 2042. The remainder, totaling $2.6 billion at June  30, 2023, may be carried forward 
indefinitely.  
NOTE 6  
EARNINGS PER SHARE  
Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble less preferred","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 59}"
,,"dividends by the weighted average number of common shares outstanding during the year. Diluted net earnings per common 
share are calculated by dividing Net earnings attributable to Procter & Gamble by the diluted weighted average number of 
common  shares outstanding during the year. The diluted shares include the dilutive effect of stock options and other share - 
based awards based on the treasury stock method (see Note 7) and the assumed conversion of preferred stock (see Note 8).","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 59}"
,,"48        The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 59}"
,,"Net earnings per common share were calculated as follows:
Fiscal years ended June 30  2023 2022 2021 
CONSOLIDATED AMOUNTS  
Net earnings  $ 14,738  $ 14,793  $ 14,352  
Less: Net earnings attributable to noncontrolling interests  85 51 46 
Net earnings attributable to P&G  14,653  14,742  14,306  
Less: Preferred dividends  282 281 271 
Net earnings attributable to P&G available to common shareholders 
(Basic)  $ 14,371  $ 14,461  $ 14,035","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 60}"
,,"(Basic)  $ 14,371  $ 14,461  $ 14,035  
Net earnings attributable to P&G available to common shareholders 
(Diluted)  $ 14,653  $ 14,742  $ 14,306  
SHARES IN MILLIONS  
Basic weighted average common shares outstanding  2,368.2  2,410.3  2,465.8  
Add effect of dilutive securities:  
Stock options and other unvested equity awards (1) 39.4 49.5 52.5 
Convertible preferred shares (2) 76.3 79.3 82.7 
Diluted weighted average common shares outstanding  2,483.9  2,539.1  2,601.0","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 60}"
,,"NET EARNINGS PER COMMON SHARE  (3) 
Basic  $ 6.07   $ 6.00   $ 5.69 
Diluted  $ 5.90 $ 5.81 $ 5.50 
(1)Excludes 19 million, 11 million and 9 million in 2023, 2022 and 2021, respectively, of weighted average stock options outstan ding
because the exercise price of these options was greater than the average market value of the Company's stock or their effect was
antidilutive.
(2)An overview of preferred shares can be found in Note 8.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 60}"
,,"(2)An overview of preferred shares can be found in Note 8.
(3)Basic net earnings per common share and Diluted net earnings per common share are calculated on Net earnings attributable to Procter &
Gamble.
NOTE 7  
SHARE -BASED  COMPENSATION  
The Company has two primary share -based compensation programs under which we annually grant stock option, restricted 
stock unit (RSU) and performance stock unit (PSU) awards to certain managers and directors.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 60}"
,,"In our main long -term incentive  program, managers can elect to receive stock options or RSUs. All options vest after three 
years and have a 10 -year life. Exercise prices on options are set equal to the market price of the underlying shares on the date of 
the grant. RSUs vest and settle  in shares of common stock three years from the grant date.  
Senior -level executives participate in an additional long -term incentive program that awards PSUs, which are paid in shares","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 60}"
,,"after the end of a three -year performance period subject to pre -establ ished performance goals. The program includes a Relative 
Total Shareholder Return (R -TSR) modifier under which the number of shares ultimately granted is also impacted by the 
Company's actual shareholder return relative to our consumer products competitive  peer set.  
In addition to these long -term incentive programs, we award RSUs to the Company's non -employee directors and make other","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 60}"
,,"minor stock option and RSU grants to employees for which the terms are not substantially different from our long -term 
incent ive awards.  
The Company's share -based compensation plan was approved by shareholders in 2019. Under the 2019 plan, a maximum of 
150 million shares of common stock was authorized for issuance and a total of 96 million shares remain available for grant.  
The Company recognizes share -based compensation expense based on the fair value of the awards at the date of grant. The","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 60}"
,,"expense is recognized on a straight -line basis over the requisite service period. Awards to employees eligible for reti rement 
prior to the award becoming fully vested are recognized as compensation expense ratably from the grant date through the date 
the employee first becomes eligible to retire and/or is no longer required to provide services to earn the award. Share -based 
compensation expense is included as part of Cost of products sold and SG&A in the Consolidated Statement of Earnings and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 60}"
,,"includes an estimate of forfeitures, which is based on historical data. 
The Procter & Gamble Company        49
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 60}"
,,"Total expense and related tax benefit were as follows:  
Fiscal years ended June 30  2023 2022 2021 
Stock options  $ 303 $ 271 $ 279 
RSUs and PSUs  242 257 261 
Total share -based expense  $ 545 $ 528 $ 540 
Income tax benefit  $ 103 $ 88 $ 102 
We utilize an industry standard lattice -based valuation model to calculate the fair value for stock options granted. Assumptions 
utilized in the model, which are evaluated and revised to reflect market conditions and experience, were as follows:","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 61}"
,,"Fiscal years ended June 30 2023 2022 2021 
Interest rate  3.7 - 4.1 % 0.1 - 1.6 % 0.1 - 0.7 %
Weighted average interest rate  3.7 % 1.5 % 0.6 %
Dividend yield  2.6 % 2.4 % 2.4 %
Expected volatility  21 % 19 % 20 %
Expected life in years  8.8 9.1 9.2 
Lattice -based option valuation models incorporate ranges of assumptions for inputs and those ranges are disclosed in the 
preceding table. Expected volatilities are based on a combination of historical volatility of our stock and implied volatilit ies of","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 61}"
,,"call options on our stock. We use historical data to estimate option exercise and employee termination patterns within the 
valuation model. The expected life of options granted is derived from the output of the option valuation model and represents  
the aver age period of time that options granted are expected to be outstanding. The interest rate for periods within the contractual 
life of the options is based on the U.S. Treasury yield curve in effect at the time of grant.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 61}"
,,"We utilize a Monte -Carlo simulation m odel to estimate the fair value of performance stock units granted. Assumptions utilized 
in the model are not substantially different from those used for stock options.  
A summary of options outstanding under the plans as of June  30, 2023, and activity dur ing the year then ended is presented 
below:  
OptionsOptions  
(in thousands)  Weighted 
Average 
Exercise Price  Weighted Average 
Contractual Life 
in Years  Aggregate 
Intrinsic Value","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 61}"
,,"Contractual Life 
in Years  Aggregate 
Intrinsic Value  
Outstanding at July 1, 2022  126,715   $ 99.59  
Granted  9,672  131.26  
Exercised  (14,667)  81.07  
Forfeited/expired  (515) 128.40
Outstanding at June 30, 2023  121,205   $ 104.18  5.1 $ 5,770  
Exercisable  86,336   $ 90.46  3.9 $ 5,291  
The following table provides additional information on stock options:  
Fiscal years ended June 30  2023 2022 2021 
Weighted average grant -date fair value of options granted  $ 29.58  $ 21.55  $ 20.94","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 61}"
,,"Intrinsic value of options exercised  979 1,886  1,401  
Grant -date fair value of options that vested  219 177 236 
Cash received from options exercised  1,189  1,930  1,705  
Actual tax benefit from options exercised  207 399 292 
At June  30, 2023, $159 of compensation cost had not yet been recognized related to stock option grants. That cost is expected 
to be recognized over a remaining weighted average period of 1.6 years.
50        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 61}"
,,"50        The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 61}"
,,"A summary of non -vested RSUs and PSUs outstanding under the plans as of June  30, 2023, and activity during the year then 
ended is presented below:  
RSUs PSUs
RSU and PSU awardsUnits (in 
thousands)  Weighted 
Average Grant 
Date Fair Value  Units (in 
thousands)  Weighted 
Average Grant 
Date Fair Value  
Non-vested at July 1, 2022  2,832   $ 130.37  928  $ 152.94  
Granted  1,727  128.78  569 133.21  
Vested  (1,286)  116.89  (453) 152.90
Forfeited  (101) 131.22 (33) 140.68","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 62}"
,,"Forfeited  (101) 131.22 (33) 140.68
Non-vested at June 30, 2023  3,172   $ 134.94  1,011   $ 142.40  
At June  30, 2023, $218 of compensation cost had not yet been recognized related to RSUs and PSUs. That cost is expected to 
be recognized over a remaining weighted average period of 1.7 years. The total grant date fair value of shares vested was $22 0, 
$248  and $266 in 2023, 2022 and 2021, respectively.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 62}"
,,"$248  and $266 in 2023, 2022 and 2021, respectively.  
The Company settles equity issuances with treasury shares. We have no specific policy to repurchase common shares to 
mitigate the dilutive impact of options, RSUs and PSUs. However, we have historically made  adequate discretionary purchases, 
based on cash availability, market trends and other factors, to offset the impacts of such activity.  
NOTE 8  
POSTRETIREMENT BENEFITS AND EMPLOYEE STOCK OWNERSHIP PLAN","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 62}"
,,"POSTRETIREMENT BENEFITS AND EMPLOYEE STOCK OWNERSHIP PLAN  
We offer various postretirement benefits to our employees.  
Defined Contribution Retirement Plans  
We have defined contribution plans, which cover the majority of our U.S. employees, as well as employees in certain other 
countries. These plans are fully funded. We generally make contributions to participants' accounts based on individual base","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 62}"
,,"salaries and years of service. Total global defined contribution expense was $392, $366 and $340 in 2023, 2022 and 2021, 
respectively.  
The primary U.S. defined contribution plan (the U.S . DC plan) comprises the majority of the expense for the Company's 
defined contribution plans. For the U.S. DC plan, the contribution rate is set annually. Total contributions for this plan 
approximated 13% of total participants' annual wages and salaries  in 2023 and 14% in 2022 and 2021.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 62}"
,,"We maintain The Procter  & Gamble Profit Sharing Trust (Trust) and Employee Stock Ownership Plan (ESOP) to provide a 
portion of the funding for the U.S. DC plan and other retiree benefits (described below). Operating deta ils of the ESOP are 
provided at the end of this Note. The fair value of the ESOP Series A shares allocated to participants reduces our cash 
contribution required to fund the U.S. DC plan.  
Defined Benefit Retirement Plans and Other Retiree Benefits","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 62}"
,,"Defined Benefit Retirement Plans and Other Retiree Benefits  
We offe r defined benefit retirement pension plans to certain employees. These benefits relate primarily to plans outside the U.S. 
and, to a lesser extent, plans assumed in previous acquisitions covering U.S. employees.  
We also provide certain other retiree benefi ts, primarily health care benefits for the majority of our U.S. employees who","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 62}"
,,"become eligible for these benefits when they meet minimum age and service requirements. The plans require cost sharing with 
retirees and the benefits are funded by  ESOP Series B  shares and certain other assets contributed by the Company.  
The Procter & Gamble Company        51
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 62}"
,,"Obligation and Funded Status . The following provides a reconciliation of benefit obligations, plan assets and funded status of 
these defined benefit plans:  
Pension Benefits (1) Other  Retiree  Benefits (2) 
Fiscal years ended June 30  2023 2022  2023 2022  
CHANGE IN BENEFIT OBLIGATION  
Benefit obligation at beginning of year (3) $ 12,608  $ 18,469  $ 3,070  $ 4,206  
Service cost  173 253 71 86 
Interest cost  430 253 142 99 
Participants' contributions  13 14 50 67 
Amendments (4) 8 5 — (586)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 63}"
,,"Amendments (4) 8 5 — (586)  
Net actuarial loss/(gain)  (550)   (4,067)   (208)   (586)  
Special termination benefits  5 4 4 1 
Currency translation and other  363 (1,720)   31 51 
Benefit payments  (551)   (603) (227) (268)  
BENEFIT OBLIGATION AT END OF YEAR (3) $ 12,499  $ 12,608  $ 2,933  $ 3,070  
CHANGE IN PLAN ASSETS  
Fair value of plan assets at beginning of year  $ 10,173  $ 13,041  $ 6,889  $ 6,444  
Actual return on plan assets  37 (1,233)   482 526 
Employer contributions  392 222 42 37","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 63}"
,,"Employer contributions  392 222 42 37 
Participants' contributions  13 14 50 67 
Currency translation and other  310 (1,268)   1 1 
ESOP debt impacts (5) — — 87 82 
Benefit payments  (551)   (603) (227) (268)  
FAIR VALUE OF PLAN ASSETS AT END OF YEAR  $ 10,374  $ 10,173  $ 7,324  $ 6,889  
FUNDED STATUS  $ (2,125)   $ (2,435)   $ 4,391  $ 3,819  
(1)Primarily non -U.S.-based defined benefit retirement plans.
(2)Primarily U.S. -based other postretirement benefit plans.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 63}"
,,"(2)Primarily U.S. -based other postretirement benefit plans.
(3)For the pension benefit  plans, the benefit obligation is the projected benefit obligation. For other retiree benefit plans, the benefit
obligation is the accumulated postretirement benefit obligation.
(4)For the other retiree benefits, the amendment primarily relates to adjustment s in the self -insured U.S. retiree health care program to 
utilize fully -insured Medicare Advantage Programs impacting fiscal year 2022.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 63}"
,,"(5)Represents the net impact of ESOP debt service requirements, which is netted against plan assets for other retiree bene fits.
The actuarial gain for pension plans in 2023 was primarily related to increases in discount rates, offset by inflation -related  
pension benefit increases. The actuarial gain for other retiree benefits in 2023 was primarily related to increases in discou nt","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 63}"
,,"rates and a decrease in assumptions for medical claims costs. The actuarial gain for pension plans in 2022 was primarily rela ted 
to increases in discount rates. The actuarial gain for other retiree benefits in 2022 was primarily related to increases in d iscount 
rates, partially offset by unfavorable medical claim experience. 
The underfunding of pension benefits is primarily a function of the different funding incentives that exist outside of the U. S. In","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 63}"
,,"certain countries, there are no legal requirements o r financial incentives provided to companies to pre -fund pension obligations 
prior to their due date. In these instances, benefit payments are typically paid directly from the Company's cash as they bec ome 
due.
Pension Benefits Other  Retiree  Benefits
As of June 30 2023 2022 2023 2022
CLASSIFICATION OF NET AMOUNT RECOGNIZED  
Noncurrent assets  $ 1,085    $ 765 $ 5,119    $ 4,525  
Current liabilities  (94)  (61) (38) (34)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 63}"
,,"Current liabilities  (94)  (61) (38) (34) 
Noncurrent liabilities  (3,116)   (3,139)   (690) (672)
NET AMOUNT RECOGNIZED  $ (2,125)   $ (2,435)   $ 4,391  $ 3,819  
AMOUNTS RECOGNIZED IN ACCUMULATED OTHER COMPREHENSIVE (INCOME)/LOSS (AOCI)  
Net actuarial loss/(gain)  $ 1,818  $ 1,906  $ (1,160)   $ (1,093)  
Prior service cost/(credit)  156 170 (787) (907)
NET AMOUNTS RECOGNIZED IN AOCI  $ 1,974  $ 2,076  $ (1,947)   $ (2,000)  
52        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 63}"
,,"52        The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 63}"
,,"The accumulated benefit obligation for all defined benefit pension plans, which differs from the projected obligation in that  it 
excludes the assumption of future sala ry increases, was $11.8 billion and $11.9 billion as of June  30, 2023 and 2022, 
respectively. Information related to the funded status of selected pension and other retiree benefits at June 30 is as follow s: 
As of June 30  2023  2022  
PENSION PLANS WITH A PROJECTED BENEFIT OBLIGATION IN EXCESS OF PLAN ASSETS","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 64}"
,,"Projected benefit obligation  $ 7,967  $ 7,989  
Fair value of plan assets  4,758  4,789  
PENSION PLANS WITH AN ACCUMULATED BENEFIT OBLIGATION IN EXCESS OF PLAN ASSETS  
Accumulated benefit obligation  $ 7,442  $ 7,191  
Fair value of plan assets  4,677  4,433  
OTHER RETIREE BENEFIT PLANS WITH AN ACCUMULATED BENEFIT OBLIGATION IN EXCESS OF 
PLAN ASSETS  
Accumulated benefit obligation  $ 818 $ 808 
Fair value of plan assets  89 102","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 64}"
,,"Fair value of plan assets  89 102 
Net Periodic Benefit Cost . Components of the net periodic benefit cost were as follows:  
Pension Benefits Other  Retiree  Benefits
Fiscal years ended June 30 2023 2022 2021 2023 2022 2021
AMOUNTS RECOGNIZED IN NET PERIODIC BENEFIT COST/(CREDIT)  
Service cost  $ 173 $ 253 $ 275 $ 71 $ 86 $ 94 
Interest cost  430 253 240 142 99 114 
Expected return on plan assets  (591)   (684)   (783)   (611)   (564)   (508)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 64}"
,,"Amortization of net actuarial loss/(gain)  133 337 423 (7)  11 47 
Amortization of prior service cost/(credit) 26 28 25 (125)   (107)   (60) 
Amortization of net actuarial loss/(gain) due to settlements  — (5)  5 — — — 
Special termination benefits  5 4 17 4 1 2 
GROSS BENEFIT COST/(CREDIT)  176 186 202 (526)   (474)   (311)  
Dividends on ESOP preferred stock  — — — — — (8) 
NET PERIODIC BENEFIT COST/(CREDIT)  $ 176 $ 186 $ 202 $ (526) $ (474)   $ (319)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 64}"
,,"CHANGE IN PLAN ASSETS AND BENEFIT OBLIGATIONS RECOGNIZED IN AOCI  
Net actuarial loss/(gain) - current year  $ 4 $ (2,150)   $ (79)  $ (548)   
Prior service cost/(credit) - current year  8 5 — (586)   
Amortization of net actuarial loss/(gain)  (133)   (337)   7 (11)  
Amortization of prior service (cost)/credit  (26)  (28)  125 107 
Amortization of net actuarial loss/(gain) due to settlements  — 5 — — 
Currency translation and other  45 (486)   — 13 
TOTAL CHANGE IN AOCI  (102)   (2,991)   53 (1,025)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 64}"
,,"TOTAL CHANGE IN AOCI  (102)   (2,991)   53 (1,025)   
NET AMOUNTS RECOGNIZED IN PERIODIC 
BENEFIT COST/(CREDIT) AND AOCI  $ 74 $ (2,805)   $ (473)   $ (1,499)   
The service cost component of the net periodic benefit cost is included in the Consolidated Statements of Earnings in Cost of 
products sold and SG&A. All other components are included in the Consolidated Statements of Earnings in Other non - 
operating income/(expense), net, unless otherwise noted.  
The Procter & Gamble Company        53","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 64}"
,,"The Procter & Gamble Company        53
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 64}"
,,"Assumptions . We determine our actuarial assum ptions on an annual basis. These assumptions are weighted to reflect each  
country that may have an impact on the cost of providing retirement benefits. The weighted average assumptions used to 
determine benefit obligations recorded on the Consolidated Bal ance Sheets as of June 30, 2023 and 2022, were as follows: (1) 
 Pension  Benefits   Other  Retiree  Benefits  
As of June 30  2023  2022  2023  2022 
Discount rate  4.2 %   3.7 %   5.6 %   5.0 %","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 65}"
,,"Discount rate  4.2 %   3.7 %   5.6 %   5.0 % 
Rate of compensation increase  2.9 %  2.8 %  N/A  N/A 
Interest crediting rate for cash balance plans  4.3 %  4.3 %  N/A  N/A 
Health care cost trend rates assumed for next year  N/A  N/A  6.1 %  6.4 % 
Rate to which the health care cost trend rate is assumed to 
decline (ultimate trend rate)  N/A  N/A  4.5 %  4.5 % 
Year that the rate reaches the ultimate trend rate  N/A  N/A  2028   2028  
(1) Determined as of end of fiscal year.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 65}"
,,"(1) Determined as of end of fiscal year. 
The weighted average assumptions used to determine net benefit cost recorded on the Consolidated Statement of Earnings for  
the fiscal years ended June 30 were as follows: (1) 
 Pension  Benefits   Other Retiree Benefits  
Fiscal years ended June 30  2023  2022  2021  2023  2022  2021 
Discount rate  3.7 %  1.7 %  1.5 %  5.0 %  3.2 %  3.1 % 
Expected return on plan asset s 5.9 %  5.5 %  6.5 %  8.4 %  8.4 %  8.4 %","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 65}"
,,"Rate of compensation increase  2.8 %  2.7 %  2.5 %  N/A  N/A  N/A 
Interest crediting rate for cash balance plans  4.3 %  4.4 %  4.4 %  N/A  N/A  N/A 
(1) Determined as of beginning of fiscal year. 
 
 For plans that make up the majority of our obligation, the Company calculates the benefit obligation and the related impacts on 
service and interest costs using specific spot rates along the corporate bond yield curve. For the remaining plans, the Compa ny","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 65}"
,,"determines these amounts utilizing a single weighted average discount rate derived from the corporate bond yield curve used t o 
measure the plan obligations.  
Several factors are considered in developing the estimate for the long -term expected rate of retur n on plan assets. For the  
defined benefit retirement plans, these factors include historical rates of return of broad equity and bond indices and proje cted","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 65}"
,,"long-term rates of return obtained from pension investment consultants. The expected long -term rate s of return for plan assets  
are 8 – 9% for equities and 3 – 5% for bonds. For other retiree benefit plans, the expected long -term rate of return reflects that  
the assets are comprised primarily of Company stock. The expected rate of return on Company sto ck is based on the long -term 
projected return of 8.5% and reflects the historical pattern of returns.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 65}"
,,"Plan Assets . Our investment objective for defined benefit retirement plan assets is to meet the plans' benefit obligations and to 
improve plan self -suffic iency for future benefit obligations. The investment strategies focus on asset class diversification,  
liquidity to meet benefit payments and an appropriate balance of long -term investment return and risk. Target ranges for asset","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 65}"
,,"allocations are determined  by assessing different investment risks and matching the actuarial projections of the plans' future 
liabilities and benefit payments with current as well as expected long -term rates of return on the assets, taking into account 
investment return volatility  and correlations across asset classes. Plan assets are diversified across several investment managers","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 65}"
,,"and are generally invested in liquid funds that are selected to track broad market equity and bond indices. Investment risk i s 
carefully controlled with plan assets rebalanced to target allocations on a periodic basis and with continual monitoring of 
investment managers' performance relative to the investment guidelines established with each investment manager.  
Our target asset allocation for the fiscal y ear ended June  30, 2023, and actual asset allocation by asset category as of June  30,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 65}"
,,"2023 and 2022, were as follows: 
 Target  Asset  Allocation   Actual  Asset  Allocation  at June  30 
 
Pension  Benefits   Other Retiree  
Benefits   Pension  Benefits   Other  Retiree  Benefits  
Asset Category    2023   2022   2023   2022  
Cash  1 %  2 %  1 %  1 %  2 %  2 % 
Debt securities  59 %  — %  60 %  58 %  1 %  1 % 
Equity securities  40 %  98 %  39 %  41 %  97 %  97 % 
TOTAL  100 %  100 %  100 %  100 %  100 %  100 %","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 65}"
,,"TOTAL  100 %  100 %  100 %  100 %  100 %  100 % 
The following table sets forth the fair value of the Company's plan assets as of Ju ne 30, 2023 and 2022, segregated by level  
within the fair value hierarchy (refer to Note 9 for further discussion on the fair value hierarchy and fair value principles ). 
54        The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 65}"
,,"Investments valued using net asset value as a practical expedient are not valued usin g the fair value hierarchy, but rather valued 
using the net asset value reported by the managers of the funds and as supported by the unit prices of actual purchase and sa le 
transactions. 
Pension Benefits Other Retiree Benefits
As of June 30Fair Value 
Hierarchy Level  2023 2022Fair Value 
Hierarchy Level  2023 2022
ASSETS AT FAIR VALUE  
Cash and cash equivalents  1 $ 54 $ 78 1 $ 148 $ 130","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 66}"
,,"Cash and cash equivalents  1 $ 54 $ 78 1 $ 148 $ 130 
Company common stock  — — 1 368 319 
Company preferred stock (1) — — 2 6,721  6,340  
Fixed income securities (2) 2 1,190  1,545  — — 
Insurance contracts (3) 3 93 94 — — 
TOTAL ASSETS IN THE FAIR 
VALUE HIERARCHY  1,337  1,717  7,237  6,789  
Investments valued at net asset value (4) 9,037  8,456  87 100 
TOTAL ASSETS AT FAIR VALUE  $ 10,374  10,173  $ 7,324  6,889","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 66}"
,,"TOTAL ASSETS AT FAIR VALUE  $ 10,374  10,173  $ 7,324  6,889  
(1)Company preferred stock is valued based on the value of Company common stock and is presented net of ESOP debt dis cussed below. 
(2)Fixed income securities are estimated by using pricing models or quoted prices of securities with similar characteristics.
(3)Fair values of insurance contracts are valued based on either their cash equivalent value or models that project future  cash flows and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 66}"
,,"discount the future amounts to a present value using market -based observable inputs, including credit risk and interest rate curves. The
activity for Level 3 assets is not significant for all years presented.
(4)Investments valued using net as set value as a practical expedient are primarily equity and fixed income collective funds.
Cash Flows . Management's best estimate of cash requirements and discretionary contributions for the defined benefit","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 66}"
,,"retirement plans and other retiree benefit plan s for the fiscal year ending June  30, 2024, is $206 and $52, respectively. Expected 
contributions are dependent on many variables, including the variability of the market value of the plan assets as compared t o the 
benefit obligation and other market or re gulatory conditions. In addition, we take into consideration our business investment","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 66}"
,,"opportunities and resulting cash requirements. Accordingly, actual funding may differ significantly from current estimates.
Total benefit payments expected to be paid to p articipants, which include payments funded from the Company's assets and 
payments from the plans are as follows: 
Fiscal years ending June 30 Pension Benefits   Other  Retiree Benefits
EXPECTED BENEFIT PAYMENTS  
2024  $ 648 $ 179 
2025  633 186 
2026  632 189 
2027  652 196 
2028  704 202 
2029 - 2033  3,800  1,102","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 66}"
,,"2027  652 196 
2028  704 202 
2029 - 2033  3,800  1,102  
Employee Stock Ownership Plan  
We maintain the ESOP to provide funding for certain employee benefits discussed in the preceding paragraphs. 
The ESOP borrowed $1.0 billion in 1989 and the proceeds were used to purchase Series A ESOP Convertible Class  A Preferred 
Stock to fund a portion of the U.S. DC plan. Principal and interest requirements of the borrowing were paid by the Trust from","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 66}"
,,"dividends on the preferred shares and from advances provided by the Company. The original borrowing of $1.0 billion has been 
repaid in full, and advances from the Company of $8 remain outstanding at June  30, 2023. Each share is convertible at the 
option of the holder into one share of the Company's common stock. The dividend for the current year was equal to the 
common stock dividend of $3.68 per share. T he liquidation value is $6.82 per share.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 66}"
,,"In 1991, the ESOP borrowed an additional $1.0 billion. The proceeds were used to purchase Series B ESOP Convertible 
Class  A Preferred Stock to fund a portion of retiree health care benefits. These shares, net of th e ESOP's debt, are considered 
plan assets of the other retiree benefits plan discussed above. The original borrowings of $1.0 billion were repaid in 2021. Debt 
service requirements were funded by preferred stock dividends, cash contributions and advances provided by the Company, of","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 66}"
,,"which $814 are outstanding at June  30, 2023. Each share is convertible at the option of the holder into one share of the 
Company's common stock. The dividend for the current year was equal to the common stock dividend of $3.68 per share. The 
liquidation value is $12.96 per share.  
The Procter & Gamble Company        55
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 66}"
,,"Our ESOP accounting practices are consistent with current ESOP accounting guidance, including the permissible continuation  
of certain provisions from prior accounting guidance. ESOP debt, which was guaranteed by the Company, was recorded as debt 
with an offset to the Reserve for ESOP debt retirement, which is presented within Shareholders' equity. Advances to the ESOP 
by the Company are recorded as an increase in the Reserve for ESOP debt retirement.  Interest incurred on the ESOP debt was","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 67}"
,,"recorded as Interest expense. Dividends on all preferred shares are charged to Retained earnings.  
The series A and B preferred shares of the ESOP are allocated to employees based on debt service requirements. The num ber of 
preferred shares outstanding at June  30 was as follows:  
Shares in thousands  2023  2022  2021 
Allocated   24,449     25,901     27,759   
Unallocated   535    1,123     1,769   
TOTAL SERIES A   24,984     27,024     29,528   
    
Allocated   32,172     30,719     29,203","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 67}"
,,"Allocated   32,172     30,719     29,203   
Unallocated   17,867     20,120     22,349   
TOTAL SERIES B   50,039     50,839     51,552   
For purposes of calculating diluted net earnings per common share, the preferred shares held by the ESOP are considered 
converted from inception.  
NOTE 9  
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS  
As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 67}"
,,"currency exchange rates and commodity prices. We evaluate exposures on a centralized basis to take advantage of natural 
exposure c orrelation and netting. To the extent we choose to manage volatility associated with the net exposures, we enter into 
various financial transactions that we account for using the applicable accounting guidance for derivative instruments and  
hedging activi ties. These financial transactions are governed by our policies covering acceptable counterparty exposure,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 67}"
,,"instrument types and other hedging practices.  
If the Company elects to do so and if the instrument meets certain specified accounting criteria, manag ement designates  
derivative instruments as cash flow hedges, fair value hedges or net investment hedges. We record derivative instruments at f air 
value and the accounting for changes in the fair value depends on the intended use of the derivative, the res ulting designation","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 67}"
,,"and the effectiveness of the instrument in offsetting the risk exposure it is designed to hedge. We generally have a high deg ree  
of effectiveness between the exposure being hedged and the hedging instrument.  
Credit Risk Management  
We h ave counterparty credit guidelines and normally enter into transactions with investment grade financial institutions, to the 
extent commercially viable. Counterparty exposures are monitored daily and downgrades in counterparty credit ratings are","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 67}"
,,"reviewed o n a timely basis. We have not incurred, and do not expect to incur, material credit losses on our risk management or 
other financial instruments.  
Substantially all of the Company's financial instruments used in hedging transactions are governed by industry  standard netting 
and collateral agreements with counterparties. If the Company's credit rating were to fall below the levels stipulated in the","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 67}"
,,"agreements, the counterparties could demand either collateralization or termination of the arrangements. The agg regate fair  
value of the instruments covered by these contractual features that are in a net liability position was $1,088 and $219 as of   
June 30, 2023 and 2022, respectively. The Company has not been required to post collateral as a result of these cont ractual 
features.  
Interest Rate Risk Management","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 67}"
,,"features.  
Interest Rate Risk Management  
Our policy is to manage interest cost using a mixture of fixed -rate and variable -rate debt. To manage this risk in a cost -efficient 
manner, we enter into interest rate swaps whereby we agree to exchange with the counterparty, at specified intervals, the  
difference between fixed and variable interest amounts calculated by reference to a notional amount.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 67}"
,,"We designate certain interest rate swaps on fixed rate debt that meet specific accounting criteria as fair v alue hedges. For fair 
value hedges, the changes in the fair value of both the hedging instruments and the underlying debt obligations are immediate ly 
recognized in earnings.  
Foreign Currency Risk Management  
We manufacture and sell our products and finance our operations in a number of countries throughout the world. As a result, w e","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 67}"
,,"are exposed to movements in foreign currency exchange rates. We leverage the Company’s diversified portfolio of exposures as 
a natural hedge. In certain cases, we enter into non -qualifying foreign currency contracts to hedge certain balance sheet items 
subject to revaluation. The change in fair value of these instruments and the underlying exposure are both immediately  
recognized i n earnings.  
56        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 67}"
,,"56        The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 67}"
,,"To manage exchange rate risk related to our intercompany financing, we primarily use forward contracts and currency swaps. 
The change in fair value of these non -qualifying instruments is immediately recognized in earnings, substantially offset ting the 
foreign currency mark -to-market impact of the related exposure.  
Net Investment Hedging  
We hedge certain net investment positions in foreign subsidiaries. To accomplish this, we either borrow directly in foreign","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 68}"
,,"currencies and designate all or a p ortion of the foreign currency debt as a hedge of the applicable net investment position or we 
enter into foreign currency swaps that are designated as hedges of net investments. The time value component of the net 
investment hedge currency swaps is exclud ed from the assessment of hedge effectiveness. Changes in the fair value of the 
swap, including changes in the fair value of the excluded time value component, are recognized in OCI and offset the value of","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 68}"
,,"the net investment being hedged. The time value c omponent is subsequently reported in income on a systematic basis.  
Commodity Risk Management 
Certain raw materials used in our products or production processes are subject to price volatility caused by weather, supply 
conditions, political and economic va riables and other unpredictable factors. As of and during the fiscal years ended June  30, 
2023 and 2022, we did not have any financial commodity hedging activity.  
Insurance","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 68}"
,,"Insurance  
We self -insure for most insurable risks. However, we purchase insurance for Directo rs and Officers Liability and certain other 
coverage where it is required by law or by contract.  
Fair Value Hierarchy  
Accounting guidance on fair value measurements for certain financial assets and liabilities requires that financial assets an d 
liabilities  carried at fair value be classified and disclosed in one of the following categories:","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 68}"
,,"•Level  1: Quoted market prices in active markets for identical assets or liabilities.
•Level 2: Observable market -based inputs or unobservable inputs that are corroborated  by market data.
•Level  3: Unobservable inputs reflecting the reporting entity's own assumptions or external inputs from inactive markets.
The Company had no significant activity with Level 3 assets and liabilities during the periods presented. When applyin g fair","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 68}"
,,"value principles in the valuation of assets and liabilities, we are required to maximize the use of quoted market prices and 
minimize the use of unobservable inputs. The Company has not changed its valuation techniques used in measuring the fair 
value of any financial assets or liabilities during the year.  
When active market quotes are not available for financial assets and liabilities, we use industry standard valuation models.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 68}"
,,"Where applicable, these models project future cash flows and discoun t the future amounts to a present value using market -based 
observable inputs including credit risk, interest rate curves and forward and spot prices for currencies. In circumstances wh ere 
market -based observable inputs are not available, management judgmen t is used to develop assumptions to estimate fair value.  
Assets and Liabilities Measured at Fair Value","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 68}"
,,"Assets and Liabilities Measured at Fair Value  
Cash equivalents were $6.8 billion and $6.0 billion as of June  30, 2023 and 2022, respectively, and are classified as Level 1 
within the fair value hierarchy. The Company had no other material investments in debt or equity securities during the period s 
presented.  
The fair value of long -term debt was $26.9 billion and $25.7 billion as of June  30, 2023 and 2022, respectively. This includes","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 68}"
,,"the current portion of long -term debt instruments ($3.9 billion as of June  30, 2023, and $3.6 billion as of June  30, 2022). 
Certain long -term debt (debt designated as a fair value hedge) is recorded at fair value. All other long -term debt is recorded at 
amortized cost but is measured at fair value for disclosure purposes. We consider our debt to be Level 2 in the fair value 
hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 68}"
,,"The Procter & Gamble Company        57
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 68}"
,,"Disclosures about Financial Instruments  
The notional amounts and fair values of financial instruments used in hedging transactions as of June  30, 2023 and 2022, are as 
follows:  
Notional Amount  Fair Value  Asset Fair Value (Liability)  
As of June 30  2023 2022 2023 2022 2023 2022 
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS  
Interest rate contracts  $ 4,044  $ 4,972  $ — $ 3 $ (445)   $ (307)  
DERIVATIVE S IN NET INVESTMENT HEDGING RELATIONSHIPS","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 69}"
,,"DERIVATIVE S IN NET INVESTMENT HEDGING RELATIONSHIPS  
Foreign cu rrency interest rate contracts  $ 11,005  $ 7,943  $ 26 $ 561 $ (631)   $ (1) 
TOTAL DERIVATIVES DESIGNATED AS 
HEDGING INSTRUMENTS  $ 15,049  $ 12,915  $ 26 $ 564 $ (1,076)   $ (308)  
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS  
Foreign currency contracts  $ 3,489  $ 5,625  $ 7 $ 6 $ (42)  $ (61) 
TOTAL DERIVATIVES AT FAIR VALUE  $ 18,538  $ 18,540  $ 33 $ 570 $ (1,118)   $ (369)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 69}"
,,"The fair value of the interes t rate derivative asset/liability directly offsets the cumulative amount of the fair value hedging 
adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt 
obligation, which includes the unamo rtized discount or premium and the fair value adjustment, was $3.6 billion and $4.7 billion","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 69}"
,,"as of June  30, 2023 and 2022, respectively. In addition to the foreign currency derivative contracts designated as net investment 
hedges, certain of our foreign cur rency denominated debt instruments are designated as net investment hedges. The carrying 
value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency 
transaction gain or loss on those instrume nts, was $11.8 billion and $11.2 billion as of June  30, 2023 and 2022, respectively.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 69}"
,,"The increase in the notional balance of derivative instruments designated as net investment hedges is primarily driven by the  
Company’s decision to leverage favorable int erest rate spreads in the foreign currency swap market. The decrease in the 
notional balance of foreign currency contracts not designated as hedging instruments reflects changes in the level of 
intercompany financing activity during the period.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 69}"
,,"intercompany financing activity during the period.  
Derivativ e assets are presented in Prepaid expenses and other current assets or Other noncurrent assets. Derivative liabilities are 
presented in Accrued and other liabilities or Other noncurrent liabilities. Changes in the fair value of net investment hedge s are 
recognized in the Foreign currency translation component of Other comprehensive income (OCI). All of the Company's","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 69}"
,,"derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy.  
Before tax gains/(losses) on our financial instruments in hedging relationships are categorized as follows:  
Amount of Gain/(Loss) 
Recognized in OCI on Derivatives  
Fiscal years ended June 30  2023  2022  
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2) 
Foreign currency interest rate contracts  $ (544) $ 1,033","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 69}"
,,"Foreign currency interest rate contracts  $ (544) $ 1,033  
(1)For the derivatives in net investment hedging relationships, the amount of gain excluded from effectiveness testing, which wa s
recognized in earnings, was $238 and $73 for the fiscal years ended June  30, 2023 and 2022, respectively.
(2)In addition to the for eign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 69}"
,,"debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in AOCI for such instruments w as
$(315) and $1,639, for the fiscal years ended June  30, 2023 and 2022, respectively.
Amount of Gain/(Loss) 
Recognized in Earnings  
Fiscal years ended June 30  2023  2022  
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS  
Interest rate contracts  $ (141) $ (450)  
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS  
Foreign currency contracts  $ (97) $ (149)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 69}"
,,"Foreign currency contracts  $ (97) $ (149)  
The loss on the derivatives in fair value hedging relationships is fully offset by the mark -to-market impact of the related 
exposure. These are both recognized in the Consolidated Statement of Earnings in Interest Expense. The loss on derivatives no t 
designated as hedging instruments is substantially offset by the currency mark -to-market of the related exposure. These are both 
recognized in the Consolidated Statements of Earnings in SG&A.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 69}"
,,"58        The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 69}"
,,"NOTE 10  
SHORT -TERM AND LONG -TERM DEBT  
As of June 30 2023 2022
DEBT DUE WITHIN ONE YEAR  
Current portion of long -term debt  $ 3,951  $ 3,647  
Commercial paper  6,236  4,805  
Other  42 193 
TOTAL  $ 10,229  $ 8,645  
Weighted average interest rate of debt due within one year (1) 4.2 %  0.8 % 
(1)Weighted average interest rate of debt due within one year includes the effects of interest rate swaps discussed in Note 9.
As of June 30 2023 2022
LONG -TERM DEBT","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 70}"
,,"As of June 30 2023 2022
LONG -TERM DEBT  
3.10% USD note due August 2023  $ 1,000  $ 1,000  
1.13% EUR note due November 2023  1,359  1,306  
0.50% EUR note due October 2024  544 523 
0.63% EUR note due October 2024  870 836 
0.55% USD note due October 2025  1,000  1,000  
4.10% USD note due January 2026  650 — 
2.70% USD note due February 2026  600 600 
1.00% USD note due April 2026  1,000  1,000  
3.25% EUR note due August 2026  707 — 
2.45% USD note due November 2026  875 875","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 70}"
,,"2.45% USD note due November 2026  875 875 
1.90% USD note due February 2027 1,000  1,000  
2.80% USD note due March 2027  500 500 
4.88% EUR note due May 2027  1,087  1,045  
2.85% USD note due August 2027  750 750 
3.95% USD note due January 2028  600 — 
1.20% EUR note due October 2028  870 836 
1.25% EUR note due October 2029  544 523 
3.00% USD note due March 2030  1,500  1,500  
0.35% EUR note due May 2030  544 523 
1.20% USD note due October 2030  1,250  1,250","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 70}"
,,"1.20% USD note due October 2030  1,250  1,250  
1.95% USD note due April 2031  1,000  1,000  
3.25% EUR note due August 2031  707 — 
2.30% USD note due February 2032  850 850 
4.05% USD note due January 2033  850 — 
5.55% USD note due March 2037  716 716 
1.88% EUR note due October 2038  544 523 
3.55% USD note due March 2040  516 516 
0.90% EUR note due November 2041  652 627 
All other long -term debt  5,244  7,196  
Current portion of long -term debt  (3,951)  (3,647)  
TOTAL  $ 24,378  $ 22,848","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 70}"
,,"TOTAL  $ 24,378  $ 22,848  
Weighted average interest rate of long -term debt (1) 2.9 % 2.2 % 
(1)Weighted average interest rate of long-term debt includes the effects of interest rate swaps discussed in Note 9.
The Procter & Gamble Company        59
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 70}"
,,"Long -term debt maturities during the next five fiscal years are as follows:
Fiscal years ending June 30 2024 2025 2026 2027 2028
Debt maturities  $3,951  $1,954  $3,364  $4,368  $1,380  
NOTE 11
ACCUMULATED OTHER COMPREHENSIVE INCOME/(LOSS)  
The table below presents the changes in Accumulated other comprehensive income/(loss) attributable to Procter & Gamble 
(AOCI), including the reclassifications out of AOCI by component:  
Changes in Accumulated Other Comprehensive Income/(Loss) by Component","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 71}"
,,"Investment 
Securities  Post-
retirement 
Benefit Plans  Foreign 
Currency 
Translation  Total AOCI  
BALANCE a t JUNE 30, 2021  $ 15 $ (2,963)   $ (10,796)   $ (13,744)  
OCI before reclassifications (1) 4 2,797  (1,451)   1,350  
Amounts reclassified to the Consolidated Statement of Earnings (2) 1 195 1 197 
Net current period OCI  5 2,992  (1,450)   1,547  
Less: OCI attributable to non -controlling interests  — 2 (10)  (8) 
BALANCE at JUNE 30, 2022  20 27 (12,236)   (12,189)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 71}"
,,"BALANCE at JUNE 30, 2022  20 27 (12,236)   (12,189)  
OCI before reclassifications (3) (7)  21 (71)  (57) 
Amounts reclassified to the Consolidated Statement of Earnings (4) — 19 — 19 
Net current period OCI  (7)  40 (71)  (38) 
Less: OCI attributable to non -controlling interests  — — (7)  (7) 
BALANCE at JUNE 30, 2023  $ 13 $ 67 $ (12,300)   $ (12,220)  
(1)Net of tax (benefit)/expense of $1, $953 and $515 for gains/losses on investment securities, postretirement benefit plans and  foreign","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 71}"
,,"currency translation, respectively, for the period ended June  30, 2022. Income tax effects within foreign currency transla tion include
impacts from items such as net investment hedge transactions.
(2)Net of tax (benefit)/expense of $0, $69 and $0 for gains/losses on investment securities, postretirement benefit plans and fo reign
currency translation, respectively, for the peri od ended June  30, 2022.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 71}"
,,"(3)Net of tax (benefit)/expense of $(2), $1 and $(197) for gains/losses on investment securities, postretirement benefit plans a nd foreign
currency translation, respectively, for the period ended June  30, 2023. Income tax effects withi n foreign currency translation include
impacts from items such as net investment hedge transactions.
(4)Net of tax (benefit)/expense of $0, $8 and $0 for gains/losses on investment securities, postretirement benefit plans and for eign currency","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 71}"
,,"translation, re spectively, for the period ended June  30, 2023. 
The below provides additional details on amounts reclassified from AOCI into the Consolidated Statement of Earnings:
•Investment securities: amounts reclassified from AOCI into Other non -operating income, net.
•Postretirement benefit plans: amounts reclassified from AOCI into Other non -operating income, net and included in the
computation of net periodic postretirement costs (see Note 8).
NOTE 12  
LEASES","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 71}"
,,"NOTE 12  
LEASES  
The Company determines whether a contrac t contains a lease at the inception of a contract by determining if the contract 
conveys the right to control the use of identified property, plant or equipment for a period of time in exchange for consider ation. 
We lease certain real estate, machinery, e quipment, vehicles and office equipment for varying periods. Many of these leases","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 71}"
,,"include an option to either renew or terminate the lease. For purposes of calculating lease liabilities, these options are in cluded 
within the lease term when it has become r easonably certain that the Company will exercise such options. The incremental 
borrowing rate utilized to calculate our lease liabilities is based on the information available at commencement date, as mos t of","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 71}"
,,"the leases do not provide an implicit borrowing  rate. Our operating lease agreements do not contain any material guarantees or 
restrictive covenants. The Company does not have any material finance leases or sublease activities. Short -term leases, defined 
as leases with initial terms of 12 months or les s, are not reflected on the Consolidated Balance Sheets. Lease expense for such","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 71}"
,,"short -term leases is not material. The most significant assets in our leasing portfolio relate to real estate and vehicles. For 
purposes of calculating lease liabilities for s uch leases, we have combined lease and non -lease components. 
60        The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 71}"
,,"The components of the Company’s total operating lease cost for the fiscal years ended June  30, 2023, 2022 and 2021, were as 
follows:  
Fiscal years ended June 30  2023  2022  2021  
Operating lease cost  $ 229 $ 220 $ 245 
Variable lease cost (1) 79 89 75 
Total lease cost  $ 308 $ 309 $ 320 
(1)Includes primarily costs for utilities, common area maintenance, property taxes and other operating costs associated with ope rating leases","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 72}"
,,"that are not included in the lease liability and are recognized in the period in which they are incu rred. 
Supplemental balance sheet and other information related to leases is as follows:
As of June 30  2023  2022  
Operating leases:  
Right -of-use assets (Other noncurrent assets)  $ 781 $ 760 
Current lease liabilities (Accrued and other liabilities)  222 205 
Noncurrent lease liabilities (Other noncurrent liabilities)  595 595 
Total operating lease liabilities  $ 817 $ 800","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 72}"
,,"Total operating lease liabilities  $ 817 $ 800 
Weighted average remaining lease term:  
Operating leases  6.2 years  6.4 years  
Weighted average discount rate:  
Operating leases  3.5 %  3.2 % 
At June  30, 2023, future payments of operating lease liabilities were as follows:
Operating Leases
June 30, 2023
1 year  $ 222 
2 years  185 
3 years  137 
4 years  100 
5 years  71 
Over 5 years  196 
Total lease payments  911 
Less: Interest  (94) 
Present value of lease liabilities $ 817","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 72}"
,,"Less: Interest  (94) 
Present value of lease liabilities $ 817 
Total cash paid for amounts included in the measurement of lease liabilities was $233 and $228 for the fiscal years ended 
June 30, 2023 and 2022, respectively. 
The right -of-use assets obtained in exchange for lease liabilities were $213 and $217 for the fiscal years ended June  30, 2023 
and 2022, respectively. 
NOTE 13  
COMMITMENTS AND CONTINGENCIES  
Guarantees","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 72}"
,,"NOTE 13  
COMMITMENTS AND CONTINGENCIES  
Guarantees  
In conjunction with certain transactions, primarily divestitures, we may provide routine indemnifications (e.g., indemnificat ion 
for representations and warranties and retention of previously existing environmental, tax and employee liabilities) for which  
terms range in duration and, in some circumstances, are not explicitly defined. The maximum obligation under some","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 72}"
,,"indemnifications  is also not explicitly stated and, as a result, the overall amount of these obligations cannot be reasonably 
estimated. We have not made significant payments for these indemnifications. We believe that if we were to incur a loss on an y 
of these matters, t he loss would not have a material effect on our financial position, results of operations or cash flows.  
The Procter & Gamble Company        61
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 72}"
,,"In certain situations, we guarantee loans for suppliers and customers. The total amount of guarantees issued under such 
arrangements is not material.  
Off-Balance Sheet Arrangements  
We do not have off -balance sheet financing arrangements, including variable interest entities, that have a material impact on our 
financial statements.  
Purchase Commitments  
We have purchase commitments for materials, supplies, services and property, plant  and equipment as part of the normal course","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 73}"
,,"of business. Commitments made under take -or-pay obligations are as follows:   
Fiscal years ending June 30 2024 2025 2026 2027 2028 Thereafter
Purchase obligations  $ 1,169   $ 597  $ 379  $ 314  $ 168  $ 362 
Such amounts represent minimum commitments under take -or-pay agreements with suppliers and are in line with expected 
usage. These amounts include purchase commitments related to service contracts for information technology, human resources","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 73}"
,,"management and facilities management activities that have been outsourced to third -party suppliers. Due to the proprietary 
nature of many of our materials and processes, certain supply contracts contain penalty provisions for early termination. We do 
not expect to incur  penalty payments under these provisions that would materially affect our financial position, results of 
operations or cash flows.  
Litigation","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 73}"
,,"operations or cash flows.  
Litigation  
We are subject, from time to time, to certain legal proceedings and claims arising out of our business, which cove r a wide range 
of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental, patent and tr ademark 
matters, labor and employment matters and tax. While considerable uncertainty exists, in the opinion of mana gement and our","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 73}"
,,"counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, result s of 
operations or cash flows.  
We are also subject to contingencies pursuant to environmental laws and regulations t hat in the future may require us to take 
action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 73}"
,,"available information, we do not believe the ultimate resolution of environmental remediation  will materially affect our 
financial position, results of operations or cash flows.  
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
Not applicable.  
Item 9A. Controls and Procedures.  
Evaluation of Disclosure Controls and Procedures.  
The Company's Chairman of the Board, President and Chief Executive Officer, Jon R. Moeller, and the Company's Chief","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 73}"
,,"Financial Officer, Andre Schulten, performed an evaluation of the Company's disclosure controls and procedures (as defined in 
Rules 13a -15(e) and 15d -15(e) of the Securities Exchange Act of 1934 (Exchange Act)) as of the end of the period covered by 
this Annual Report on Form 10 -K. 
Messrs. Moeller and S chulten have concluded that the Company's disclosure controls and procedures were effective to ensure","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 73}"
,,"that information required to be disclosed in reports we file or submit under the Exchange Act is (1)  recorded, processed, 
summarized and reported within t he time periods specified in Securities and Exchange Commission rules and forms, and 
(2)accumulated and communicated to our management, including Messrs. Moeller and Schulten, to allow their timely
decisions regarding required disclosure.
Reports on Inte rnal Control over Financial Reporting.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 73}"
,,"Reports on Inte rnal Control over Financial Reporting.  
The information required by this item is incorporated by reference to ""Management's Report on Internal Control over Financial  
Reporting"" and ""Report of Independent Registered Public Accounting Firm"" included in Item 8  of this Form 10 -K. 
Changes in Internal Control over Financial Reporting.  
There were no changes in our internal control over financial reporting that occurred during the Company's fourth fiscal quart er","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 73}"
,,"that have materially affected, or are reasonably likel y to materially affect, the Company's internal control over financial reporting.  
Item 9B. Other Information.  
Not applicable.  
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.  
Not applicable.  
62        The Procter & Gamble Company
Amounts in millions of dollars except per share amounts or as otherwise specified.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 73}"
,,"PART III  
Item 10. Directors, Executive Officers and Corporate Governance.  
The Board of Directors has determined that the following members of the Audit Committee are independent and are Audit 
Committee financial experts as defined by SEC rules: Ms.  Patricia  A. Woertz (Chair) and Ms. Christine M. McCarthy.  
The information required by this item is incorporated by reference to the following sections of the 2023  Proxy Statement filed","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 74}"
,,"pursuant to Re gulation 14A, which will be filed no later than 120 days after June 30, 2023 : the section entitled Election of 
Directors; the subsection of the Corporate Governance section entitled Board Meetings and Committees of the Board; the 
subsection of the Corporat e Governance section entitled Code of Ethics; and the subsection of the Other Matters section entitled 
Shareholder Recommendations or Nominations of Director Candidates. Pursuant to the Instruction to Item  401 of Regulation S -","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 74}"
,,"K, Executive Officers of the R egistrant are reported in Part I of this report.  
Item 11. Executive Compensation.  
The information required by this item is incorporated by reference to the following sections of the 2023  Proxy Statement filed 
pursuant to Regulation 14A, w hich will be filed no later than 120 days after June 30, 2023 : the subsections of the Corporate 
Governance section entitled Board Meetings and Committees of the Board, Compensation Committee Interlocks and Insider","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 74}"
,,"Participation, and Risk Oversight - Compen sation -Related Risk; and the portion beginning with the section entitled Director 
Compensation up to but not including the section entitled Pay Versus Performance.  
Item 12. Security Ownership of Certain Beneficial Owners and Management an d Related Stockholder Matters.  
The following table gives information about the Company's common stock that may be issued upon the exercise of options,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 74}"
,,"warrants and rights under all of the Company's equity compensation plans as of June 30, 2023 . The table i ncludes the following 
plans: The Procter & Gamble 1992 Stock Plan; The Procter  & Gamble 2001 Stock and Incentive Compensation Plan; The 
Procter & Gamble 2003 Non -Employee Directors' Stock Plan; The Procter & Gamble 2009 Stock and Incentive Compensation 
Plan; The Procter & Gamble 2014 Stock and Incentive Compensation Plan; and The Procter & Gamble 2019 Stock and 
Incentive Compensation Plan.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 74}"
,,"Incentive Compensation Plan.  
Plan Category  (a) 
Number  of securities  
to be issued upon 
exercise of 
outstanding options,  
warrants and rights  (b) 
Weighted 
average  exercise  
price of outstanding  
options, warrants and  
rights  (c) 
Number of securities  
remaining available for  
future issuance under  
equity  compensation  plans  
(excluding securities  
reflected in column (a))  
Equity compensation plans approved by 
security holders","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 74}"
,,"Equity compensation plans approved by 
security holders  
Stock Options/Stock Appreciation Rights  121,226,313  $104.1900  (1) 
Restricted Stock Units (RSUs)/Performance 
Stock Units (PSUs)  6,430,184  N/A  (1) 
TOTAL  127,656,497  $104.1900   (2) 
(1)Of the plans listed above, only The Procter & Gamble 2019 Stock and Incentive Compensation Plan (the “2019 Plan”) allows for future","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 74}"
,,"grants of securities. The maximum number of shares that may be granted under this plan is 187 million shares. Stock options and stock
appreciation rights are counted on a one -for-one basis while full value awards (such as RSUs and PSUs) are counted as five shares for each
share awarded. Total shares available for future issuance under this plan is 96 million. 
(2)Weighted average exercise price of outstanding options only.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 74}"
,,"Additional information required by this item is incorporated by reference to the following section of the 2023  Proxy Statement 
filed pursuant to Regulation 14A, which will be filed no later than 120 days after June 30, 2023 : the subsection of the Beneficia l 
Ownership section entitled Security Ownership of Management and Certain Beneficial Owners.  
Item 13. Certain Relationships and Related Transactions and Director Independence.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 74}"
,,"The information required by this item is incorporated by refer ence to the following sections of the 2023  Proxy Statement filed 
pursuant to Regulation 14A, which will be filed no later than 120 days after June 30, 2023 : the subsections of the Corporate 
Governance section entitled Director Independence and Review and A pproval of Transactions with Related Persons.  
Item 14. Principal Accountant Fees and Services.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 74}"
,,"Item 14. Principal Accountant Fees and Services.  
The information required by this item is incorporated by reference to the following section of the 2023  Proxy Statement filed 
pursuant to Regul ation 14A, which will be filed no later than 120 days after June 30, 2023 : Report of the Audit Committee, which 
ends with the subsection entitled Services Provided by Deloitte.  
The Procter & Gamble Company        63","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 74}"
,,"PART IV  
Item 15. Exhibits and Financial State ment Schedules.  
1.Financial Statements:
The following Consolidated Financial Statements of The Procter  & Gamble Company and subsidiaries, management's report 
and the reports of the independent registered public accounting firm are incorporated by reference in Part II, Item  8 of this Form 
10-K.
•Management's Report on Internal Control over Financial Reporting","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 75}"
,,"•Report of Independent Registered Public Accounting Firm on Internal Control over Financial Reporting (PCAOB Firm ID
is 34)
•Report of Independent Register ed Public Accounting Firm on Consolidated Financial Statements
•Consolidated Statements of Earnings - for fiscal years ended June 30, 2023 , 2022  and 2021
•Consolidated Statements of Comprehensive Income - for fiscal years ended June 30, 2023 , 2022  and 2021
•Consolidated Balance Sheets - as of June 30, 2023  and 2022","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 75}"
,,"•Consolidated Balance Sheets - as of June 30, 2023  and 2022
•Consolidated Statements of Shareholders' Equity - for fiscal years ended June 30, 2023 , 2022  and 2021
•Consolidated Statements of Cash Flows - for fiscal years ended June 30, 2023 , 2022  and 2021
•Notes to Consolidated Financial Statements
2.Financial Statement Schedules:
These schedules are omitted because of the absence of the conditions under which they are required or because the information","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 75}"
,,"is set forth in the Consolidated Financial Statements or Notes thereto.  
EXHIBITS  
Exhibit      (3-1) - Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 11, 2011 and 
consolidated by the Board of Directors on April 8, 2016) (Incorporated by reference to Exhibit (3 -1) of the Company's 
Annual Report on Form 10 -K for the yea r ended June 30, 2016) .","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 75}"
,,"(3-2) - Regulations (as approved by the Board of Directors on Dece mber  13, 2022, pursuant to authority granted by 
shareholders at the annual meeting on October 13, 2009) (Incorporated by ref erence to Exhibit (3 -2) of the Company's 
Current  Report on Form 8-K filed December 13, 2022 ). 
Exhibit   (4-1) - Indenture, dated as of September 3, 2009, between the Company and Deutsche Bank Trust Company Americas, as","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 75}"
,,"Trustee  (Incorporated by reference to Exhibit (4 -1) of the Company's Annual Report on Form 10 -K for the year ended 
June 30, 2015) . 
 (4-2) - The Company agrees to furnish to the Securities and Exchange Commission, upon request, a copy of any other 
instrument defining the rights of holders of the Company’s long -term debt.  
 (4-3) - Descript ion of the Company’s Common Stock (Incorporated by reference to Exhibit (4 -3) of the Company’s Annual 
report on Form 10 -K for the year ended June 30, 2019) .","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 75}"
,,"report on Form 10 -K for the year ended June 30, 2019) . 
 (4-4) - Descript ion of the Company’s 0.625% Notes due 2024, 1.200% Notes due 2028, and 1.875% Notes due 2038 
(Incorporated by reference to Exhibit (4 -4) of the Company’s Annual report on Form 10 -K for the year ended June 30, 
2019) . 
 (4-5) - Description of the Company’s 4.875% EUR notes due May 2027, 6.250% GBP notes due January 2030, and 5.250%","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 75}"
,,"GBP notes due January 2033 (Incorporated by refer ence to Exhibit (4 -5) of the Company’s Annual report on Form 10 -
K for the year ended June 30, 2021) . 
 (4-6) - Descript ion of the Company’s 0.500% Notes due 2024 and 1.250% Notes due 2029 (Incorporated by reference to 
Exhibit (4 -6) of the Company’s Annual report on Form 10 -K for the year ended June 30, 2019) . 
 (4-7) - Descript ion of the Company’s 1.375% Notes due 2025 and 1.800% Notes due 2029 (Incorporated by reference to","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 75}"
,,"Exhibit (4 -7) of the Company’s Annual report on Form 10 -K for the year ended June 30, 2019) . 
 (4-8) - Descript ion of the Company’s 1.125% Notes due 2023 (Incorporated by reference to Exhibit (4 -8) of the Company’s 
Annual report on Form 10 -K for the year ended June 30, 2019) . 
 (4-9) - Descr iption of the Company's 0.350% EUR Notes due 2030 and 0.900% EUR Notes due 2041 (Incorporated by 
reference to Exhibit (4 -10) of the Company's Annual Report on Form 10 -K for the year ended June 30, 2022) .","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 75}"
,,"(4-10) - Descr iption of the Company's 0.110% Yen Notes due 2026 and 0.230% Yen Notes due 2031  (Incorporated by reference 
to Exhibit (4 -11) of the Company's Annual Report on Form 10 -K for the year ended June 30, 2022 ). 
(4-11) - Description of the Company's 3.250% Notes due 2026 and 3.250% Notes due 2031 .+ 
64        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 75}"
,,"Exhibit    (10-1) - The P rocter & Gamble 2001 Stock and Incentive Compensation Plan (as amended), which was originally adopted by 
shareholders at the annual meeting on October 9, 2001 (Incorporated by reference to Exhibit (10 -1) of the Company’s 
Annual Report on Form 10 -K for the year ended June 30, 2018) .* 
(10-2) - The Procter & Gamble 2001 Stock and Incentive Compensation Plan related correspondence and terms and conditions","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 76}"
,,"(Incorporated by reference to Exhibit (10 -1) of the Company's Form 10 -Q for the quarter ended December 31, 2013) .* 
(10-3) - The Procter & Gamble 1992 Stock Plan (as amended December 11, 2001), which was originally adopted by the 
shareholders at the annual meeting on October 12,  1992 (Incorporated by reference to Exhibit (10 -2) of the Company’s 
Annual Report on Form 10 -K for the year ended June 30, 2018) .*","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 76}"
,,"(10-4) - The P rocter & Gamble Executive Group Life Insurance Policy (Incorporated by reference to Exhibit (10 -3) of the 
Company’s Annual Report on Form 10 -K for the year ended June 30, 2018) .* 
(10-5) - Summary of the Company’s Retirement Plan Restoration Program (Incorporated by reference to Exhibit (10 -5) of the 
Company's Form 10 -Q for the quarter ended December 31, 2019) .* 
(10-6) - Retirement Plan Restoration Program - Related  Correspondence and Terms and Conditions . * +","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 76}"
,,"(10-7) - Summary of the Company’s Long -Term Incentive Program (Incorporated by reference to Exhibit (10 -3) of the 
Compan y's Form 10 -Q for the quarter ended September 30, 2020) .* 
(10-8) - Long -Term Incentive Program related correspondence and terms and conditions (Incorporated by reference to Exhibit 
(10-3) of the Company's Form 10 -Q for the quarter ended September 30, 2021) .*","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 76}"
,,"(10-9) - The Procter & Gamble Company Executive Deferred Compensation Plan (Incorporated by reference to Exhibit (10 -2) 
of the Company's Form 10 -Q for the quarter ended March 31, 2020) .* 
(10-10) - Summary of the Company's Short Term Achievement Reward Program  (Incorporated by reference to Exhibit (10-1) of 
the Company's Form 10 -Q for the quarter ended December 31, 2022) .* 
(10-11) - Short Term Achievement Reward Program – related correspondence and terms and conditions (Incorporated by","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 76}"
,,"reference to Exhibit (10 -2) of the Company's Form 10 -Q for the quarter ended September 30, 2021) .* 
(10-12) - Company's Form of Separation Agreement & Release  (Incorporated by reference to Exhibit (10 -12) of the Company's 
Annual Report on Form 10 -K for the year ended June 30, 2022) .* 
(10-13) - Company's Form of Separation Letter and Release  (Incorporated by reference to Exhibit (10-1) of the Company's Form 
10-Q for the quarter ended March 3 1, 2023) .*","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 76}"
,,"10-Q for the quarter ended March 3 1, 2023) .*
(10-14) - Summary of personal benefits available to certain officers and non -employee directors (Incorporated by refer ence to 
Exhibit (10 -5) of the Company's Form 10 -Q for the quarter ended September 30, 2021) .* 
(10-15) - The Gillette Company Deferred Compensation Plan (Incorporated by reference to Exhibit (10 -18) of the Company’s 
Annual Report on Form 10 -K for the year ended June 30, 2017) .*","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 76}"
,,"(10-16) - Senior Executive Recoupment Policy (Incorporated by reference to Exhibit (10 -19) of the Company’s Annual Report 
on Form 10 -K for the year ended June 30, 2018) .* 
(10-17) - The Gillette Company Deferred Compensation Plan (for salary deferrals prior to January 1, 2005) as amended through 
August 21, 2006 (Incorporated by reference to Exhibit (10 -20) of the Company's Annual Report on Form 10 -K for the 
year ended June 30, 2017) .*","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 76}"
,,"year ended June 30, 2017) .* 
(10-18) - The Procter & Gamble 2009 Stock and Incentive Compensation Plan, which was originally adopted by shareholders at  
the annual meeting on October 13, 2009 (Incorporated by reference to Exhibit (10 -21) of the Company's Annual Report 
on Form 10 -K for the year ended June 30, 2017) .* 
(10-19) - Regulations of the Compensation and Leadership Development Committee for The Procter & Gamble 2009 Stock and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 76}"
,,"Incentive Compensation Plan, The Procter & Gamble 2001 Stock and Incentive Compensation Plan, The Procter & 
Gamble 1992 Stock Plan, The Procter & Gam ble 1992 Stock Plan (Belgium Version), The Gillette Company 2004 
Long -Term Incentive Plan and the Gillette Company 1971 Stock Option Plan (Incorporated by reference to Exhibit 
(10-21) of the Company’s Annual Report on Form 10 -K for the year ended June 30, 2018) .*","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 76}"
,,"(10-20) - The Procter & Gamble 2009 Stock and Incentive Compensation Plan - Additional terms and conditions and related 
correspo ndence (Incorporated by reference to Exhibit (10 -2) of the Company Form 10 -Q for the quarter ended 
December 31, 2013) .* 
(10-21) - The Procter & Gamble Performance Stock Program Summary (Incorporated by reference to Exhibit (10 -5) of the 
Company's Form 10 -Q for the quarter ended September 30, 2020) .*","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 76}"
,,"(10-22) - Performance Stock Program related correspondence and terms and conditions (Incorporated by reference to Exhibit 
(10-4) of the Company’s Form 10 -Q for the quarter ended September 30, 2021) .* 
(10-23) - The Procter & Gamble 2013 Non -Employee Directors' Stock Plan (Incorporated by reference to Exhibit (10 -3) of the 
Company's Form 10 -Q for the quarter ended December 31, 2013) . * 
The Procter & Gamble Company        65","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 76}"
,,"(10-24) - The Procter & Gamble 2014 Stock and Incentive Compensation Plan, which was originally adopted by shareholders at 
the annual meeting on October 14, 2014 (Incorporated by reference to Exhibit (10 -25) of the Company's Annual Report 
on Form 10 -K for the year end ed June 30, 2016) .* 
(10-25) - Regulations of the Compensation and Leadership Development Committee for The Procter & Gamble 2019 Stock and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 77}"
,,"Incentive Compensation Plan and The Procter & Gamble 2014 Stock and Incentive Compensation Plan (Incorporated 
by reference to Exhibit (10 -1) of th e Company's Form 10 -Q for the quarter ended December 31, 2019) .* 
(10-26) - The Procter & Gamble 2014 Stock and Incentive Compensation Plan - Additional terms and conditions (Incorporated 
by reference to Exhibit (10 -26) of the Company's Annual Report on Form 10 -K for the year ended June 30, 2017) .*","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 77}"
,,"(10-27) - The Procter & Gamble 2019 Stock and Incentive Compensation Plan, which was originally adopted by sharehold ers at 
the annual meeting on October 8, 2019 (Incorporated by reference to Exhibit (10 -1) of the Company’s Current Report 
on Form 8 -K filed October 11, 2019) .* 
(10-28) - The Procter & Gamble 2019 Stock and Incentive Compensation Plan - Additional terms and conditions (Incorporated","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 77}"
,,"by reference to Exhibit (10 -28) of the Company's Annual Report on Form 10 -K for the year ended June 30, 2021) .* 
Exhibit       (21) - Subsidiaries of the Registrant . + 
Exhibit       (23) - Consent of Independent Registered Public Accounting Firm . + 
Exhibit       (31) - Rule 13a -14(a)/15d -14(a) Certifications . + 
Exhibit       (32) - Section 1350 Certifications . + 
Exhibit    (99-1) - Summary of Directors and Officers Insurance Program . + 
101.INS  (1) Inline XBRL Instance Document","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 77}"
,,"101.INS  (1) Inline XBRL Instance Document  
101.SCH  (1) Inline XBRL Taxonomy Extension Schema Document  
101.CAL  (1) Inline XBRL Taxonomy Extension Calculation Linkbase Document  
101.DEF  (1) Inline XBRL Taxonomy Definition Linkbase Document  
101.LAB  (1) Inline XBRL Taxonomy Extension Label Linkbase Document  
101.PRE  (1) Inline XBRL Taxonomy Extension Presentation Linkbase Document  
104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 77}"
,,"(1) Pursuant to Rule 406T of Regulation S -T, these interactive data files are deemed not filed or part of a registration
statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section  18 of the Securities
Exchange Act of 1934 and otherwise are not subject to liability.
*Compensatory plan or arrangement.
+Filed herewith.
Item 16. Form 10 -K Summary.  
Not applicable.  
66        The Procter & Gamble Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 77}"
,,"SIGNATURES  
Pursuant to the requirements of Section  13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this 
report to be signed on its behalf by the undersigned, thereunto duly authorized in the city of Cincinnati, State of Ohio.  
THE PROCTER  & GAMBLE COMPANY  
By /s/ JON R. MOELLER  
(Jon R. Moeller)  
Chairman of the Board, President and Chief Executive Officer  
August 04, 2023","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 78}"
,,"August 04, 2023  
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following 
persons in the capacities and on the dates indicated.  
Signature  Title Date  
/s/  JON R. MOELLER  
(Jon R. Moeller)  Chairman of the Board, President and Chief 
Executive Officer (Principal Executive Officer)  August 04, 2023  
/s/ ANDRE SCHULTEN  
(Andre Schulten)  Chief Financial Officer  
(Principal Financial Officer)  August 04, 2023  
/s/  MATTHEW  W. JANZARUK","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 78}"
,,"/s/  MATTHEW  W. JANZARUK  
(Matthew W. Janzaruk)  Senior Vice President - Chief Accounting Officer  
(Principal Accounting Officer)  August 04, 2023  
/s/  B. MARC ALLEN  
(B. Marc Allen)  Director  August 04, 2023  
/s/  SHEILA BONINI  
(Sheila Bonini)  Director  August 04, 2023  
/s/  ANGELA F. BRALY  
(Angela F. Braly)  Director  August 04, 2023  
/s/  AMY L. CHANG  
(Amy L. Chang)  Director  August 04, 2023  
/s/  JOSEPH JIMENEZ  
(Joseph Jimenez)  Director  August 04, 2023","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 78}"
,,"(Joseph Jimenez)  Director  August 04, 2023  
/s/  CHRISTOPHER J. KEMPCZINSKI  
(Christopher J. Kempczinski)  Director  August 04, 2023  
/s/  DEBRA L. LEE  
(Debra L. Lee)  Director  August 04, 2023  
/s/  TERRY J. LUNDGREN  
(Terry J. Lundgren)  Director  August 04, 2023  
/s/  CHRISTINE M. MCCARTHY  
(Christine M. McCarthy)  Director  August 04, 2023  
/s/  ROBERT J. PORTMAN  
(Robert J. Portman)  Director  August 04, 2023  
/s/  RAJESH SUBRAMANIAM  
(Rajesh Subramaniam)  Director  August 04, 2023","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 78}"
,,"(Rajesh Subramaniam)  Director  August 04, 2023  
/s/  PATRICIA A. WOERTZ  
(Patricia A. Woertz)  Director  August 04, 2023  
The Procter & Gamble Company        67","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 78}"
,,[THIS PAGE INTENTIONALLY LEFT BLANK],"{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 79}"
,,"Company and Shareholder Information
P&G’s Purpose
We will provide branded products 
and services of superior quality and 
value that improve the lives of the 
world’s consumers, now and for generations to come. As a result, 
consumers will reward us with 
leadership sales, profit and value creation, allowing our people, our 
shareholders and the communities  
in which we live and work to prosper. 
To learn more, please visit pg.com .
Brands
P&G brands are trusted to provide products of the highest quality","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 80}"
,,"and superior performance and value  
for the daily-use cleaning, health  
and hygiene needs of consumers 
around the world. For information  
on our portfolio of brands and 
our latest innovations please visit 
pg.com/brands .
Citizenship
We are committed to doing 
what’s right and being a good 
corporate citizen. Our Citizenship 
efforts are focused on Community Impact, Equality & Inclusion and 
Environmental Sustainability, with 
a foundation of Ethics & Corporate Responsibility guiding everything","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 80}"
,,"we do.
P&G Online
 •pg.com
 •pginvestor.com
 •news.pg.com
 •twitter.com/proctergamble
 •linkedin.com/company/  
procter-and-gamble
 •youtube.com/proctergamble
 •instagram.com/proctergambleShareowner Services
EQ Shareowner Services serves as transfer and dividend paying 
agent for P&G Common Stock 
and Administrator of the Procter & Gamble Direct Stock Purchase 
Plan. Registered shareholders and 
Plan participants needing account assistance with share transfers,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 80}"
,,"plan purchases/sales, lost stock certificates, etc., should contact  
EQ Shareowner Services at:
Website  shareowneronline.com
Email  shareowneronline.com  
Click Email under the Contact Us 
section.
Phone  Mon–Fri, 7 a.m.–7 p.m., CST
1-800-742-6253 or 1-651-450-4064
P&G Direct Stock  
Purchase Plan
The Procter & Gamble Direct Stock 
Purchase Plan (DSPP) is a direct  
stock purchase and dividend reinvestment plan. The DSPP is open to current P&G shareholders as well 
as new investors and is designed to","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 80}"
,,"as new investors and is designed to 
encourage long-term investment in P&G by providing a convenient 
and economical way to purchase 
P&G stock and reinvest dividends. Highlights of the plan include:
 •Minimum initial investment — $250
 •Twice-weekly purchases
 •24/7 online account access
 •Optional cash investment —   
minimum $50
 •Administered by EQ  
Shareowner Services
For complete information on the DSPP, please read the Plan Prospectus. The Prospectus and 
online Plan Application are available","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 80}"
,,"online Plan Application are available 
at shareowneronline.com  or by 
contacting EQ Shareowner Services.
P&G shares can also be purchased 
through any financial institution  
that offers stock purchase services  
for shares traded on the New York Stock Exchange.Stock Symbol
PG
Transfer Agent
EQ Shareowner Services1110 Centre Pointe Curve, Suite 101
Mendota Heights, MN 55120-4100
Registrar
EQ Shareowner Services
P.O. Box 64874
St. Paul, MN 55164-0874
Exchange Listings
New York Stock Exchange","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 80}"
,,"Exchange Listings
New York Stock Exchange
Corporate Headquarters
The Procter & Gamble Company
1 P&G Plaza
Cincinnati, OH 45202-3315
Annual Meeting
The next annual meeting of 
shareholders will be held on Tuesday, 
October 10, 2023. A full transcript of 
the meeting will be available from P&G’s Assistant Secretary, who can 
be reached at 1 P&G Plaza, Cincinnati, 
OH 45202-3315.
Form 10-K
Shareholders may obtain a copy of P&G’s 2023 report to the Securities 
and Exchange Commission on Form","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 80}"
,,"and Exchange Commission on Form 
10-K at no charge at pginvestor.com .
The most recent certifications  
by our Chief Executive and Chief Financial Officers pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 
are filed as exhibits to our Form 10-K 
for the fiscal year ended June 30,  
2023. We have also filed with the  
New York Stock Exchange the most recent Annual CEO certification as required by Section 303A.12(a) of the 
New York Stock Exchange Listed","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 80}"
,,"New York Stock Exchange Listed 
Company Manual.The Procter & Gamble Company • 69","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 80}"
,,"70 • The Procter & Gamble Company
Measures Not Defined by U.S. GAAP
The following provides definitions of the non-GAAP measures used in Procter & Gamble’s 2023 Annual Report and the 
reconciliation to the most closely related GAAP measure. We believe that these measures provide useful perspective on 
underlying business trends (i.e., trends excluding non-recurring or unusual items) and results and provide a supplemental","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 81}"
,,"measure of year-on-year results. The non-GAAP measures described below are used by management in making operating 
decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors,  
as they provide supplemental information about business performance and provide investors a view of our business  
results through the eyes of management. These measures are also used to evaluate senior management and are a factor","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 81}"
,,"in determining their at-risk compensation. These non-GAAP measures are not intended to be considered by the user  
in place of the related GAAP measure, but rather as supplemental information to our business results. These non-GAAP 
measures may not be the same as similar measures used by other companies due to possible differences in method  
and in the items or events being adjusted.
Organic sales growth.  Organic sales growth is a non-
GAAP measure of sales growth excluding the impacts of","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 81}"
,,"GAAP measure of sales growth excluding the impacts of  
the July 1, 2018, adoption of the new accounting standard  
for “Revenue from Contracts with Customers,” acquisitions  
and divestitures and foreign exchange from year-over-year 
comparisons. We believe this measure provides investors 
with a supplemental understanding of underlying sales 
trends by providing sales growth on a consistent basis. 
This measure is used in assessing the achievement of 
management goals for at-risk compensation.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 81}"
,,"management goals for at-risk compensation.
The following tables provide a numerical reconciliation  
of organic sales growth to reported net sales growth:
FYNet Sales 
GrowthForeign 
Exchange 
ImpactAcquisition 
& Divestiture 
Impact/Other1Organic Sales 
Growth
2023 2% 5% –% 7%
2022 5% 2% –% 7%
2021 7% (1)% –% 6%
2020 5% 2% (1)% 6%
2019 1% 4% –% 5%
(1)  Acquisitions & Divestitures Impact/Other includes the volume and mix 
impact of acquisitions and divestitures, the impact from the July 1, 2018,","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 81}"
,,"adoption of the new accounting standard for “Revenue from Contracts  
with Customers” and rounding impacts necessary to reconcile net sales  
to organic sales.Adjusted free cash flow. Adjusted free cash flow is 
defined as operating cash flow less capital spending and excluding payments for the transitional tax resulting from 
the U.S. Tax Act. Adjusted free cash flow represents the 
cash that the Company is able to generate after taking 
into account planned maintenance and asset expansion.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 81}"
,,"into account planned maintenance and asset expansion. 
We view adjusted free cash flow as an important measure 
because it is one factor used in determining the amount 
of cash available for dividends, share repurchases, 
acquisitions and other discretionary investments. 
($ millions)Operating 
Cash FlowCapital 
SpendingAdjustments2Adjusted 
Free Cash 
Flow
FY 2023 $16,848 $(3,062) $225 $14,011
(2)  Adjustments relate to tax payments for the transitional tax resulting from 
the U.S. Tax Act.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 81}"
,,"the U.S. Tax Act.
Adjusted free cash flow productivity.  Adjusted free  
cash flow productivity is defined as the ratio of adjusted 
free cash flow to net earnings. We view adjusted free cash 
flow productivity as a useful measure to help investors 
understand P&G’s ability to generate cash. Adjusted free 
cash flow productivity is used by management in making 
operating decisions, in allocating financial resources and 
for budget planning purposes. This measure is used in","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 81}"
,,"for budget planning purposes. This measure is used in 
assessing the achievement of management goals for  
at-risk compensation.
($ millions)Adjusted Free 
Cash FlowNet  
EarningsAdjusted Free 
Cash Flow 
Productivity
FY 2023 $14,011 $14,738 95%","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 81}"
,,"The Procter & Gamble Company • 71
Core EPS. Core EPS is a measure of the Company’s diluted 
net earnings per common share excluding items that are 
not judged by management to be part of the Company’s 
sustainable results or trends. Management views this  
non-GAAP measure as a useful supplemental measure  
of Company performance over time. This measure is  
also used in assessing the achievement of management 
goals for at-risk compensation. The table below provides","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 82}"
,,"goals for at-risk compensation. The table below provides  
a reconciliation of diluted net earnings per share to Core  
EPS, including the following reconciling items.
Charges for early debt extinguishment : During fiscal years  
2021 and 2018, the Company recorded after-tax charges 
due to the early extinguishment of certain long-term  
debt. These charges represent the difference between  
the reacquisition price and the par value of the  
debt extinguished.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 82}"
,,"debt extinguished.
Incremental Restructuring: The Company has historically 
had an ongoing restructuring program with annual 
spending in the range of $250 to $500 million before  
tax. Starting in 2012 through fiscal 2020, the Company  
had a strategic productivity and cost savings initiative  
that resulted in incremental restructuring charges.  
The adjustment to Core earnings includes only the 
restructuring costs above the normal recurring level  
of restructuring costs.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 82}"
,,"of restructuring costs.
Gain on Dissolution of the PGT Healthcare Partnership :  
The Company dissolved our PGT Healthcare partnership,  
a venture between the Company and Teva Pharmaceuticals 
Industries, Ltd (Teva) in the OTC consumer healthcare 
business, during the year ended June 30, 2019. The 
transaction was accounted for as a sale of the Teva  
portion of the PGT business; the Company recognized  
an after-tax gain on the dissolution.Shave Care Impairment : In fiscal 2019, the Company","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 82}"
,,"recognized a one-time, non-cash, after-tax charge of  
$8.0 billion to adjust the carrying value of the Shave  
Care reporting unit. This was comprised of a before-  
and after-tax impairment charge of $6.8 billion related  
to goodwill and an after-tax impairment charge of  
$1.2 billion to reduce the carrying value of the Gillette indefinite-lived intangible asset.
Anti-Dilutive Impacts : The Shave Care impairment  
charges caused certain equity instruments that are","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 82}"
,,"charges caused certain equity instruments that are 
normally dilutive (and hence normally assumed converted 
or exercised for the purposes of determining diluted  
net earnings per common share) to be anti-dilutive. 
Accordingly for U.S. GAAP diluted net earnings per 
common share, the instruments were not assumed to be converted or exercised. Specifically, in fiscal 2019, certain of our outstanding preferred shares and share-based equity 
awards were not included in the diluted weighted average","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 82}"
,,"awards were not included in the diluted weighted average 
common shares outstanding. As a result of the non-GAAP 
Shave Care impairment adjustment, these instruments 
were dilutive for non-GAAP earnings per share.
Transitional Impacts of the U.S. Tax Act : The U.S. 
government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act  
(the “U.S. Tax Act”) in December 2017. This resulted in  
a net charge for the fiscal year 2018. The adjustment","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 82}"
,,"a net charge for the fiscal year 2018. The adjustment  
to core earnings includes only this transitional impact.  
It does not include the ongoing impacts of the lower  
U.S. statutory rate on pre-tax earnings.
We do not view these items to be part of our sustainable 
results and their exclusion from Core earnings per  
share provides a more comparable measure of year-  
on-year results.
Years ended June 30 2023 2022 2021 2020 2019 2018","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 82}"
,,"Years ended June 30 2023 2022 2021 2020 2019 2018
Diluted net earnings per common share $5.90 $5.81 $5.50 $4.96 $1.43 $3.67
Early debt extinguishment charges – – $0.16 – – $0.09
Incremental restructuring charges – – – $0.16 $0.13 $0.23
Gain on dissolution of PGT Healthcare partnership – – – – $(0.13) –
Shave Care impairment – – – – $3.03 –
Anti-dilutive impacts – – – – $0.06 –
Transitional impacts of the U.S. Tax Act – – – – – $0.23
Core EPS $5.90 $5.81 $5.66 $5.12 $4.52 $4.22","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 82}"
,,"Core EPS $5.90 $5.81 $5.66 $5.12 $4.52 $4.22
Core EPS growth vs. prior year 2% N/A N/A N/A N/A N/A
Currency Impact to Earnings $0.55 N/A N/A N/A N/A N/A
Currency neutral Core EPS $6.45 N/A N/A N/A N/A N/A
Currency neutral Core EPS growth 11% N/A N/A N/A N/A N/A
2018–2023 Core EPS growth 40% N/A N/A N/A N/A N/A","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 82}"
,,"72 • The Procter & Gamble Company
Board of Directors
B. Marc Allen
Chief Strategy Officer and Senior Vice President of 
Strategy and Corporate Development at The Boeing Company (aerospace, commercial jetliners, and military defense systems). Director since 2021. Age 50.
Sheila Bonini
Senior Vice President of Private Sector Engagement at the World Wildlife Fund (nonprofit wildlife conservation organization). Director since April 2023. Age 59.
Angela F. Braly","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 83}"
,,"Angela F. Braly
Former Chair of the Board, President and Chief Executive Officer of WellPoint, Inc. (healthcare insurance), now known as Elevance Health. Director since 2009. Also a Director of Brookfield Corporation and ExxonMobil Corporation. Age 62.
Amy L. Chang
Former Executive Vice President at Cisco Systems,  
Inc. (networking technology). Founder and former Chief Executive Officer of Accompany, Inc. (relationship intelligence). Director since 2017. Also a Director of","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 83}"
,,"The Walt Disney Company. Age 46.
Joseph Jimenez
Co-Founder and Managing Director of Aditum Bio  
(a biotech venture fund). Former Chief Executive Officer  
of Novartis AG (global healthcare). Director since 2018.  
Also a Director of General Motors, Graphite Bio, Inc.  
and Century Therapeutics, Inc. Age 63. Independent  
Lead Director.
Christopher Kempczinski
President and Chief Executive Officer of McDonald’s Corporation (restaurant operator and franchisor).","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 83}"
,,"Director since 2021. Also a Director of McDonald’s.  
Age 54.Debra L. Lee
Chair of Leading Women Defined Foundation (nonprofit education and advocacy organization). Former Chairman and Chief Executive Officer of BET Networks (media  
and entertainment). Director since 2020. Also a Director  
of Marriott International, Inc., Burberry Group plc, and Warner Bros. Discovery. Age 69.
Terry J. Lundgren","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 83}"
,,"Terry J. Lundgren
Former Executive Chairman, Chairman of the Board and Chief Executive Officer of Macy’s, Inc. (national retailer). Director since 2013. Age 71.
Christine M. McCarthy
Strategic Advisor and former Senior Executive Vice President and Chief Financial Officer of The Walt Disney Company (global entertainment). Director since 2019.  
Age 68.
Jon R. Moeller
Chairman of the Board, President and Chief Executive Officer of the Company. Director since 2021. Age 59.
Robert J. Portman","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 83}"
,,"Robert J. Portman
Former United States Senator, Director of the U.S. Office of Management and Budget, and United States Trade Representative. Director since April 2023. Age 67.
Rajesh Subramaniam
President and Chief Executive Officer of FedEx  
Corporation (transportation and business services). Director since 2022. Also a Director of FedEx. Age 57.
Patricia A. Woertz","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 83}"
,,"Patricia A. Woertz
Former Chairman of the Board and Chief Executive Officer of Archer Daniels Midland Company (agricultural origination and processing). Director since 2008. Age 70.
The Board of Directors Has Four Committees:
 •Audit
 •Compensation & Leadership Development
 •Governance & Public Responsibility
 •Innovation & Technology","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 83}"
,,"The Procter & Gamble Company • 73
Company Leadership
Jon R. Moeller
Chairman of the Board, President and Chief Executive Officer
Shailesh G. Jejurikar
Chief Operating Officer
Gary Coombe
Chief Executive Officer – Grooming
Executive Sponsor – Corporate Wellbeing
Jennifer Davis
Chief Executive Officer –  
Health CareMa. Fatima D. Francisco
Chief Executive Officer – Baby, Feminine and Family CareExecutive Sponsor – Gender Equality
R. Alexandra Keith
Chief Executive Officer – Beauty","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 84}"
,,"R. Alexandra Keith
Chief Executive Officer – Beauty  
Executive Sponsor – Corporate SustainabilitySundar G. Raman
Chief Executive Officer –  
Fabric & Home Care
Andre Schulten
Chief Financial Officer
Hesham Tohamy  
Abd El Hak
President – Feminine Care
Victor Aguilar
Chief Research, Development  
and Innovation Officer
Juliana Azevedo
President – Latin America
Laura Becker
President – Global Business Services
Eric Breissinger
President – Family Care
Vittorio Cretella
Chief Information Officer","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 84}"
,,"Vittorio Cretella
Chief Information Officer
Philip J. Duncan
Chief Design Officer
Christophe Duron
President – Go-To-Market,  
China, and Market Operations,  
Hong Kong and TaiwanPaul Gama
President – Personal Health Care
Virginie Helias
Chief Sustainability Officer
Damon Jones
Chief Communications Officer
Shelly McNamara
Chief Equality & Inclusion Officer
Ken Patel
Chief Ethics & Compliance Officer  
and Chief Patent Counsel
Guy Persaud
President – New Business
Matthew S. Price
President – Home Care and","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 84}"
,,"Matthew S. Price
President – Home Care and  
P&G Professional
Marc S. Pritchard
Chief Brand Officer
Bala Purushothaman
Chief Human Resources OfficerLuc Reynaert
Chief Product Supply Officer
Mindy Sherwood
President – Global Walmart  
and Chief Sales Officer
Kirti Singh
Chief Analytics and Insights Officer
Markus Strobel
President – Skin & Personal Care
Loïc Tassel
President – Europe
Monica Turner
President – North America
Stanislav Vecera
President – Asia Pacific,  
Middle East and Africa","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 84}"
,,"President – Asia Pacific,  
Middle East and Africa
Susan Street Whaley 
Chief Legal Officer and Secretary
Jasmine Xu
President – Greater China
A s of August 4, 2023 Visit us at us.pg.com/leadership-tea m to learn more about P&G’s global leaders.","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 84}"
,,"74 • The Procter & Gamble Company
Recognitions and Awards
P&G’s dedication to superiority allows us to serve the world’s consumers better and create 
shareholder value in the process. These recognitions demonstrate our impact as a force  
for growth and a force for good.
Brands  
& InnovationCommunity  
ImpactEquality  
& Inclusion Environmental 
SustainabilityEthics & Corporate 
Responsibility
DiversityInc Top Companies  
for Board of Directors
DiversityInc Top Companies  
for Mentoring","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 85}"
,,"DiversityInc Top Companies  
for Mentoring
2022 Circana New Products Pacesetter Report:
7 of the Top 25 non-food product launches
3BL M
edia 100 Best  
Corporate Citizens of 2022Barron’s Most Sustainable 
Companies 2023Forbes 2023 America’s Best 
Employers For Diversity
Fortune 2023 America’s  
Most Innovative CompaniesFortune 2023 World’s  
Most Admired CompaniesNewsweek Most Trustworthy 
Companies in America 2023
Score of 100 for 3rd consecutive year
The pape","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 85}"
,,"Score of 100 for 3rd consecutive year
The pape
r utilized in the printing of this annual report is certified to the  
FSC® Standards, which promotes environmentally appropriate, socially 
beneficial and economically viable management of the world’s forests.Logos are property of their respective  
owners; used with permission.
Design: Madison Design","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 85}"
,,"P&G’s Portfolio
Ten Categories Organized  
in Five Operating Sectors
P&G has a focused portfolio of daily-
use products in categories where performance plays a significant role in brand choice. Our focus is on delivering superior products with the best performance, in every price tier in  which we compete.HEALTH CARE
Personal Health Care
 Oral Care
FABRIC AND HOME CARE
Fab
ric Care
 Hom
e Care
BEAUTY
Skin & Personal Care Hair CareGROOMING
Grooming
B
ABY, FEMININE AND FAMILY CARE
Bab
y Care
 Fe
minine Care","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 86}"
,,"B
ABY, FEMININE AND FAMILY CARE
Bab
y Care
 Fe
minine Care
 Family Care","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 86}"
,,"Explore the digital version of  
the P&G 2023 Annual Report  
at pg.com/annualreport2023
© 2023 Procter & Gamble • 00387138","{'source': './sample/Procter&Gamble_annualreport_2023.pdf', 'page': 87}"
